Document:

DEBT
PURCHASE AGREEMENT

 

This
Debt Purchase Agreement (the “Agreement”) made as of this 7th day of April 2017, by and between Eagle Equities, LLC
(the “Buyer or Investor”) and Bellridge Capital LLC (the “Seller”).

 

1.PURCHASE
AND SALE OF THE CONVERTIBLE NOTE

 

Upon
the terms and conditions herein contained, at the Closing (as hereinafter defined), the Seller hereby sells, assigns and transfers
to the Buyer and the Buyer agrees to purchase from the Seller the “Transferred Rights” of the Seller and all rights
thereto, free and clear of all liens, claims, pledges, mortgages, restrictions (other than as set forth in the Notes (which are
the subject of the Transferred Rights) and securities purchase agreement for pursuant to which the Note was purchased), obligations,
security interests and encumbrances of any kind, nature and description. Transferred Rights shall mean all rights with respect
to the principal and accrued interest under the series of convertible notes of Endonovo Therapeutics, Inc. (“Borrower”
or “Company”) issued to the Seller and listed below, true and correct copies which have been provided to New Venture
Attorneys, P.C. (collectively, the “Note”). By its signatures hereto the Borrower accepts the assignment of the Transferred
Rights to Buyer and agrees that Buyer may convert the Transferred Rights into shares of the Company’s common stock.

 

	Note
    Date	 	Face
    Amount	 	 	Outstanding
    Principal

 to be purchased	 	 	Accrued
    Interest
	July
    8, 2016	 	$	400,000	 	 	$	320,000	 	 	$14,255.34
	August 5, 2016	 	$	200,000	 	 	$	200,000	 	 	TBD at time of purchase
	October 19, 2016	 	$	400,000	 	 	$	400,000	 	 	TBD at time of purchase

 

2.
CONSIDERATION

 

The
purchase price for the Transferred Rights shall be the Buyer’s payments aggregating a total of $920,000 in principal and
all accrued interest (the “Purchase Price”) for the 3 notes listed above, to the Seller, in accordance with the wiring
instructions attached as Exhibit A.

 

3.
CLOSING

 

The
closings of the transactions contemplated by this Agreement (the “Closing”) shall take place

simultaneously
with the assignment of each purchased note against the delivery of funds in the amount of outstanding principal plus accrued interest
for the note being purchased. At each Closing, the funds will be wired as set forth in Exhibit A. Upon the receipt of the funds
set forth above, the Seller will release the reserves associated with the Note (if any) to the Buyer. Each closing is subject
to the following conditions: (i) the Company’s Common stock is not “chilled” by DTC, (ii) the Company is current
in its periodic filings with the Securities and Exchange Commission, (iii) the Company has a “bid” price for its Common
Stock and (iv) the Company has shares available to reserve three times the discounted amount of the purchased principal and accrued
interest at the time of purchase, or as long as the Company is proceeding in good faith with such filings and the necessary approvals,
to fulfil the reserve.

 

    	 

    	 

    

 

The
projected timetable for each closing is as follows:

 

	Purchased
    Note	Purchase
    Date
	7-8-16
    Note	April
    10, 2017
	8-5-16
    Note	+
    30 days
	10-19-16
    Note (first $200,000)	+
    30 days from purchase 8-5-16 Note
	10-19-16
    Note (next $200,000)	+
    30 days from prior purchase

 

The
Buyer shall have a 5-day grace period for the purchase of the above notes. The Buyer shall have the right, but not the obligation,
to accelerate the purchases set forth above.

 

4.
REPRESENTATIONS AND WARRANTIES OF SELLER. The Seller hereby represents and warrants to the Buyer as follows:

 

4.1
Status of the Seller and the Note. The Seller is the beneficial owner of the Note, and the Note is free and clear of all
mortgages, pledges, restrictions, liens, charges, encumbrances, security interests, obligations or other claims. Other than the
Notes referenced above the Seller has not owned any other Notes of the Company and does not own any other Note(s) of the Company.
Provided that (i) all of the above-referenced Notes are purchased as stated in this Agreement, (ii) by August 15, 2017 Seller
has received an aggregate purchase price of $920,000 plus accrued interest of 6% per annum, and such purchase price is received
by the Seller by such date and (iii) the shares referenced in the Share Purchase Agreement dated the date hereof between the Buyer
and the Seller have been purchased as set forth in the Share Purchase Agreement the Seller waives any event of default that may
exist under the Notes.

 

4.2
Authorization; Enforcement. (i) Seller has all requisite corporate power and authority to enter into and perform the Agreement
and to consummate the transactions contemplated hereby and to sell each Note, in accordance with the terms hereof, (ii) the execution
and delivery of this Agreement by the Seller and the consummation by it of the transactions contemplated hereby (including, without
limitation, the sale of the Note to the Buyer) have been duly authorized by the Seller and no further consent or authorization
of the Seller or its members is required, (iii) this Agreement has been duly executed and delivered by the Seller, and (iv) this
Agreement constitutes a legal, valid and binding obligation of the Seller enforceable against the Seller in accordance with its
terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
or similar laws relating to, or affecting generally, the enforcement of creditors’ rights and remedies or by other equitable
principles of general application.

 

4.3
No Conflicts. The execution, delivery and performance of this Agreement by the Seller and the consummation by the Seller
of the transactions contemplated hereby (including, without limitation, the sale of the Note to the Buyer) will not (i) conflict
with or result in a violation of any provision of its certificate of formation or other organizational documents, or (ii) violate
or conflict with or result in a breach of any provision of, or constitute a default (or an event which with notice or lapse of
time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, note, bond, indenture or other instrument to which Seller are a party, or (iii) result in a violation of any
law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations and regulations
of any self-regulatory organizations to which Seller are subject) applicable to Seller or the Note is bound or affected. The Seller
is not required to obtain any consent, authorization or order of, or make any filing or registration with, any court, governmental
agency, regulatory agency, self-regulatory organization or stock market or any third party (other than the Company) in order for
it to execute, deliver or perform any of its obligations under this Agreement in accordance with the terms hereof.

 

    	 

    	 

    

 

4.4
Title; Rule 144 Matters. Seller has good and marketable title to the Note, free and clear of all liens, restrictions, pledges
and encumbrances of any kind. Seller is not an “Affiliate” of the Company, as that term is defined in Rule 144 of
the Securities Act of 1933, as amended (the “1933 Act”).

 

4.5
Consent of the Company.

 

(i)
The Company, as evidence by its signature at the foot of this Agreement, hereby represents and warrants that, upon delivery to
the Company of the Note, the Company shall promptly cause to be issued to and in the name of Buyer one of more new executed Notes
in the purchased amount, but otherwise having the sale terms (including, but not necessarily limited to, referring to the original
issue date) as in the Note. The Note may contain the same restrictive legend as provided in the original Note, but no stop transfer
order. The Notes are currently outstanding in the entire amount stated and represents bona fide debt obligation of the Company.

 

(ii)
The signature by the Company also represents the Company’s agreement to treat Buyer as a party to, and having all the rights
of the Seller with respect to the Transferred Rights.

 

5. REPRESENTATIONS,
WARRANTIES AND ACKNOWLEDGEMENTS OF THE BUYER. The Buyer hereby represents warrants and acknowledges to the Seller as
follows:

 

5.1
Accredited Investor. The Buyer has sufficient knowledge and experience of financial and business matters, is able to evaluate
the merits and risks of the partial purchase of the Note and has had substantial experience in previous private and public purchases
of securities. The Buyer is an “accredited investor” as that term is defined in Rule 501 of Regulation D of the Securities
Act of 1933, as amended.

 

5.2
Authorization; Enforcement. (i) Buyer has all requisite corporate power and authority to enter into and perform the Agreement
and to consummate the transactions contemplated hereby and to purchase each Note, in accordance with the terms hereof, (ii) the
execution and delivery of this Agreement by the Buyer and the consummation by it of the transactions contemplated hereby (including,
without limitation, the purchase of the Note by the Buyer) have been duly authorized by the Buyer and no further consent or authorization
of the Buyer or its members is required, (iii) this Agreement has been duly executed and delivered by the Buyer, and (iv) this
Agreement constitutes a legal, valid and binding obligation of the Buyer enforceable against the Buyer in accordance with its
terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
or similar laws relating to, or affecting generally, the enforcement of creditors’ rights and remedies or by other equitable
principles of general application.

 

    	 

    	 

    

 

5.3
No Conflicts. The execution, delivery and performance of this Agreement by the Buyer and the consummation by the Buyer
of the transactions contemplated hereby will not (i) conflict with or result in a violation of any provision of its certificate
of formation or other organizational documents, or (ii) violate or conflict with or result in a breach of any provision of, or
constitute a default (or an event which with notice or lapse of time or both could become a default) under, or give to others
any rights of termination, amendment, acceleration or cancellation of, any agreement, note, bond, indenture or other instrument
to which Buyer is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal
and state securities laws and regulations and regulations of any self-regulatory organizations to which Buyer is subject) applicable
to Seller or the Note is bound or affected. The Buyer is not required to obtain any consent, authorization or order of, or make
any filing or registration with, any court, governmental agency, regulatory agency, self-regulatory organization or stock market
or any third party in order for it to execute, deliver or perform any of its obligations under this Agreement in accordance with
the terms hereof.

 

6.
MISCELLANEOUS

 

6.1 Binding Effect;
Benefits. This Agreement shall inure to the benefit of, and shall bebinding upon, the parties hereto and their respective successors
and permitted assigns. Except as otherwise set forth herein, this Agreement may not be assigned by any party hereto without the
prior written consent of the Company. Except as otherwise set forth herein, nothing in this Agreement, expressed or implied, is
intended to confer on any person other than the parties hereto or their respective successors and permitted assigns any rights,
remedies, obligations or liabilities under or by any reason of this Agreement.

 

6.2
Notices. All notices, requests, demands and other communications which are required to be or may be given under this Agreement
shall be in writing and shall be deemed to have been duly given when delivered in person, or transmitted by telecopy or telex,
or upon receipt after dispatch by certified or registered first class mail, postage prepaid, return receipt requested, to the
party to whom the same is so given or made, at the following addresses (or such others as shall be provided in writing hereafter):

 

(a)
If to the Buyer to:

 

Eagle
Equities, LLC

91
Shelton Avenue, Suite 107

New
Haven, CT 06511

Attn:
Yakov Borenstein

 

    	 

    	 

    

 

(b)
If to the Seller to:

Bellridge
Capital, LLC

5150
E. Las Olas Blvd suite 120a

Fort
Lauderdale, FL 33301

Attn:
Robert Klimov

 

6.3
Entire Agreement. This Agreement constitutes the entire agreement and supersedes all prior agreements and understandings,
oral and written, between the parties hereto with respect to the subject matter hereof.

 

6.4
Further Assurances. After the Closing, at the request of either party, the other party shall execute, acknowledge and deliver,
without further consideration, all such further assignments, conveyances, endorsements, deeds, powers of attorney, consents and
other documents and take such other action as may be reasonably requested to consummate the transactions contemplated by this
Agreement.

 

6.5
Headings. The section and other headings contained in this Agreement are for reference purposes only and shall not be deemed
to be part of this Agreement or to affect the meaning or interpretation of this Agreement.

 

6.6
Counterparts. This Agreement may be executed in any number of counterparts and by facsimile, each of which, when executed,
shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.

 

6.7
Governing Law. This Agreement shall be construed as to both validity and performance and enforced in accordance with and
governed by the laws of the State of New York, without giving effect to the conflicts of law principles thereof.

 

6.8
Severability. If any term or provision of this Agreement shall to any extent be invalid or unenforceable, the remainder
of this Agreement shall not be affected thereby, and each term and provision of the Agreement shall be valid and enforced to the
fullest extent permitted by law.

 

6.9
Amendments. This Agreement may not be modified or changed except by an instrument or instruments in writing executed by
the parties hereto.

 

6.10
Release. Provided that (i) all of the above-referenced Notes are purchased as stated in this Agreement (ii) by August 15,
2017 Seller has received an aggregate purchase price of $920,000 plus accrued interest of 6% per annum, and (iii) the shares referenced
in the Share Purchase Agreement dated the date hereof between the Buyer and the Seller have been purchased as set forth in the
Share Purchase Agreement, the Seller and the Company shall at that time automatically release each other from any and all claims
and liabilities between the two parties.

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

 

	 	BUYER:
	 	 	 
	 	Eagle
    Equities, LLC
	 	 	 
	 	By:	 
	 	Yakov
    Borenstein, Managing Member
	 	 	 
	 	SELLER:
	 	 	 
	 	BELLRIDGE
    CAPITAL, LLC.
	 	 	 
	 	By:	
	 	 	Robert
    Klimov, Managing Partner

 

	ACCEPTED
    AND AGREED:	 
	 	 	 
	ENDONOV
    THERAPEUTICS, INC.	 
	 	 	 
	By:	 	 
	 	 	 
	Title:	 	 

 

    	 

    	 

    

 

EXHIBIT
A

WIRE
INSTRUCTIONS FOR SELLER

 

[INSERT
WIRING INFO]

 

    	 

    	 

    

 

NON-AFFILIATION
LETTER

 

April
5, 2017

 

Counsel
to Eagle Equities, LLC

 

Gentlemen:

 

Please
let this letter serve as confirmation that LLC is not now, and has not been during the preceding 90 days, an officer, director,
10% or more shareholder of Endonovo Therapeutics, Inc., or in any other way an “affiliate” (as that term is defined
in Rule 144(a)(1) adopted pursuant to the Securities Act of 1933, as amended) of said issuer.

 

	Very
    truly yours,	 
	 	 
	BELLRIDGE
    CAPITAL, LLC.	 
	 	 	 
	By:
    	 	 
	 	 	 
	Title:Exhibit 10.1

 

 

FORM OF SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE AGREEMENT (the
“Agreement”), dated as of [_____], 2017, is by and among Amyris, Inc., a Delaware corporation (the “Company”),
and [_______] (the “Investor”).

 

RECITALS

 

A.       The
Company and the Investor desire to enter into this transaction to purchase the Securities (as defined below) set forth herein pursuant
to the Registration Statement (as defined below) that has been declared effective in accordance with the Securities Act of 1933,
as amended (the “Securities Act”), by the United States Securities and Exchange Commission (the “SEC”).
“Registration Statement” means the effective registration statement on Form S-3 (Commission File No. 333-203216)
filed by the Company with the SEC pursuant to the Securities Act for the registration of certain of its securities, including the
Securities, as such Registration Statement has been or may be amended and supplemented from time to time, including all documents
filed as part thereof or incorporated by reference therein, and including all information deemed to be a part thereof at the time
of effectiveness pursuant to Rule 430B of the Securities Act, including any comparable successor registration statement filed by
the Company with the SEC pursuant to the Securities Act for the registration of shares of its Common Stock, including the Securities.

 

B.       The
Company has authorized the issuance of convertible notes, in the aggregate original principal amount of $15,000,000, in the form
attached hereto as Exhibit A (the “Notes”), which Notes shall be convertible into shares of Common
Stock (as defined below) in accordance with the terms of the Notes. “Common Stock” means (i) the Company’s
common stock, par value $0.0001 per share, and (ii) any capital stock into which such common stock shall have been changed or any
share capital resulting from a reclassification of such common stock.

 

C.        The
Investor wishes to purchase, and the Company wishes to sell, upon the terms and subject to the conditions stated in this Agreement,
(i) at the Initial Closing (as defined below), a Note in the original principal amount of $7,000,000 (the “Initial Note”)
(and the Common Stock issuable upon conversion, redemption or amortization thereof, collectively, the “Initial Conversion
Shares”), and (ii) at the Additional Closing (as defined below), if any, a Note in the original principal amount of $8,000,000
(the “Additional Note”) (and the Common Stock issuable upon conversion, redemption or amortization thereof,
collectively, the “Additional Conversion Shares” and, collectively with the Initial Conversion Shares, the “Conversion
Shares”).

 

D.       The
Notes are entitled to redemption and amortization payments and certain other amounts, which, at the option of the Company and subject
to certain conditions, may be paid in shares of Common Stock or in cash.

 

E.       The
Notes and the Conversion Shares are collectively referred to herein as the “Securities.”

 

F.       The
parties have agreed that the obligation to repay the Notes shall be an unsecured obligation of the Company.

 

     

     

    

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the premises
and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Company and the Investor hereby agree as follows:

 

		1.	PURCHASE AND SALE OF NOTES.

 

 (a)           Initial Note. Subject to the satisfaction (or, where legally permissible, the waiver) of the conditions set forth in Section 6, the Company shall issue and sell to the Investor, and the Investor shall purchase from the Company on the Initial Closing Date (as defined below), the Initial Note (the “Initial Closing”).

 

 (b)           Additional Note. Subject to the satisfaction (or, where legally permissible, the waiver) of the conditions set forth in Sections 1(f)(ii) and 6, upon the election of the Investor in its sole and absolute discretion, the Company shall issue and sell to the Investor, and the Investor shall purchase from the Company on the Additional Closing Date (as defined below), the Additional Note (the “Additional Closing”).

 

		(c)	Form of Payment.

 

(i)                
Initial Closing. On the Initial Closing Date, (A) the Investor shall pay the Initial Purchase Price (as defined below)
(less the amounts withheld pursuant to Section 4(g)) to the Company for the Initial Note to be issued and sold to the Investor
at the Initial Closing, by wire transfer of immediately available funds in accordance with the Company’s written wire instructions
and (B) immediately following the Company’s receipt of such amount, the Company shall deliver to the Investor the Initial
Note duly executed on behalf of the Company and registered in the name of the Investor or its designee.

 

(ii)              
Additional Closing. On the Additional Closing Date, if any, (A) the Investor shall pay the Additional Purchase Price
(as defined below) to the Company for the Additional Note to be issued and sold to the Investor at the Additional Closing, by wire
transfer of immediately available funds in accordance with the Company’s written wire instructions and (B) immediately
following the Company’s receipt of such amount, the Company shall deliver to the Investor the Additional Note duly executed
on behalf of the Company and registered in the name of the Investor or its designee.

 

(d)             
Rank. The parties hereto acknowledge that the Initial Note and the Additional Note shall be part of a single series
of notes and shall rank pari passu with each other and with the convertible note in the original principal amount of $10,000,000
issued by the Company to the Investor on December 1, 2016 (the “December 2016 Convertible Note”).

 

(e)              
Purchase Price. The purchase price for the Initial Note to be purchased by the Investor shall be $7,000,000 (the
“Initial Purchase Price”). The purchase price for the Additional Note, if any, to be purchased by the Investor
shall be $8,000,000 (the “Additional Purchase Price,” and together with the Initial Purchase Price, each, a
“Purchase Price”).

 

    	 	2	 

     

    

 

 (f)                Closings. The Initial Closing and the Additional Closing are each sometimes referred to in this Agreement as a “Closing”. Each Closing shall occur at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., 666 Third Avenue, New York, NY 10017. As used herein “Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law to remain closed.

 

(i)                
Initial Closing. The date and time of the Initial Closing (the “Initial Closing Date”) shall be
10:00 a.m., New York time, on the first (1st) Trading Day (as defined below) (and including the date hereof if a Trading
Day) on which the conditions to the Initial Closing set forth in Section 6 below are satisfied or waived (or such later date as
is mutually agreed to by the Company and the Investor).

 

(ii)              
Additional Closing. Subject to the satisfaction (or, where legally permissible, the waiver) of the conditions set
forth in this Section 1(f)(ii) and Section 6 below, the Investor shall have the right, in its sole and absolute discretion, but
not the obligation, to require the Company to sell to the Investor the Additional Note on the Additional Closing Date by delivering
to the Company, in accordance with Section 8(f) hereof, an irrevocable written notice that the Investor has exercised its right
to require the Company to sell the Additional Note (the “Additional Closing Notice,” and such date, the “Additional
Closing Notice Date”). Notwithstanding anything herein to the contrary, if the Additional Closing does not occur by December
31, 2017, the Investor’s right to effect an Additional Closing hereunder shall automatically terminate. If the Investor delivers
an Additional Closing Notice in accordance with this Section 1(f)(ii), the date and time of the Additional Closing shall be 10:00
a.m., New York time, on a date that is no later than the third (3rd) Trading Day next following the later of (i) the
Additional Closing Notice Date and (ii) the date on which the conditions to the Additional Closing set forth in Section 6 below
are satisfied or waived (or such later date as is mutually agreed to by the Company and the Investor) (the “Additional
Closing Date,” and the Initial Closing Date and the Additional Closing Date are each sometimes referred to in this Agreement
as a “Closing Date”).

 

		2.	INVESTOR’S REPRESENTATIONS AND WARRANTIES.

 

The Investor represents and warrants to the
Company, as of the Initial Closing Date and the Additional Closing Date, that:

 

(a)               
Organization; Authority. The Investor is an entity duly organized, validly existing and in good standing under the
laws of the jurisdiction of its organization with the requisite power and authority to enter into and to consummate the transactions
contemplated by the Transaction Documents (as defined below) to which it is a party and otherwise to carry out its obligations
hereunder and thereunder.

 

(b)              
Validity; Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the
Investor and constitutes the legal, valid and binding obligations of the Investor enforceable against the Investor in accordance
with its terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable
creditors’ rights and remedies.

 

(c)               
No Conflicts. The execution, delivery and performance by the Investor of this Agreement and the consummation by the
Investor of the transactions contemplated hereby will not (i) result in a violation of the organizational documents of the Investor,
(ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under,
or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument
to which the Investor is a party or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including
federal and state securities laws) applicable to the Investor, except, in the case of clauses (ii) and (iii) above, for such conflicts,
defaults, rights or violations which would not, individually or in the aggregate, reasonably be expected to have a material adverse
effect on the ability of the Investor to perform its obligations hereunder.

 

    	 	3	 

     

    

 

(d)              
Selling Materials. Other than the Registration Statement, the Prospectus and, when delivered, the Prospectus Supplement,
the Investor has not received from the Company any written offering materials with respect to the transactions contemplated hereby.

 

		3.	REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

Except as set forth in the Registration Statement,
the Prospectus or the SEC Documents, the Company represents and warrants to the Investor, as of the Initial Closing Date and the
Additional Closing Date, that:

 

(a)               
Organization and Qualification. Each of the Company and each of its Subsidiaries are entities duly organized and
validly existing and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite power
and authorization to own their properties and to carry on their business as now being conducted and as presently proposed to be
conducted. Each of the Company and each of its Subsidiaries is duly qualified as a foreign entity to do business and is in good
standing in every jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so qualified or be in good standing would not have a Material Adverse Effect.
“Material Adverse Effect” means any material adverse effect on (i) the business, properties, assets, liabilities,
operations (including results thereof) or financial condition of the Company and its Subsidiaries, taken as a whole, (ii) the transactions
contemplated hereby or in any of the other Transaction Documents or (iii) the authority or ability of the Company to perform any
of its obligations under any of the Transaction Documents; provided, however, that no facts, circumstances, changes
or effects resulting from, relating to or arising out of the following, individually or in the aggregate, shall be taken into account
in determining whether a Material Adverse Effect has occurred or insofar as reasonably can be foreseen would likely occur: (a) changes
in conditions in the U.S. or global capital, credit or financial markets generally, including changes in the availability of capital
or currency exchange rates, provided such changes shall not have affected the Company in a materially disproportionate manner as
compared to other similarly situated companies; (b) changes generally affecting the industries in which the Company and its
Subsidiaries operate, provided such changes shall not have affected the Company in a materially disproportionate manner as compared
to other similarly situated companies; and (c) any effect of the announcement of, or the consummation of the transactions
contemplated by, this Agreement and the other Transaction Documents on the Company’s relationships, contractual or otherwise,
with customers, suppliers, vendors, bank lenders, strategic venture partners or employees. Other than the Persons (as defined below)
set forth on Schedule 3(a), the Company has no Subsidiaries. “Subsidiaries” means any Person in which the Company,
directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or similar interest of such Person or
(II) controls or operates all or any part of the business, operations or administration of such Person, and each of the foregoing,
is individually referred to herein as a “Subsidiary.”

 

    	 	4	 

     

    

 

(b)              
Authorization; Enforcement; Validity. The Company has the requisite power and authority to enter into and perform
its obligations under this Agreement and the other Transaction Documents and to issue the Securities in accordance with the terms
hereof and thereof. The execution and delivery of this Agreement and the other Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Notes and
the reservation for issuance and issuance of the Conversion Shares issuable upon conversion of the Notes) have been duly authorized
by the Company’s board of directors and (other than the filing with the SEC of the Prospectus Supplement (as defined below)
supplementing the Prospectus (as defined below) forming part of the Registration Statement and the 8-K Filing (as defined herein),
and any other filings as may be required by any state securities agencies) no further filing, consent or authorization is required
by the Company, its board of directors or its stockholders or other governing body. This Agreement has been, and the other Transaction
Documents will be prior to the Closing, duly executed and delivered by the Company, and each constitutes the legal, valid and binding
obligations of the Company, enforceable against the Company in accordance with its respective terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except
as rights to indemnification and to contribution may be limited by federal or state securities law. “Transaction Documents”
means, collectively, this Agreement, the Notes, the Irrevocable Transfer Agent Instructions (as defined below) and each of the
other agreements and instruments entered into or delivered by any of the parties hereto in connection with the transactions contemplated
hereby and thereby, as may be amended from time to time. “Prospectus Supplement” means the prospectus supplement
to the Prospectus relating to the Securities complying with Rule 424(b) under the Securities Act that is filed with the SEC and
delivered by the Company to the Investor upon the execution and delivery of this Agreement in accordance with Section 4(b), including
the documents incorporated by reference therein, and any amendment or supplement thereto. “Prospectus” means
the Company’s final base prospectus, dated April 9, 2015, a preliminary form of which is included in the Registration Statement,
including the documents incorporated by reference therein, and any amendment or supplement thereto.

 

    	 	5	 

     

    

 

(c)               
Issuance of Securities; Registration Statement. The issuance of the Notes is duly authorized and, upon issuance in
accordance with the terms of the Transaction Documents, will be validly issued, fully paid and non-assessable and free from all
preemptive or similar rights, taxes, liens, charges and other encumbrances with respect to the issue thereof. As of the Closing,
the Company shall have reserved from its duly authorized capital stock not less than 150% of the maximum number of Conversion Shares
issuable upon conversion of the Notes and without taking into account any limitations on the conversion of the Notes set forth
therein. The issuance of the Conversion Shares is duly authorized, and upon conversion in accordance with the Notes, the Conversion
Shares, when issued, will be validly issued, fully paid and non-assessable and free from all preemptive or similar rights, taxes,
liens, charges and other encumbrances with respect to the issue thereof, with the holders thereof being entitled to all rights
accorded to a holder of Common Stock. The issuance by the Company of the Securities has been registered under the Securities Act,
the Securities are being issued pursuant to the Registration Statement and all of the Securities are freely transferable and freely
tradable by Investor without restriction. The Registration Statement is effective and available for the issuance of the Securities
thereunder and the Company has not received any notice that the SEC has issued or intends to issue a stop-order with respect to
the Registration Statement or that the SEC otherwise has suspended or withdrawn the effectiveness of the Registration Statement,
either temporarily or permanently, or intends or has threatened in writing to do so. The “Plan of Distribution” section
under the Registration Statement permits the issuance and sale of the Securities hereunder and as contemplated by the other Transaction
Documents. Upon receipt of the Securities, the Investor will have good and marketable title to the Securities. The Registration
Statement and any prospectus included therein, including the Prospectus and the Prospectus Supplement, complied in all material
respects with the requirements of the Securities Act and the rules and regulations of the SEC promulgated thereunder and all other
applicable laws and regulations. At the time the Registration Statement and any amendments thereto became effective, at the date
of this Agreement and at each deemed effective date thereof pursuant to Rule 430B(f)(2) under the Securities Act, the Registration
Statement and any amendments thereto complied and will comply in all material respects with the requirements of the Securities
Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendments or supplements thereto
(including, without limitation the Prospectus Supplement), at the time the Prospectus or any amendment or supplement thereto was
issued and at the Closing Date, complied, and will comply, in all material respects with the requirements of the Securities Act
and did not, and will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in light of the circumstances under which they were made, not misleading. The Company meets all
of the requirements for the use of Form S-3 under the Securities Act for the offering and sale of the Securities contemplated by
this Agreement and the other Transaction Documents, and the SEC has not notified the Company of any objection to the use of the
form of the Registration Statement pursuant to Rule 401(g)(1) under the Securities Act. The Registration Statement meets the requirements
set forth in Rule 415(a)(1)(x) under the Securities Act. At the earliest time after the filing of the Registration Statement that
the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Securities Act)
relating to any of the Securities, the Company was not and is not an “Ineligible Issuer” (as defined in Rule 405 under
the Securities Act). The Company (i) has not distributed any offering material in connection with the offer or sale of any of the
Securities and (ii) until the Investor no longer holds any of the Securities, shall not distribute any offering material in connection
with the offer or sale of any of the Securities to, or by, the Investor (if required), in each case, other than the Registration
Statement, the Prospectus or the Prospectus Supplement.

 

    	 	6	 

     

    

 

(d)              
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Notes, and
the reservation for issuance and issuance of the Conversion Shares issuable upon conversion of the Notes) will not (i) result in
a violation of the Charter (as defined below) (including, without limitation, any certificate of designation contained therein)
or other organizational documents of the Company or any of its Subsidiaries, any capital stock of the Company, or Bylaws (as defined
below) or the bylaws of any of its Subsidiaries, (ii) conflict with, or constitute a default (or an event which with notice or
lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party or (iii) result in a violation
of any law, rule, regulation, order, judgment or decree (including, without limitation, foreign, federal and state securities laws
and regulations and the rules and regulations of The NASDAQ Stock Market (the “Principal Market”)) applicable
to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound
or affected, other than, in the case of clause (ii) above, for such conflicts, defaults or rights that could not reasonably be
expected to have a Material Adverse Effect. Without limiting the generality of the foregoing, at the maturity dates of the Notes
or at any other times when payments are required to be made in cash pursuant to the terms of the Notes, there shall be no covenant,
agreement, arrangement, prohibition, limitation or restriction in effect that would prohibit, limit, restrict, delay, conflict
with or impair the ability or right of the Company to repay in cash all outstanding principal and other amounts outstanding under
the Notes.

 

(e)               
Consents. The Company is not required to obtain any consent from, authorization or order of, or make any filing or
registration with (other than the filing with the SEC of the Prospectus Supplement and the 8-K Filing and any other filings as
may be required by any state securities agencies), any court, governmental agency or any regulatory or self-regulatory agency or
any other Person in order for it to execute, deliver or perform any of its respective obligations under, or contemplated by, the
Transaction Documents, in each case, in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings
and registrations which the Company is required to obtain at or prior to the Closing have been obtained or effected on or prior
to the Closing Date, and neither the Company nor any of its Subsidiaries are aware of any facts or circumstances which might prevent
the Company from obtaining or effecting any of the registration, application or filings contemplated by the Transaction Documents.
The Company is not in violation of the requirements of the Principal Market and has no knowledge of any facts or circumstances
which could reasonably lead to delisting or suspension of the Common Stock in the foreseeable future.

 

(f)               
Acknowledgment Regarding Investor’s Purchase of Securities. The Company acknowledges and agrees that the Investor
is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions
contemplated hereby and thereby and that the Investor is not (i) an officer or director of the Company or any of its Subsidiaries,
(ii) an “affiliate” (as defined in Rule 144 promulgated under the Securities Act (or a successor rule thereto) (collectively,
“Rule 144”)) of the Company or any of its Subsidiaries or (iii) to its knowledge, a “beneficial owner”
of more than 10% of the Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”)). The Company further acknowledges that the Investor is not acting as a financial advisor
or fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and
the transactions contemplated hereby and thereby, and any advice given by the Investor or any of its representatives or agents
in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to the Investor’s
purchase of the Securities. The Company further represents to the Investor that the Company’s decision to enter into the
Transaction Documents has been based solely on the independent evaluation by the Company and its representatives.

 

    	 	7	 

     

    

 

(g)              
Placement Agent’s Fees. The Company shall be responsible for the payment of any placement agent’s fees,
financial advisory fees, or brokers’ commissions (other than for Persons engaged by the Investor or its investment advisor)
relating to or arising out of the transactions contemplated hereby. Neither the Company nor any of its Subsidiaries has engaged
any placement agent or other agent in connection with the offer or sale of the Securities.

 

(h)              
No Integrated Offering. None of the Company, its Subsidiaries or any of their affiliates, nor, to the knowledge of
the Company, any Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited
any offers to buy any security, under circumstances that would cause this offering of the Securities to require approval of stockholders
of the Company under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations
of any exchange or automated quotation system on which any of the securities of the Company are listed or designated for quotation.
None of the Company, its Subsidiaries, their affiliates nor, to the knowledge of the Company, any Person acting on their behalf
will take any action or steps that would cause the offering of any of the Securities to be integrated with other offerings of securities
of the Company.

 

(i)                
Dilutive Effect. The Company understands and acknowledges that the number of Conversion Shares will increase in certain
circumstances. The Company further acknowledges that its obligation to issue the Conversion Shares upon conversion of the Notes
in accordance with this Agreement and the Notes is absolute and unconditional (subject to any limitations on conversion as set
forth in the Notes), regardless of the dilutive effect that such issuance may have on the ownership interests of other stockholders
of the Company.

 

(j)                
Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary
action, if any, in order to render inapplicable any control share acquisition, interested stockholder, business combination, poison
pill (including, without limitation, any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover
provision under the Charter, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise
which is or could become applicable to the Investor as a result of the transactions contemplated by this Agreement, including,
without limitation, the Company’s issuance of the Securities and the Investor’s ownership of the Securities. The Company
and its board of directors have taken all necessary action, if any, in order to render inapplicable any stockholder rights plan
or similar arrangement relating to accumulations of beneficial ownership of Common Stock or a change in control of the Company
or any of its Subsidiaries.

 

    	 	8	 

     

    

 

(k)              
SEC Documents; Financial Statements. During the one (1) year prior to the date hereof, the Company has timely filed
all reports, schedules, forms, proxy statements, statements and other documents required to be filed by it with the SEC pursuant
to the reporting requirements of the Exchange Act (all of the foregoing filed prior to the date hereof and all exhibits and appendices
included therein and financial statements, notes and schedules thereto and documents incorporated by reference therein being hereinafter
referred to as the “SEC Documents”). The Company has delivered to the Investor or its representative true, correct
and complete copies of each of the SEC Documents not available on the EDGAR system. As of their respective dates, the SEC Documents
complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated
thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. As of their respective
dates, the financial statements of the Company included in the SEC Documents complied in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC with respect thereto as in effect as of the time of
filing. Such financial statements have been prepared in accordance with generally accepted accounting principles, consistently
applied, during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto,
or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements)
and fairly present in all material respects the financial position of the Company as of the dates thereof and the results of its
operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments
which will not be material, either individually or in the aggregate). No other information provided by or on behalf of the Company
to the Investor which is not included in the SEC Documents contains any untrue statement of a material fact or omits to state any
material fact necessary in order to make the statements therein not misleading, in the light of the circumstance under which they
are or were made. The Company is not contemplating amending or restating any of the financial statements (including without limitation,
any notes or any letter of any independent accountant of the Company with respect thereto) included in any of the SEC Documents
(the “Financial Statements”). No facts or circumstances exist that would require the Company to amend or restate
any of the Financial Statements in order for each of the Financial Statements to be in compliance with generally accepted accounting
principles and applicable law (including, without limitation, the rules and regulations of the SEC). The Company has not been informed
by any of its independent accountants that they recommend that the Company amend or restate any of the Financial Statements or
that there is any need for the Company to amend or restate any of the Financial Statements.

 

(l)                
Absence of Certain Changes. Since the date of the Company’s most recent audited financial statements contained
in an Annual Report on Form 10-K, except as disclosed in the SEC Documents filed subsequent to such Form 10-K, there has been no
Material Adverse Effect. Since the date of the Company’s most recent audited financial statements contained in an Annual
Report on Form 10-K, neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets
outside of the ordinary course of business or (iii) made any capital expenditures outside of the ordinary course of business. Neither
the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to any law or statute relating to bankruptcy,
insolvency, reorganization, receivership, liquidation or winding up, nor does the Company or any Subsidiary have any knowledge
or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy proceedings or any actual
knowledge of any fact which would reasonably lead a creditor to do so. The Company and its Subsidiaries, individually and on a
consolidated basis, are not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur at
the Closing will not be, Insolvent (as defined below). “Insolvent” means, (I) with respect to the Company and
its Subsidiaries, on a consolidated basis, (i) the present fair saleable value of the Company’s and its Subsidiaries’
assets is less than the amount required to pay the Company’s and its Subsidiaries’ total Indebtedness (as defined below),
(ii) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated, contingent or otherwise, as
such debts and liabilities become absolute and matured or (iii) the Company and its Subsidiaries intend to incur or believe that
they will incur debts that would be beyond their ability to pay as such debts mature; and (II) with respect to the Company and
each Subsidiary, individually, (i) the present fair saleable value of the Company’s or such Subsidiary’s (as the case
may be) assets is less than the amount required to pay its respective total Indebtedness, (ii) the Company or such Subsidiary (as
the case may be) is unable to pay its respective debts and liabilities, subordinated, contingent or otherwise, as such debts and
liabilities become absolute and matured or (iii) the Company or such Subsidiary (as the case may be) intends to incur or believes
that it will incur debts that would be beyond its respective ability to pay as such debts mature. Neither the Company nor any of
its Subsidiaries has engaged in any business or in any transaction, and is not about to engage in any business or in any transaction,
for which the Company’s or such Subsidiary’s remaining assets constitute unreasonably small capital.

 

    	 	9	 

     

    

 

(m)            
No Undisclosed Events, Liabilities, Developments or Circumstances. No event, liability, development or circumstance
has occurred or exists, or could reasonably expected to occur or exist, with respect to the Company, any of its Subsidiaries or
any of their respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial
or otherwise) that (i) would be required to be disclosed by the Company under applicable laws on a registration statement on Form
S-1 filed with the SEC relating to an issuance and sale by the Company of its Common Stock and which has not been publicly announced,
(ii) could have a material adverse effect on the Investor’s investment hereunder or (iii) could have a Material Adverse Effect.

 

(n)              
Conduct of Business; Regulatory Permits. The Company is not in violation of any term of or in default under its Charter,
any certificate of designation, preferences or rights of any other outstanding series of preferred stock of the Company or its
Bylaws. None of the Company’s Subsidiaries is in violation of any term of or in default under its organizational charter,
certificate of formation or certificate of incorporation or bylaws, or any certificate of designation, preferences or rights of
any other outstanding series of preferred stock of such Subsidiary. Neither the Company nor any of its Subsidiaries is in violation
of any judgment, decree or order or any statute, ordinance, rule or regulation applicable to the Company or any of its Subsidiaries,
and neither the Company nor any of its Subsidiaries will conduct its business in violation of any of the foregoing, except in all
cases for possible violations which could not, individually or in the aggregate, have a Material Adverse Effect. Without limiting
the generality of the foregoing, the Company is not in violation of any of the rules, regulations or requirements of the Principal
Market and has no knowledge of any facts or circumstances that could reasonably lead to delisting or suspension of the Common Stock
by the Principal Market in the foreseeable future. Since September 2010, (i) the Common Stock has been listed or designated for
quotation on the Principal Market, (ii) trading in the Common Stock has not been suspended by the SEC or the Principal Market and
(iii) the Company has received no communication, written or oral, from the SEC or the Principal Market regarding the suspension
or delisting of the Common Stock from the Principal Market. The Company and each of its Subsidiaries possess all certificates,
authorizations and permits issued by the appropriate regulatory authorities necessary to conduct their respective businesses, and
neither the Company nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of
any such certificate, authorization or permit.

 

(o)              
Foreign Corrupt Practices. Neither the Company nor any of its Subsidiaries nor any director, officer, agent, employee
or other Person acting on behalf of the Company or any of its Subsidiaries has, in the course of its actions for, or on behalf
of, the Company or any of its Subsidiaries (i) used any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic
government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt
Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful
payment to any foreign or domestic government official or employee.

 

    	 	10	 

     

    

 

(p)              
Sarbanes-Oxley Act. The Company and each Subsidiary is in material compliance with all applicable requirements of
the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and all applicable rules and regulations promulgated by
the SEC thereunder that are effective as of the date hereof.

 

(q)              
Transactions With Affiliates. Except as disclosed in the SEC Documents, none of the officers, directors, employees
or affiliates of the Company or any of its Subsidiaries is presently a party to any transaction with the Company or any of its
Subsidiaries (other than for ordinary course services as employees, officers or directors), including any contract, agreement or
other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
or otherwise requiring payments to or from any such officer, director, employee or affiliate or, to the knowledge of the Company
or any of its Subsidiaries, any corporation, partnership, trust or other Person in which any such officer, director, employee or
affiliate has a substantial interest or is an employee, officer, director, trustee or partner.

 

(r)                
Equity Capitalization. The issued and outstanding shares of capital stock of the Company have been validly issued,
are fully paid and non-assessable. The Company has an authorized, issued and outstanding capitalization as set forth in the Registration
Statement, the Prospectus and the Prospectus Supplement as of the dates referred to therein (other than (i) the grant of additional
options or other awards under the Company’s existing equity incentive plans, (ii) changes in the number of outstanding Common
Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible
into, Common Stock outstanding on the date hereof, (iii) the vesting of awards under the Company’s existing equity incentive
plans outstanding on the date hereof, (iv) as a result of the issuance of shares of Common Stock pursuant to the Notes, (v) any
repurchases of capital stock of the Company, or (v) as otherwise disclosed in the Registration Statement, Prospectus or Prospectus
Supplement), and such authorized capital stock conforms to the description thereof set forth in the Registration Statement, the
Prospectus and the Prospectus Supplement. The description of the Common Stock in the Registration Statement, the Prospectus and
the Prospectus Supplement is complete and accurate in all material respects. (i) None of the Company’s or any Subsidiary’s
capital stock is subject to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by
the Company or any Subsidiary; (ii) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any capital
stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company
or any of its Subsidiaries is or may become bound to issue additional capital stock of the Company or any of its Subsidiaries or
options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or
rights convertible into, or exercisable or exchangeable for, any capital stock of the Company or any of its Subsidiaries; (iii)
there are no outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments
evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may
become bound; (iv) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register
the sale of any of their securities under the Securities Act (except pursuant to this Agreement); (v) there are no outstanding
securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there
are no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become
bound to redeem a security of the Company or any of its Subsidiaries; (vi) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by the issuance of the Securities; (vii) neither the Company nor any Subsidiary has
any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement; and (viii) neither
the Company nor any of its Subsidiaries have any liabilities or obligations required to be disclosed in the SEC Documents which
are not so disclosed in the SEC Documents, other than those incurred in the ordinary course of the Company’s or its Subsidiaries’
respective businesses and which, individually or in the aggregate, do not or could not have a Material Adverse Effect. The SEC
Documents contain true, correct and complete copies of the Company’s Certificate of Incorporation, as amended and as in effect
on the date hereof (the “Charter”), and the Company’s Bylaws, as amended and as in effect on the date
hereof (the “Bylaws”), and the terms of all Convertible Securities. “Convertible Securities”
means any capital stock or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances
directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire,
any capital stock or other security of the Company (including, without limitation, Common Stock) or any of its Subsidiaries.

 

    	 	11	 

     

    

 

(s)               
Indebtedness and Other Contracts. Except as set forth in the SEC Documents, neither the Company nor any of its Subsidiaries
(i) has any outstanding Indebtedness (as defined below), (ii) is a party to any contract, agreement or instrument, the violation
of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected
to result in a Material Adverse Effect, (iii) is in violation of any term of, or in default under, any contract, agreement or instrument
relating to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate, in
a Material Adverse Effect, or (iv) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance
of which, in the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect. (x) “Indebtedness”
of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed
as the deferred purchase price of property or services (including, without limitation, “capital leases” in accordance
with generally accepted accounting principles) (other than trade payables incurred in the ordinary course of business), (C) all
reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations
evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection with the
acquisition of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other title
retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds
of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are
limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which,
in connection with generally accepted accounting principles, consistently applied for the periods covered thereby, is classified
as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for which the holder of such
Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest
or other encumbrance upon or in any property or assets (including accounts and contract rights) owned by any Person, even though
the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all
Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G)
above; (y) “Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or
otherwise, of that Person with respect to any indebtedness, lease, dividend or other obligation of another Person if the primary
purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee
of such liability that such liability will be paid or discharged, or that any agreements relating thereto will be complied with,
or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto; and (z) “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.

 

    	 	12	 

     

    

 

(t)                
Absence of Litigation(a). There is no action, suit, proceeding, inquiry or investigation before or by the Principal Market, any court, public board,
government agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting
the Company or any of its Subsidiaries, the Common Stock or any of the Company’s or its Subsidiaries’ officers or directors
which is outside of the ordinary course of business or individually or in the aggregate material to the Company or any of its Subsidiaries.
No director, officer or employee of the Company or any of its Subsidiaries has willfully violated 18 U.S.C. §1519 or engaged
in spoliation in reasonable anticipation of litigation. There has not been, and to the knowledge of the Company, there is not pending
or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries or any current or former director
or officer of the Company or any of its Subsidiaries. The SEC has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company under the Securities Act or the Exchange Act, including, without limitation,
the Registration Statement.

 

(u)              
Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses
in which the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance
coverage sought or applied for, and neither the Company nor any such Subsidiary has any reason to believe that it will be unable
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.

 

(v)              
Employee Relations. Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement
or employs any member of a union. The Company believes that its and its Subsidiaries’ relations with their respective employees
are good. No executive officer (as defined in Rule 501(f) promulgated under the Securities Act) or other key employee of the Company
or any of its Subsidiaries has notified the Company or any such Subsidiary that such officer intends to leave the Company or any
such Subsidiary or otherwise terminate such officer’s employment with the Company or any such Subsidiary. No executive officer
or other key employee of the Company or any of its Subsidiaries is, or is now expected to be, in violation of any material term
of any employment contract, confidentiality, disclosure or proprietary information agreement, non-competition agreement, or any
other contract or agreement or any restrictive covenant, and the continued employment of each such executive officer or other key
employee (as the case may be) does not subject the Company or any of its Subsidiaries to any liability with respect to any of the
foregoing matters. The Company and its Subsidiaries are in compliance with all federal, state, local and foreign laws and regulations
respecting labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except
where failure to be in compliance would not, either individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect.

 

    	 	13	 

     

    

 

(w)            
Title. The Company and its Subsidiaries have good and marketable title in fee simple to all real property, and have
good and marketable title to all personal property, owned by them which is material to the business of the Company and its Subsidiaries,
in each case, free and clear of all liens, encumbrances and defects except such as do not materially affect the value of such property
and do not interfere with the use made and proposed to be made of such property by the Company and any of its Subsidiaries. Any
real property and facilities held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting
and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made
of such property and buildings by the Company or any of its Subsidiaries.

 

(x)              
Intellectual Property Rights. The Company and its Subsidiaries own or possess (or, in the case of third-party patents,
patent applications, trademarks, trademark applications, service marks, or service mark applications, to the Company’s knowledge,
the Company and its Subsidiaries own or possesses) adequate rights or licenses to use all trademarks, trade names, service marks,
service mark registrations, service names, patents, patent rights, copyrights, original works, inventions, licenses, approvals,
governmental authorizations, trade secrets and other intellectual property rights and all applications and registrations therefor
(“Intellectual Property Rights”) necessary to conduct their respective businesses as now conducted and as presently
proposed to be conducted. None of the Company’s or its Subsidiaries’ Intellectual Property Rights have expired, terminated
or been abandoned, or are expected to expire, terminate or be abandoned, within three years from the date of this Agreement, except
as would reasonably be expected to result in a Material Adverse Effect. The Company has no knowledge of any infringement by the
Company or any of its Subsidiaries of Intellectual Property Rights of others. There is no claim, action or proceeding being made
or brought, or to the knowledge of the Company or any of its Subsidiaries, being threatened, against the Company or any of its
Subsidiaries regarding their Intellectual Property Rights that is material to the Company’s business. The Company is not
aware of any facts or circumstances which would reasonably be expected to give rise to any of the foregoing infringements or claims,
actions or proceedings. The Company and each of its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their Intellectual Property Rights.

 

(y)              
Environmental Laws. The Company and its Subsidiaries (i) are in compliance with all Environmental Laws (as defined
below), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct
their respective businesses and (iii) are in compliance with all terms and conditions of any such permit, license or approval where,
in each of the foregoing clauses (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually
or in the aggregate, a Material Adverse Effect. “Environmental Laws” means all federal, state, local or foreign
laws relating to pollution or protection of human health or the environment (including, without limitation, ambient air, surface
water, groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions, discharges,
releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively,
“Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees,
demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations issued,
entered, promulgated or approved thereunder.

 

    	 	14	 

     

    

 

(z)               
Subsidiary Rights. The Company or one of its Subsidiaries has the unrestricted right to vote, and (subject to limitations
imposed by applicable law) to receive dividends and distributions on, all capital securities of its Subsidiaries as owned by the
Company or such Subsidiary.

 

(aa)           
Tax Status. The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state
income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has timely
paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably
adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply,
except in each case where failure to do so would not reasonably be expected to result in a Material Adverse Effect. There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
and its Subsidiaries know of no basis for any such claim. The Company is not operated in such a manner as to qualify as a passive
foreign investment company, as defined in Section 1297 of the U.S. Internal Revenue Code of 1986, as amended (the “Code”).

 

(bb)          
Internal Accounting and Disclosure Controls. The Company maintains internal control over financial reporting (as
such term is defined in Rule 13a-15(f) under the Exchange Act) that is effective to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles, including that (i) transactions are executed in accordance with management’s general or specific
authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally
accepted accounting principles and to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities
is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability
for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action
is taken with respect to any difference. The Company maintains disclosure controls and procedures (as such term is defined in Rule
13a-15(e) under the Exchange Act) that are effective in ensuring that information required to be disclosed by the Company in the
reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the rules and forms of the SEC, including, without limitation, controls and procedures designed to ensure that information
required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated
to the Company’s management, including its principal executive officer or officers and its principal financial officer or
officers, as appropriate, to allow timely decisions regarding required disclosure. The Company has not received any notice or correspondence
from any accountant or other Person relating to any potential material weakness or significant deficiency in any part of the internal
controls over financial reporting of the Company.

 

    	 	15	 

     

    

 

(cc)           
Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or
any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company
in its Exchange Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.

 

(dd)         
Investment Company Status. The Company is not, and upon consummation of the sale of the Securities will not be required
to register as, an “investment company,” an affiliate of an “investment company,” a company controlled
by an “investment company” or an “affiliated person” of, or “promoter” or “principal
underwriter” for, an “investment company” as such terms are defined in the Investment Company Act of 1940, as
amended.

 

(ee)           
Manipulation of Price. Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company,
no Person acting on their behalf has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company or any of its Subsidiaries to facilitate the sale or resale of any
of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities,
or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company
or any of its Subsidiaries.

 

(ff)            
U.S. Real Property Holding Corporation. Neither the Company nor any of its Subsidiaries is, or has ever been, and
so long as any of the Securities are held by the Investor, shall become, a U.S. real property holding corporation within the meaning
of Section 897 of the Code, and the Company and each Subsidiary shall so certify upon the Investor’s request.

 

(gg)          
Registration Eligibility. The Company is eligible to register the issuance and sale of the Securities to the Investor
using Form S-3 promulgated under the Securities Act.

 

(hh)          
Transfer Taxes. On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which
are required to be paid in connection with the issuance, sale and/or transfer of the Securities to be sold to the Investor hereunder
will be, or will have been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been
complied with.

 

(ii)              
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company
Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System
(the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly
or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%)
or more of the total equity of a bank or any equity that is subject to the BHCA and to regulation by the Federal Reserve. Neither
the Company nor any of its Subsidiaries or affiliates exercises a controlling influence over the management or policies of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

    	 	16	 

     

    

 

(jj)              
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).

 

(kk)          
Public Utility Holding Act. None of the Company nor any of its Subsidiaries is a “holding company,” or
an “affiliate” of a “holding company,” as such terms are defined in the Public Utility Holding Act of 2005.

 

(ll)              
Federal Power Act. None of the Company nor any of its Subsidiaries is subject to regulation as a “public utility”
under the Federal Power Act, as amended.

 

(mm)        
No Additional Agreements. The Company does not have any agreement or understanding with the Investor with respect
to the transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents.

 

(nn)          
Real Property. Each of the Company and its Subsidiaries holds good title to all real property, leases in real property,
or other interests in real property owned or held by the Company or any of its Subsidiaries (the “Real Property”)
owned by the Company or any of its Subsidiaries (as applicable). The Real Property (a) is free and clear of all mortgages, defects,
claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances (collectively
“Encumbrances”) and (b) is not subject to any rights of way, building use restrictions, exceptions, variances,
reservations, or limitations of any nature (collectively, “Use Restrictions”) except for (i) liens for current
taxes not yet due and (ii) zoning laws and other land use restrictions that do not impair the present or anticipated use of the
property subject thereto, other than, with respect to clauses (a) and (b) above, for such Encumbrances or Use Restrictions that
would not reasonably be expected to have a Material Adverse Effect.

 

(oo)          
Fixtures and Equipment. Each of the Company and its Subsidiaries (as applicable) has good title to, or a valid leasehold
interest in, the tangible personal property, equipment, improvements, fixtures, and other personal property and appurtenances that
are used by the Company or its Subsidiary in connection with the conduct of its business (the “Fixtures and Equipment”).
The Fixtures and Equipment are structurally sound, are in good operating condition and repair, are adequate for the uses to which
they are being put, are not in need of maintenance or repairs except for ordinary, routine maintenance and repairs and are sufficient
for the conduct of the Company’s and/or its Subsidiaries’ businesses (as applicable) in the manner as conducted prior
to the Closing. Each of the Company and its Subsidiaries owns all of its Fixtures and Equipment free and clear of all Encumbrances
except for (a) liens for current taxes not yet due, (b) zoning laws and other land use restrictions that do not impair the present
or anticipated use of the property subject thereto, and (c) Encumbrances that would not reasonably be expected to have a Material
Adverse Effect.

 

(pp)          
Illegal or Unauthorized Payments; Political Contributions. Neither the Company nor any of its Subsidiaries nor, to
the best of the Company’s knowledge (after reasonable inquiry of its officers and directors), any of the officers, directors,
employees, agents or other representatives of the Company or any of its Subsidiaries or any other business entity or enterprise
with which the Company or any Subsidiary is or has been affiliated or associated, has, directly or indirectly, made or authorized
any payment, contribution or gift of money, property, or services, whether or not in contravention of applicable law, (a) as a
kickback or bribe to any Person or (b) to any political organization, or the holder of or any aspirant to any elective or appointive
public office except for personal political contributions not involving the direct or indirect use of funds of the Company or any
of its Subsidiaries.

 

    	 	17	 

     

    

 

(qq)          
Money Laundering. The Company and its Subsidiaries are in compliance with, and have not previously violated, the
USA Patriot Act of 2001 and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, without
limitation, the laws, regulations and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets
Control, including, without limitation, (i) Executive Order 13224 of September 23, 2001 entitled, “Blocking Property and
Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism” (66 Fed. Reg. 49079 (2001));
and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter V.

 

(rr)             
Registration Rights. No holder of securities of the Company has rights to the registration of any securities of the
Company because of the transactions contemplated by the Transaction Documents, including, without limitation, the issuance of the
Securities hereunder or the filing of the Prospectus Supplement, which could expose the Company to material liability or the Investor
to any liability or that could impair the Company’s ability to consummate the issuance and sale of the Securities in the
manner, and at the times, contemplated hereby, which rights have not been waived by the holder thereof as of the date hereof.

 

(ss)            
Management. During the prior two (2) year period ending on the day immediately preceding the date hereof, to the
knowledge of the Company, no current officer or director of the Company has been the subject of:

 

(i)                
a petition under bankruptcy laws or any other insolvency or moratorium law or the appointment by a court of a receiver,
fiscal agent or similar officer for such Person, or any partnership in which such Person was a general partner at or within two
years before the filing of such petition or such appointment, or any corporation or business association of which such Person was
an executive officer at or within two years before the time of the filing of such petition or such appointment;

 

(ii)              
a conviction in a criminal proceeding or a named subject of a pending criminal proceeding (excluding traffic violations
that do not relate to driving while intoxicated or driving under the influence);

 

(iii)            
any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction,
permanently or temporarily enjoining any such Person from, or otherwise limiting, the following activities:

 

(1)              
acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker,
leverage transaction merchant, any other Person regulated by the United States Commodity Futures Trading Commission or an associated
Person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated Person,
director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing
any conduct or practice in connection with such activity;

 

    	 	18	 

     

    

 

(2)              
engaging in any type of business practice; or

 

(3)              
engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any
violation of securities laws or commodities laws;

 

(iv)            
any order, judgment or decree, not subsequently reversed, suspended or vacated, of any authority barring, suspending or
otherwise limiting for more than sixty (60) days the right of any such Person to engage in any activity described in the preceding
sub paragraph, or to be associated with Persons engaged in any such activity;

 

(v)              
a finding by a court of competent jurisdiction in a civil action or by the SEC or other authority to have violated any securities
law, regulation or decree and the judgment in such civil action or finding by the SEC or any other authority has not been subsequently
reversed, suspended or vacated; or

 

(vi)            
a finding by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have
violated any federal commodities law, and the judgment in such civil action or finding has not been subsequently reversed, suspended
or vacated.

 

(tt)             
Stock Option Plans. Since January 1, 2013, each stock option granted by the Company was granted (i) in accordance
with the terms of the applicable stock option plan of the Company or outside of the Company’s stock option plan as an inducement
to employment or the engagement as a director of the Company and (ii) with an exercise price at least equal to the fair market
value of the Common Stock on the date such stock option would be considered granted under generally accepted accounting principles
and applicable law. No stock option granted under the Company’s stock option plan has been backdated. Since January 1, 2013,
the Company has not knowingly granted, and there is no, and has been, no policy or practice of the Company to knowingly grant stock
options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of
material information regarding the Company or any of its Subsidiaries or any of its or their respective financial results or prospects.

 

(uu)          
No Disagreements with Accountants and Lawyers. There are no material disagreements of any kind presently existing,
or reasonably anticipated by the Company to arise, between the Company, on the one hand, and any accountants or lawyers formerly
or presently employed or engaged by the Company, on the other hand. The Company is current with respect to any fees owed to its
accountants and lawyers which could reasonably affect the Company’s ability to perform any of its obligations under any of
the Transaction Documents.

 

(vv)          
Disclosure. The Company confirms that neither it nor any other Person acting on its behalf has provided the Investor
or its agents or counsel with any information that constitutes or could reasonably be expected to constitute material, non-public
information regarding the Company or any of its Subsidiaries, other than the existence of the transactions contemplated by this
Agreement and the other Transaction Documents. The Company understands and confirms that the Investor will rely on the foregoing
representations in effecting transactions in securities of the Company. All disclosure provided to the Investor regarding the Company
and its Subsidiaries, their businesses and the transactions contemplated hereby, including the schedules to this Agreement, furnished
by or on behalf of the Company or any of its Subsidiaries is true and correct and does not contain any untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading. Each press release issued by the Company or any of its Subsidiaries during the twelve
(12) months preceding the date of this Agreement did not at the time of release contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light
of the circumstances under which they are made, not misleading. No event or circumstance has occurred or information exists with
respect to the Company or any of its Subsidiaries or its or their business, properties, liabilities, prospects, operations (including
results thereof) or conditions (financial or otherwise), which, under applicable law, rule or regulation, requires public disclosure
at or before the date hereof or announcement by the Company but which has not been so publicly disclosed. The Company acknowledges
and agrees that the Investor does not make and has not made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in Section 2.

 

    	 	19	 

     

    

 

		4.	COVENANTS.

 

(a)               
Reasonable Best Efforts Each of the Company and the Investor shall use its reasonable best efforts to timely satisfy
each of the conditions to closing to be satisfied by it in this Agreement.

 

(b)              
Prospectus Supplement and Blue Sky. Prior to execution of this Agreement, the Company shall have delivered to the
Investor, and within the time required under Rule 424(b) under the Securities Act (without reliance on Rule 424(b)(8) under the
Securities Act) the Company shall file with the SEC, the Prospectus Supplement with respect to the Securities as required hereunder,
and in conformity with, the Securities Act, including Rule 424(b) thereunder. If required, the Company, on or before each Closing
Date, shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to,
qualify the Securities for sale to the Investor at the applicable Closing pursuant to this Agreement under applicable securities
or “Blue Sky” laws of the states of the United States (or to obtain an exemption from such qualification), and shall
provide evidence of any such action so taken to the Investor on or prior to the applicable Closing Date. Without limiting any other
obligation of the Company under this Agreement, the Company shall timely make all filings and reports relating to the offer and
sale of the Securities required under all applicable securities laws (including, without limitation, all applicable federal securities
laws and all applicable “Blue Sky” laws), and the Company shall comply with all applicable foreign, federal, state
and local laws, statutes, rules, regulations and the like relating to the offering and sale of the Securities to the Investor.

 

(c)               
Reporting Status. Until the date on which the Investor shall have sold all of the Conversion Shares (the “Reporting
Period”), the Company shall timely file all reports required to be filed with the SEC pursuant to the Exchange Act, and
the Company shall not terminate its status as an issuer required to file reports under the Exchange Act even if the Exchange Act
or the rules and regulations thereunder would no longer require or otherwise permit such termination.

 

(d)              
Use of Proceeds. The Company shall use the proceeds from the sale of the Securities solely for general working capital
purposes and as otherwise set forth in the Prospectus Supplement under “Use of Proceeds.”

 

    	 	20	 

     

    

 

(e)               
Financial Information. The Company agrees to send the following to the Investor during the Reporting Period (i) unless
the following are filed with the SEC through EDGAR and are available to the public through the EDGAR system, within one (1) Business
Day after the filing thereof with the SEC, a copy of its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, any interim
reports or any consolidated balance sheets, income statements, stockholders’ equity statements and/or cash flow statements
for any period other than annual periods, and any registration statements or amendments filed pursuant to the Securities Act and
(ii) copies of any notices and other information made available or given to the stockholders of the Company generally, contemporaneously
with the making available or giving thereof to the stockholders.

 

(f)               
Listing. The Company shall promptly secure the listing or designation for quotation (as the case may be) of (i) all
of the Initial Conversion Shares upon each national securities exchange and automated quotation system, if any, upon which the
Common Stock is then listed or designated for quotation (as the case may be) (subject to official notice of issuance) (but in no
event later than the Initial Closing Date) and (ii) all of the Additional Conversion Shares upon each national securities exchange
and automated quotation system, if any, upon which the Common Stock is then listed or designated for quotation (as the case may
be) (subject to official notice of issuance) (but in no event later than the Additional Closing Date), and shall maintain such
listing or designation for quotation (as the case may be) of all the shares of Common Stock from time to time issuable under the
terms of the Transaction Documents on such national securities exchange or automated quotation system. The Company shall maintain
the listing or designation for quotation (as the case may be) of the Common Stock on the Principal Market, The New York Stock Exchange,
the NYSE MKT, The NASDAQ Global Market or The NASDAQ Global Select Market (each, an “Eligible Market”). Neither
the Company nor any of its Subsidiaries shall take any action which could be reasonably expected to result in the delisting or
suspension of the Common Stock on an Eligible Market. The Company shall pay all fees and expenses in connection with satisfying
its obligations under this Section 4(f).

 

(g)              
Fees. The Company shall reimburse the Investor or its designee(s) for all costs and expenses incurred by it or its
affiliates in connection with the transactions contemplated by the Transaction Documents (including, without limitation, all legal
fees and disbursements in connection therewith, structuring, documentation and implementation of the transactions contemplated
by the Transaction Documents and due diligence and regulatory filings in connection therewith) in an amount up to $35,000, which
amount shall be withheld by the Investor from the Initial Purchase Price at the Initial Closing or paid by the Company on demand
by the Investor if the Investor terminates its obligations under this Agreement in accordance with Section 7 (as the case may be).
The Company shall be responsible for the payment of any placement agent’s fees, financial advisory fees, transfer agent fees,
DTC fees or broker’s commissions (other than for Persons engaged by the Investor) relating to or arising out of the transactions
contemplated hereby. The Company shall pay, and hold the Investor harmless against, any liability, loss or expense (including,
without limitation, reasonable attorneys’ fees and out-of-pocket expenses) arising in connection with any claim relating
to any such payment. Except as otherwise set forth in the Transaction Documents, each party to this Agreement shall bear its own
expenses in connection with the sale of the Securities to the Investor.

 

    	 	21	 

     

    

 

(h)              
Pledge of Securities. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges
and agrees that the Securities may be pledged by the Investor in connection with a bona fide margin agreement or other loan or
financing arrangement that is secured by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or
assignment of the Securities hereunder, and the Investor effecting a pledge of Securities shall be required to provide the Company
with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document.
The Company hereby agrees to execute and deliver such documentation as a pledgee of the Securities may reasonably request in connection
with a pledge of the Securities to such pledgee by the Investor.

 

(i)                
Disclosure of Transactions and Other Material Information. file a Current Report on Form 8-K with the SEC under the
Exchange Act describing all the material terms of the transactions contemplated by the Transaction Documents in the form required
by the Exchange Act and attaching all the material Transaction Documents (including, without limitation, this Agreement (and all
schedules to this Agreement) and the form of Notes) (including all attachments, the “Transaction 8-K Filing”),
and (ii) file an additional Current Report on Form 8-K with the SEC under the Exchange Act disclosing all material, non-public
information, if any, regarding the Company or any of its Subsidiaries provided to the Investor by the Company or any of its Subsidiaries,
or any of their respective officers, directors, employees or agents, prior to the time of such filing that was not disclosed in
the Transaction 8-K Filing and, as applicable, attaching all material transaction documents (including all attachments, the “Cleansing
8-K Filing”). From and after the filing of the Cleansing 8-K Filing with the SEC, the Company shall have disclosed all
material, non-public information (if any) regarding the Company or any of its Subsidiaries provided or delivered to the Investor
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with
the transactions contemplated by the Transaction Documents or otherwise. The Company shall not, and the Company shall cause each
of its Subsidiaries and each of its and their respective officers, directors, employees and agents, not to, provide the Investor
with any material, non-public information regarding the Company or any of its Subsidiaries from and after the time of filing of
the Cleansing 8-K Filing without the express prior written consent of the Investor (which may be granted or withheld in the Investor’s
sole discretion). In the event of a breach of any of the foregoing covenants by the Company, any of its Subsidiaries, or any of
its or their respective officers, directors, employees and agents (as determined in the reasonable good faith judgment of the Investor),
in addition to any other remedy provided herein or in the Transaction Documents, the Investor shall have the right, subject to
giving the Company at least one (1) Business Day’s prior written notice, to make a public disclosure, in the form of a press
release, public advertisement or otherwise, of such material, non-public information without the prior approval by the Company,
any of its Subsidiaries, or any of its or their respective officers, directors, employees or agents. The Investor shall not have
any liability to the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees, stockholders
or agents, for any such disclosure. Subject to the foregoing, neither the Company, its Subsidiaries nor the Investor shall issue
any press releases or any other public statements with respect to the transactions contemplated hereby without the prior written
consent of the other parties hereto; provided, however, the Company shall be entitled, without the prior approval of the Investor,
to make any press release or other public disclosure with respect to such transactions (i) in substantial conformity with the Transaction
8-K Filing or the Cleansing 8-K Filing (as applicable) and contemporaneously therewith and (ii) as is required by applicable law
and regulations (provided that the Investor shall be consulted by the Company in connection with any such press release or other
public disclosure prior to its release). Other than with respect to the Transaction 8-K Filing, without the prior written consent
of the Investor (which may be granted or withheld in the Investor’s sole discretion), the Company shall not (and shall cause
each of its Subsidiaries and affiliates to not) disclose the name of the Investor in any filing, announcement, release or otherwise.
Notwithstanding anything contained in this Agreement to the contrary and without implication that the contrary would otherwise
be true, the Company expressly acknowledges and agrees that the Investor has not had, and the Investor shall not have (unless expressly
agreed to by the Investor in a written definitive and binding agreement executed by the Company and the Investor), any duty of
confidentiality with respect to, or a duty not to trade on the basis of, any information regarding the Company or any of its Subsidiaries.

 

    	 	22	 

     

    

 

(j)                
Reservation of Shares. Until the date on which the Notes are no longer outstanding, the Company shall take all action
necessary to at all times have authorized, and reserved for the purpose of issuance, no less than the Required Reserve Amount (as
defined in the Notes).

 

(k)              
Conduct of Business. The business of the Company and its Subsidiaries shall not be conducted in violation of any
law, ordinance or regulation of any governmental entity, except where such violations would not reasonably be expected to result,
either individually or in the aggregate, in a Material Adverse Effect.

 

(l)                
Participation Right. For as long as the Investor holds any Securities, neither the Company nor any of its Subsidiaries
shall, directly or indirectly, effect any Subsequent Placement involving a Variable Rate Transaction unless the Company shall have
first complied with this Section 4(l).

 

(i)                
At least five (5) Trading Days prior to any proposed or intended Subsequent Placement involving a Variable Rate Transaction,
the Company shall deliver to the Investor a written notice of its proposal or intention to effect a Subsequent Placement involving
a Variable Rate Transaction (each such notice, a “Pre-Notice”), which Pre-Notice shall not contain any information
(including, without limitation, material, non-public information regarding the Company or any of its Subsidiaries) other than:
(i) a statement that the Company proposes or intends to effect a Subsequent Placement involving a Variable Rate Transaction, (ii)
a statement that the statement in clause (i) above does not constitute material, non-public information and (iii) a statement informing
the Investor that it is entitled to receive an Offer Notice (as defined below) with respect to such Subsequent Placement upon its
written request. Upon the written request of the Investor within three (3) Trading Days after the Company’s delivery
to the Investor of such Pre-Notice, and only upon a written request by the Investor, the Company shall promptly, but no later than
one (1) Trading Day after such request, deliver to the Investor an irrevocable written notice (the “Offer Notice”)
of any proposed or intended issuance or sale or exchange (the “Offer”) of the securities being offered (the
“Offered Securities”) in a Subsequent Placement involving a Variable Rate Transaction, which Offer Notice shall
(w) identify and describe the Offered Securities, (x) describe the price and other terms upon which they are to be issued, sold
or exchanged, and the number or amount of the Offered Securities to be issued, sold or exchanged, (y) identify the Persons (if
known) to which or with which the Offered Securities are to be offered, issued, sold or exchanged and (z) offer to issue and sell
to or exchange with the Investor in accordance with the terms of the Offer 100% of the Offered Securities.

 

    	 	23	 

     

    

 

(ii)              
To accept an Offer, in whole or in part, the Investor must deliver a written notice to the Company prior to the end of the
fifth (5th) Business Day after the Investor’s receipt of the Offer Notice (the “Offer Period”),
setting forth the portion of the Offered Securities that the Investor elects to purchase (the “Notice of Acceptance”).
Notwithstanding the foregoing, if the Company desires to modify or amend the terms and conditions of the Offer prior to the expiration
of the Offer Period, the Company may deliver to the Investor a new Offer Notice and the Offer Period shall expire on the fifth
(5th) Business Day after the Investor’s receipt of such new Offer Notice.

 

(iii)            
The Company shall have five (5) days from the expiration of the Offer Period above (i) to offer, issue, sell or exchange
all or any part of such Offered Securities as to which a Notice of Acceptance has not been given by the Investor (the “Refused
Securities”) pursuant to a definitive agreement(s) (the “Subsequent Placement Agreement”), but only
to the offerees described in the Offer Notice (if so described therein) and only upon terms and conditions (including, without
limitation, unit prices and interest rates) that are not more favorable to the acquiring Person or Persons or less favorable to
the Company than those set forth in the Offer Notice and (ii) to publicly announce (a) the execution of such Subsequent Placement
Agreement, and (b) either (x) the consummation of the transactions contemplated by such Subsequent Placement Agreement or (y) the
termination of such Subsequent Placement Agreement, which shall be filed with the SEC on a Current Report on Form 8-K with such
Subsequent Placement Agreement and any documents contemplated therein filed as exhibits thereto.

 

(iv)            
In the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and
on the terms specified in Section 4(l)(iii) above), then the Investor may, at its sole option and in its sole discretion, reduce
the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall be not less than the
number or amount of the Offered Securities that the Investor elected to purchase pursuant to Section 4(l)(ii) above multiplied
by a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually proposes to
issue, sell or exchange (including Offered Securities to be issued or sold to the Investor pursuant to this Section 4(l) prior
to such reduction) and (ii) the denominator of which shall be the original amount of the Offered Securities. In the event that
the Investor so elects to reduce the number or amount of Offered Securities specified in its Notice of Acceptance, the Company
may not issue, sell or exchange more than the reduced number or amount of the Offered Securities unless and until such securities
have again been offered to the Investor in accordance with Section 4(l)(i) above.

 

(v)              
Upon the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, the Investor shall
acquire from the Company, and the Company shall issue to the Investor, the number or amount of Offered Securities specified in
its Notice of Acceptance. The purchase by the Investor of any Offered Securities is subject in all cases to the preparation, execution
and delivery by the Company and the Investor of a separate purchase agreement relating to such Offered Securities reasonably satisfactory
in form and substance to the Investor and its counsel.

 

    	 	24	 

     

    

 

(vi)            
Any Offered Securities not acquired by the Investor or other Persons in accordance with this Section 4(l) may not be issued,
sold or exchanged until they are again offered to the Investor under the procedures specified in this Agreement.

 

(vii)          
The Company and the Investor agree that if the Investor elects to participate in the Offer, neither the Subsequent Placement
Agreement with respect to such Offer nor any other transaction documents related thereto (collectively, the “Subsequent
Placement Documents”) shall include any term or provision whereby the Investor shall be required to agree to any restrictions
on trading as to any securities of the Company (other than restrictions required by applicable securities laws on the resale of
the specific “restricted securities” (as that term is defined under Rule 144) being issued in the Subsequent Placement)
or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection
with, any agreement previously entered into with the Company or any instrument received from the Company.

 

(viii)        
Notwithstanding anything to the contrary in this Section 4(l) and unless otherwise agreed to by the Investor, the Company
shall either confirm in writing to the Investor that the transaction with respect to the Subsequent Placement involving a Variable
Rate Transaction has been abandoned or shall publicly disclose its intention to issue the Offered Securities, in either case in
such a manner such that the Investor will not be in possession of any material, non-public information regarding the Company or
any of its Subsidiaries, by the seventh (7th) Business Day following delivery of the Offer Notice. If by such seventh
(7th) Business Day, no public disclosure regarding a transaction with respect to the Offered Securities has been made,
and no notice regarding the abandonment of such transaction has been received by the Investor, such transaction shall be deemed
to have been abandoned and the Investor shall not be in possession of any material, non-public information regarding the Company
or any of its Subsidiaries. Should the Company decide to pursue such transaction with respect to the Offered Securities, the Company
shall provide the Investor with another Offer Notice in accordance with, and subject to, the terms of this Section 4(l) and the
Investor will again have the right of participation set forth in this Section 4(l). The Company shall not be permitted to deliver
more than one Offer Notice to the Investor in any sixty (60) day period, except as expressly contemplated by the last sentence
of Section 4(l)(ii).

 

    	 	25	 

     

    

 

(ix)            
The restrictions contained in this Section 4(l) shall not apply in connection with the issuance of any Excluded Securities.
“Excluded Securities” shall mean (A) shares of Common Stock or standard options to purchase Common Stock to
directors, officers, employees or consultants of the Company in their capacity as such pursuant to an Approved Share Plan (as defined
below) (it being expressly understood and agreed for all purposes of this Agreement that lawyers, law firms, accountants and accounting
firms do not constitute consultants), provided that the exercise price of any such options is not lowered, none of such options
are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such options are otherwise
materially changed in any manner that adversely affects the Investor; (B) shares of Common Stock issued upon the conversion, exercise
or exchange of Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Share
Plan that are covered by clause (A) above) issued prior to the date hereof, provided that the conversion, exercise or exchange
(as the case may be) of any such Convertible Security is made solely pursuant to the conversion, exercise or exchange (as the case
may be) provisions of such Convertible Security that were in effect (and expressly set forth in such Convertible Security) on the
date immediately prior to the date of this Agreement, the conversion, exercise or exchange price of any such Convertible Securities
(other than standard options to purchase Common Stock issued pursuant to an Approved Share Plan that are covered by clause (A)
above) is not lowered, none of such Convertible Securities are (other than standard options to purchase Common Stock issued pursuant
to an Approved Share Plan that are covered by clause (A) above) (nor is any provision of any such Convertible Securities) amended
or waived in any manner (whether by the Company or the holder thereof) to increase, or which results in an increase in, the number
of shares issuable thereunder and none of the terms or conditions of any such Convertible Securities (other than standard options
to purchase Common Stock issued pursuant to an Approved Share Plan that are covered by clause (A) above) are otherwise materially
changed or waived (whether by the Company or the holder thereof) in any manner that adversely affects the Investor; (C) the Notes
and the December 2016 Convertible Note; (D) the Conversion Shares and the shares of Common Stock issuable upon conversion, redemption
or amortization of the December 2016 Convertible Note; and (E) shares issued pursuant to that At Market Issuance Sales Agreement
dated as of March 8, 2016 by and among the Company, FBR Capital Markets & Co. and MLV & Co. LLC, as amended from time to
time. “Approved Share Plan” means any employee benefit plan which has been approved by the board of directors
of the Company prior to the date hereof pursuant to which shares of Common Stock and standard options to purchase Common Stock
may be issued to any employee, officer or director for services provided to the Company in their capacity as such. “Subsequent
Placement” means a transaction in which the Company or any of its Subsidiaries shall directly or indirectly issue, offer,
sell, grant any option or right to purchase, or otherwise dispose of (or announce any issuance, offer, sale, grant of any option
or right to purchase or other disposition of) any equity security or any equity-linked or related security (including, without
limitation, any “equity security” (as that term is defined under Rule 405 promulgated under the Securities Act)), any
Convertible Securities, any debt, any preferred stock or any purchase rights. “Variable Rate Transaction” means
a transaction in which the Company or any Subsidiary (i) issues or sells any Convertible Securities either (A) at a conversion,
exercise or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares
of Common Stock at any time after the initial issuance of such Convertible Securities, or (B) with a conversion, exercise or exchange
price that is subject to being reset at some future date after the initial issuance of such Convertible Securities or upon the
occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the
Common Stock, including, without limitation, pursuant to any “weighted average” or “full-ratchet” anti-dilution
provision, or (ii) enters into or offers or sells any securities pursuant to any agreement (including, without limitation, an agreement
providing for an “equity line of credit” or an “at-the-market” offering) whereby the Company or any Subsidiary
may sell securities at a future determined price.

 

    	 	26	 

     

    

 

(m)            
Passive Foreign Investment Company. The Company shall conduct its business, and shall cause its Subsidiaries to conduct
their respective businesses, in such a manner as will ensure that the Company will not be deemed to constitute a passive foreign
investment company within the meaning of Section 1297 of the Code.

 

(n)              
Corporate Existence. So long as any of the Notes remain outstanding, the Company shall not be party to any Fundamental
Transaction (as defined in the Notes) unless the Company is in compliance with the applicable provisions governing Fundamental
Transactions set forth in the Notes.

 

(o)              
Restriction on Cash Dividends. So long as any of the Notes remain outstanding, the Company shall not, directly or
indirectly, declare or pay any cash dividend or distribution on, any securities of the Company without the prior express written
consent of the Investor.

 

(p)              
No Net Short Sales. So long as any of the Notes remain outstanding, neither the Investor nor any of its affiliates
nor any entity managed or controlled by the Investor (collectively, the “Restricted Persons” and each of the
foregoing is referred to herein as a “Restricted Person”) shall maintain, in the aggregate, a Net Short Position. 
For purposes hereof, a “Net Short Position” by a Restricted Person means a position whereby such Restricted
Person has executed one or more sales of Common Stock that is marked as a short sale (but not including any sale marked “short
exempt”) and that is executed at a time when such Restricted Person does not have an equivalent offsetting long position
in the Common Stock (or is deemed to have a long position hereunder or otherwise in accordance with Regulation SHO under the Exchange
Act); provided, further that no “Short Sale” shall be deemed to exist as a result of any failure by the Company (or
its agents) to deliver Conversion Shares upon conversion of the Notes to any Restricted Person converting such Notes. For purposes
of determining whether a Restricted Person has an equivalent offsetting long position in the Common Stock, such Restricted Person
shall be deemed to hold “long” all shares of Common Stock that is either (i) then owned by such Restricted Person,
if any, or (ii) then issuable to such Restricted Person as Conversion Shares pursuant to the terms of the Notes then held by such
Restricted Person, if any, (without regard to any limitations on conversion set forth in the Notes and giving effect to any conversion
price adjustments that would take effect given only the passage of time). Notwithstanding the foregoing, nothing contained herein
shall (without implication that the contrary would otherwise be true) prohibit any Restricted Person from selling “long”
(as defined under Rule 200 promulgated under Regulation SHO under the Exchange Act) the Securities or any other shares of Common
Stock then owned by such Restricted Person. “Short Sales” means “short sales” as defined in Rule
200 promulgated under Regulation SHO under the Exchange Act. Notwithstanding anything in this Agreement or that certain Common
Stock Purchase Agreement, dated February 24, 2015, by and between the Company and the Investor (the “Prior Agreement”)
to the contrary, any transaction in the Common Stock or other securities of the Company by the Investor or any Restricted Person
that is in compliance with the provisions of this Section 4(p) shall not be deemed to be a breach of the Prior Agreement, including,
without limitation, Section 6.13 of the Prior Agreement, by the Investor or any Restricted Person.

 

(q)              
Resale Restrictions. For so long as the Investor owns any Securities, the Investor shall not sell any shares of Common
Stock at a per share price below $1.05 (as adjusted for stock splits, stock combinations and other similar transactions that occur
with respect to the Common Stock after the date of this Agreement) (the “Resale Price Threshold”); provided,
however, that with respect to any sale by the Investor of Conversion Shares or any other shares of Common Stock issued pursuant
to the Notes that were issued to the Investor at a Conversion Price (as defined in the Notes) or an Installment Conversion Price
(as defined in the Notes) that is less than $1.00 (as adjusted for stock splits, stock combinations and other similar transactions
that occur with respect to the Common Stock after the date of this Agreement), the Resale Price Threshold solely for such shares
of Common Stock shall be deemed to be the applicable Floor Price for the applicable Installment Period with respect to which such
shares of Common Stock were issued to the Investor.

 

    	 	27	 

     

    

 

(r)                
No Frustration. So long as any of the Notes remain outstanding, neither the Company nor any of its affiliates or
Subsidiaries, nor any of its or their respective officers, employees, directors, agents or other representatives, will, without
the prior written consent of the Investor (which consent may be withheld, delayed or conditioned in the Investor’s sole discretion),
effect, enter into, amend the terms of, extend the maturity or term of, or announce or recommend to its stockholders any covenant,
agreement, plan, arrangement or transaction (or issue, amend or waive any security of the Company or any agreement with respect
to any Indebtedness) that would or would reasonably be expected to prohibit, limit, restrict, delay, conflict with or impair the
ability or right of the Company to timely perform its obligations under this Agreement or the Notes, including, without limitation,
the obligation of the Company to timely (i) deliver shares of Common Stock to the Investor or its affiliates in accordance with
this Agreement or the Notes and/or (ii) repay in cash all outstanding principal and other amounts outstanding under the Notes at
maturity or at any other times when payments are required to be made in cash pursuant to the terms of the Notes.  

 

(s)         
Stockholder Approval. If at any time (such time, the “Market Cap Threshold Time”) the sum of (i)
the aggregate number of Conversion Shares issuable under the Notes, without regard to any limitations on conversion set forth in
the Notes, plus (ii) the aggregate number of shares of Common Stock issuable upon conversion, redemption or amortization of the
December 2016 Convertible Note, without regard to any limitations on conversion set forth in the December 2016 Convertible Note
(collectively, the “December 2016 Convertible Note Conversion Shares”), would equal or exceed 49,233,710 shares
of Common Stock, representing 18% of the total number of shares of Common Stock outstanding immediately prior to the issuance of
the December 2016 Convertible Note to the Investor, then, at either (x) the next annual meeting of stockholders of the Company
or (y) a special meeting of stockholders of the Company (the “Stockholder Meeting”), which shall be promptly
called and held not later than 60 days after the Market Cap Threshold Time (the “Stockholder Meeting Deadline”),
the Company shall take all action necessary to obtain the approval of its stockholders of the issuance of all of the Conversion
Shares issuable under the Notes, without regard to any limitations on conversion set forth in the Notes, and the issuance of all
of the December 2016 Convertible Note Conversion Shares issuable under the December 2016 Convertible Note, without regard to any
limitations on conversion set forth in the December 2016 Convertible Note, pursuant to and in accordance with the applicable rules
and regulations of the Principal Market (such affirmative stockholder approval being referred to herein as the “Stockholder
Approval”, and the date such Stockholder Approval is obtained, the “Stockholder Approval Date”). In
connection therewith, the Company shall provide each stockholder entitled to vote at the Stockholder Meeting a proxy statement
soliciting the affirmative vote of the Company’s stockholders necessary to obtain the Stockholder Approval at the Stockholder
Meeting, and the Company shall use its reasonable best efforts to solicit and obtain the Stockholder Approval at the Stockholder
Meeting and to cause the Board of Directors of the Company to recommend, to the extent possible consistent with its fiduciary duties
under Delaware law, to the Company’s stockholders that they vote to approve the Stockholder Approval proposal at the Stockholder
Meeting.

 

    	 	28	 

     

    

 

		5.	REGISTER; TRANSFER AGENT INSTRUCTIONS; NO LEGEND.

 

(a)               
Register. The Company shall maintain at its principal executive offices (or such other office or agency of the Company
as it may designate by notice to each holder of Securities), a register for the Notes in which the Company shall record the name
and address of the Person in whose name the Notes have been issued (including the name and address of each transferee), the principal
amount of the Notes held by such Person, the number of Conversion Shares issuable upon conversion of the Notes held by such Person.
The Company shall keep the register open and available at all times during business hours for inspection of the Investor or its
legal representatives.

 

(b)              
Transfer Agent Instructions. On each Installment Date (as defined in the Notes), and on all such other dates as may
be required for the Company to comply with its obligations under the Notes, the Company shall issue irrevocable instructions to
the Transfer Agent in a form reasonably acceptable to the Investor and its counsel (the “Irrevocable Transfer Agent Instructions”)
to issue certificates or credit shares to the applicable balance accounts at DTC, registered in the name of the Investor or its
respective nominee(s), for the Conversion Shares in such amounts as specified from time to time either by the Company in accordance
with any Installment Conversion in accordance with the terms of the Notes, or by the Investor to the Company upon conversion of
the Notes in such amounts as specified by the Company in accordance with the terms of the Notes. The Company represents and warrants
that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(b) will be given by the
Company to the Transfer Agent with respect to the Securities, and that the Securities shall otherwise be freely transferable on
the books and records of the Company. If the Investor effects a sale, assignment or transfer of the Securities, the Company shall
permit the transfer and shall promptly instruct the Transfer Agent to issue one or more certificates or credit shares to the applicable
balance accounts at DTC in such name and in such denominations as specified by the Investor to effect such sale, transfer or assignment.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Investor. Accordingly,
the Company acknowledges that the remedy at law for a breach of its obligations under this Section 5(b) will be inadequate and
agrees, in the event of a breach or threatened breach by the Company of the provisions of this Section 5(b), that the Investor
shall be entitled, in addition to all other available remedies, to an order and/or injunction restraining any breach and requiring
immediate issuance and transfer, without the necessity of showing economic loss and without any bond or other security being required.

 

(c)               
No Restrictive Legends or Stop Transfer Instructions. Certificates and any other instruments evidencing the Securities
shall not bear any restrictive or other legend and no stop transfer or similar instructions shall be maintained against any of
the Securities.

 

		6.	CLOSING CONDITIONS.

 

(a)               
Conditions of the Company to the Closing. The obligation of the Company to issue and sell the Initial Note to the
Investor at the Initial Closing is subject to the satisfaction, or (where legally permissible) the waiver by the Company, prior
to or at the Initial Closing, and the obligation of the Company to issue and sell the Additional Note, if any, to the Investor
at the Additional Closing is subject to the satisfaction, or (where legally permissible) the waiver by the Company, prior to or
at the Additional Closing, of each of the following conditions:

 

    	 	29	 

     

    

 

(i)                
Representations and Warranties. The representations and warranties of the Investor contained in this Agreement (x)
that are not qualified by “materiality” shall have been true and correct in all material respects when made and shall
be true and correct in all material respects as of the applicable Closing Date with the same force and effect as if made on such
dates, except to the extent such representations and warranties are as of another date, in which case, such representations and
warranties shall be true and correct in all material respects as of such other date and (y) that are qualified by “materiality”
shall have been true and correct when made and shall be true and correct as of the applicable Closing Date with the same force
and effect as if made on such dates, except to the extent such representations and warranties are as of another date, in which
case, such representations and warranties shall be true and correct as of such other date.

 

(ii)              
Performance of the Investor. The Investor shall have performed, satisfied and complied in all material respects with
all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Investor
at or prior to the applicable Closing Date.

 

(iii)            
Registration Statement Effective. The Registration Statement shall continue to be effective and shall be available
for the sale of all Securities contemplated to be issued and sold pursuant to the Transaction Documents and no stop order with
respect to the Registration Statement shall be pending or threatened by the SEC.

 

(iv)            
No Injunction. No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered,
promulgated, threatened or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents.

 

(v)              
No Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any court or governmental authority
shall have been commenced or threatened, and no inquiry or investigation by any governmental authority shall have been commenced
or threatened, against the Company or any Subsidiary, or any of the officers, directors or affiliates of the Company or any Subsidiary,
seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents, or seeking material damages
in connection with such transactions.

 

(vi)            
Agreement; Purchase Price. On the Initial Closing Date, the Investor shall have (x) duly executed and delivered this
Agreement to the Company and (y) paid the Initial Purchase Price (less the amounts withheld pursuant to Section 4(g)) to the Company
for the Initial Note to be issued and sold to the Investor at the Initial Closing, by wire transfer of immediately available funds
in accordance with the Company’s written wire instructions. On the Additional Closing Date, the Investor shall have paid
the Additional Purchase Price to the Company for the Additional Note to be issued and sold to the Investor at the Additional Closing,
by wire transfer of immediately available funds in accordance with the Company’s written wire instructions.

 

(b)              
Conditions of the Investor to the Closing. The obligation of the Investor to purchase the Initial Note at the Initial
Closing is subject to the satisfaction, or (where legally permissible) the waiver by the Investor, prior to or at the Initial Closing,
and the obligation of the Investor to purchase the Additional Note, if any, at the Additional Closing is subject to the satisfaction,
or (where legally permissible) the waiver by the Investor, prior to or at the Additional Closing, of each of the following conditions:

 

    	 	30	 

     

    

 

(i)                
Representations and Warranties. The representations and warranties of the Company contained in this Agreement (x)
that are not qualified by “materiality” or “Material Adverse Effect” shall have been true and correct in
all material respects when made and shall be true and correct in all material respects as of the applicable Closing Date with the
same force and effect as if made on such dates, except to the extent such representations and warranties are as of another date,
in which case, such representations and warranties shall be true and correct in all material respects as of such other date and
(y) that are qualified by “materiality” or “Material Adverse Effect” shall have been true and correct
when made and shall be true and correct as of the applicable Closing Date with the same force and effect as if made on such dates,
except to the extent such representations and warranties are as of another date, in which case, such representations and warranties
shall be true and correct as of such other date.

 

(ii)              
Performance of the Company. The Company shall have performed, satisfied and complied in all material respects with
all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company
at or prior to the applicable Closing Date. The Company shall have delivered to the Investor on the applicable Closing Date a written
certification by an executive officer of the Company to the foregoing effect.

 

(iii)            
Registration Statement Effective. The Registration Statement shall continue to be effective and shall be available
for the sale of all Securities contemplated to be issued and sold pursuant to the Transaction Documents and no stop order with
respect to the Registration Statement shall be pending or threatened by the SEC. The Prospectus Supplement shall have been filed
with the SEC within the applicable time period prescribed for such filing by Rule 424(b) (without reliance on Rule 424(b)(8) of
the Securities Act).

 

(iv)            
No Material Notices. None of the following events shall have occurred and be continuing: (a) receipt of any request
by the SEC or any other federal or state governmental authority for any additional information relating to the Registration Statement,
the Prospectus, the Prospectus Supplement, or any amendment or supplement thereto, or for any amendment of or supplement to the
Registration Statement, the Prospectus, or the Prospectus Supplement; (b) the issuance by the SEC or any other federal or state
governmental authority of any stop order suspending the effectiveness of the Registration Statement or prohibiting or suspending
the use of the Prospectus or the Prospectus Supplement, or of the suspension of qualification or exemption from qualification of
the Securities for offering or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such
purpose; or (c) the occurrence of any event or the existence of any condition or state of facts, which makes any statement of a
material fact made in the Registration Statement, the Prospectus or the Prospectus Supplement untrue or which requires the making
of any additions to or changes to the statements then made in the Registration Statement, the Prospectus or the Prospectus Supplement
in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make the statements
then made therein (in the case of the Prospectus or the Prospectus Supplement, in light of the circumstances under which they were
made) not misleading, or which requires an amendment to the Registration Statement or a supplement to the Prospectus or the Prospectus
Supplement to comply with the Securities Act or any other law. The Company shall have no knowledge of any event that could reasonably
be expected to have the effect of causing the suspension of the effectiveness of the Registration Statement or the prohibition
or suspension of the use of the Prospectus or the Prospectus Supplement in connection with the sale of the Securities.

 

    	 	31	 

     

    

 

(v)              
No Suspension of Trading in or Notice of Delisting of Common Stock. Trading in the Common Stock shall not have been
suspended by the SEC, the Principal Market or the Financial Industry Regulatory Authority (except for any suspension of trading
of less than two (2) days, which suspension shall be terminated prior to the applicable Closing Date), the Company shall not have
received any final and non-appealable notice that the listing or quotation of the Common Stock on the Principal Market shall be
terminated on a date certain (unless, prior to such date certain, the Common Stock is listed or quoted on any other Eligible Market),
trading in securities generally as reported on the Principal Market shall not have been suspended or limited, nor shall a banking
moratorium have been declared either by the U.S. or New York State authorities (except for any suspension, limitation or moratorium
which shall be terminated prior to the applicable Closing Date), there shall not have been imposed any suspension of electronic
trading or settlement services by DTC with respect to the Common Stock that is continuing, the Company shall not have received
any notice from DTC to the effect that a suspension of electronic trading or settlement services by DTC with respect to the Common
Stock is being imposed or is contemplated (unless, prior to such suspension, DTC shall have notified the Company in writing that
DTC has determined not to impose any such suspension), nor shall there have occurred any material outbreak or escalation of hostilities
or other national or international calamity or crisis that has had or would reasonably be expected to have a material adverse change
in any U.S. financial, credit or securities market that is continuing.

 

(vi)            
Compliance with Laws. The Company shall have complied with all applicable federal, state and local governmental laws,
rules, regulations and ordinances in connection with the execution, delivery and performance of this Agreement and the other Transaction
Documents to which it is a party and the consummation of the transactions contemplated hereby and thereby, including, without limitation,
the Company shall have obtained all permits and qualifications required of the Company by any applicable state securities or “Blue
Sky” laws for the offer and sale of the Securities by the Company to the Investor and the subsequent resale of the Securities
by the Investor (or shall have the availability of exemptions therefrom).

 

(vii)          
No Injunction. No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered,
promulgated, threatened or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents.

 

    	 	32	 

     

    

 

(viii)        
No Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any court or governmental authority
shall have been commenced or threatened, and no inquiry or investigation by any governmental authority shall have been commenced
or threatened, against the Company or any Subsidiary, or any of the officers, directors or affiliates of the Company or any Subsidiary,
seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents, or seeking material damages
in connection with such transactions.

 

(ix)            
Listing of Securities. All of the Initial Conversion Shares that may be issued pursuant to the Initial Note shall
have been approved for listing or quotation on the Trading Market as of the Initial Closing Date, without regard to any limitations
on conversion set forth in the Initial Note, subject only to notice of issuance. All of the Additional Conversion Shares that may
be issued pursuant to the Additional Note shall have been approved for listing or quotation on the Trading Market as of the Additional
Closing Date, without regard to any limitations on conversion set forth in the Additional Note, subject only to notice of issuance.

 

(x)              
No Material Adverse Effect. No condition, occurrence, state of facts or event constituting a Material Adverse Effect
shall have occurred and be continuing.

 

(xi)            
Compliance with Terms of Initial Note. With respect to the Additional Closing, prior to such Additional Closing,
the Company shall have complied with all of its obligations pursuant to the Initial Note, including, without limitation, the delivery
on a timely basis of all of the Initial Conversion Shares issuable upon any conversion, redemption or amortization of the Initial
Note.

 

(xii)          
No Restrictive Legends or Stop Transfer Instructions. Certificates and any other instruments evidencing the Securities
shall not bear any restrictive or other legend and no stop transfer Instructions shall be maintained against any of the Securities.

 

(xiii)        
Opinion of Counsel. On the Initial Closing Date, the Investor shall have received an opinion from outside counsel
to the Company, dated the Initial Closing Date, in the form mutually agreed to by the parties hereto prior to the date hereof.
On the Additional Closing Date, the Investor shall have received an opinion from outside counsel to the Company, dated the Additional
Closing Date, in the form mutually agreed to by the parties hereto prior to the date hereof.

 

(xiv)        
Transaction Documents. On the Initial Closing Date, the Company shall have duly executed and delivered to the Investor
(x) this Agreement, (y) the Initial Note registered in the name of the Investor or its designee, and (z) the Irrevocable Transfer
Agent Instructions. On the Additional Closing Date, the Company shall have duly executed and delivered to the Investor the Additional
Note registered in the name of the Investor or its designee.

 

(xv)          
Good Standing. On each Closing Date, the Company shall have delivered a certificate evidencing the formation and
good standing of the Company issued by the Secretary of State of the State of Delaware as of a date within ten (10) days of such
Closing Date.

 

    	 	33	 

     

    

 

(xvi)        
Secretary’s Certificate. On each Closing Date, the Company shall have delivered a certificate, in the form
acceptable to the Investor, executed by the Secretary of the Company and dated as of such Closing Date, as to (x) the resolutions
consistent with Section 3(b) as adopted by the Company’s board of directors in a form reasonably acceptable to the Investor,
(y) the Charter and (z) the Bylaws, each as in effect at such Closing.

 

(xvii)      
Current Public Information. All reports, schedules, registrations, forms, statements, information and other documents
required to have been filed by the Company with the SEC pursuant to the reporting requirements of the Exchange Act, including all
material required to have been filed pursuant to Section 13(a) or 15(d) of the Exchange Act, shall have been filed with the SEC
under the Exchange Act.

 

(xviii)    
No Event of Default; No Equity Conditions Failure. With respect to the Initial Closing, no condition, occurrence,
state of facts or event that would constitute an Event of Default or Equity Conditions Failure (as such terms are defined in the
Notes) shall exist on the Initial Closing Date. With respect to the Additional Closing, (x) no Event of Default (as defined in
the Notes) and no Equity Conditions Failure (as defined in the Notes) shall have occurred with respect to the Initial Note and
(y) no condition, occurrence, state of facts or event that would constitute an Event of Default or Equity Conditions Failure (as
such terms are defined in the Notes) shall exist on the Additional Closing Date.

 

(xix)        
Other Documents. The Company shall have executed and delivered such other documents, instruments or certificates
relating to the transactions contemplated by this Agreement as the Investor or its counsel may reasonably request.

 

		7.	TERMINATION.

 

In the event that (i) the Initial Closing shall
not have occurred within five (5) days after the date hereof or (ii) the Company breaches this Agreement in any material respect
prior to the Initial Closing or the Additional Closing, then the Investor shall have the right to terminate its obligations under
this Agreement at any time on or after the close of business on such date without liability of the Investor to any other party;
provided, however, the right of the Investor to terminate its obligations under this Agreement pursuant to this Section 7 shall
not be available to the Investor if the failure of the transactions contemplated by this Agreement to have been consummated by
such date is the result of the Investor’s breach of this Agreement, provided further that no such termination shall affect
any obligation of the Company under this Agreement to reimburse the Investor for the expenses described in Section 4(g) above.
Nothing contained in this Section 7 shall be deemed to release any party from any liability for any breach by such party of the
terms and provisions of this Agreement or the other Transaction Documents or to impair the right of any party to compel specific
performance by any other party of its obligations under this Agreement or the other Transaction Documents.

 

    	 	34	 

     

    

 

		8.	MISCELLANEOUS.

 

(a)               
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or under any of the other Transaction Documents or in connection herewith or with any transaction contemplated hereby or thereby
or discussed herein or therein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought
in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof
to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall (i) limit, or be deemed to limit, in any way any
right to serve process in any manner permitted by law, (ii) operate, or shall be deemed to operate, to preclude the Investor from
bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company’s obligations
to the Investor or to enforce a judgment or other court ruling in favor of the Investor or (iii) limit, or be deemed to limit,
any provision of Section 21 of the Notes. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST,
A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT OR IN CONNECTION WITH OR ARISING
OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY.

 

(b)              
Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and
the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party.
In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format
(.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

(c)               
Headings; Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or
affect the interpretation of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed
to include the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,” “includes,”
“include” and words of like import shall be construed broadly as if followed by the words “without limitation.”
The terms “herein,” “hereunder,” “hereof” and words of like import refer to this entire Agreement
instead of just the provision in which they are found.

 

    	 	35	 

     

    

 

(d)              
Severability. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed
amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified
continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited
nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the
parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).
Notwithstanding anything to the contrary contained in this Agreement or any other Transaction Document (and without implication
that the following is required or applicable), it is the intention of the parties that in no event shall amounts and value paid
by the Company and/or its Subsidiaries (as the case may be), or payable to or received by the Investor, under the Transaction Documents
(including without limitation, any amounts that would be characterized as “interest” under applicable law) exceed amounts
permitted under any applicable law. Accordingly, if any obligation to pay, payment made to the Investor, or collection by the Investor
pursuant the Transaction Documents is finally judicially determined to be contrary to any such applicable law, such obligation
to pay, payment or collection shall be deemed to have been made by mutual mistake of such Investor, the Company and its Subsidiaries
and such amount shall be deemed to have been adjusted with retroactive effect to the maximum amount or rate of interest, as the
case may be, as would not be so prohibited by the applicable law. Such adjustment shall be effected, to the extent necessary, by
reducing or refunding, at the option of such Investor, the amount of interest or any other amounts which would constitute unlawful
amounts required to be paid or actually paid to such Investor under the Transaction Documents. For greater certainty, to the extent
that any interest, charges, fees, expenses or other amounts required to be paid to or received by such Investor under any of the
Transaction Documents or related thereto are held to be within the meaning of “interest” or another applicable term
to otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time to which they relate.

 

    	 	36	 

     

    

 

(e)               
Entire Agreement; Amendments. This Agreement, the other Transaction Documents and the schedules and exhibits attached
hereto and thereto and the instruments referenced herein and therein supersede all other prior oral or written agreements between
the Investor, the Company, its Subsidiaries, their affiliates and Persons acting on their behalf solely with respect to the matters
contained herein and therein, and this Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and
thereto and the instruments referenced herein and therein contain the entire understanding of the parties solely with respect to
the matters covered herein and therein; provided, however, nothing contained in this Agreement or any other Transaction Document
shall (or shall be deemed to) (i) have any effect on any agreements the Investor or any of its affiliates has entered into with,
or any instruments the Investor or any of its affiliates has received from, the Company or any of its Subsidiaries prior to the
date hereof with respect to any prior investment made by the Investor or any of its affiliates in the Company or (ii) waive, alter,
modify or amend in any respect any obligations of the Company or any of its Subsidiaries, or any rights of or benefits to the Investor
or any of its affiliates or any other Person, in any agreement entered into prior to the date hereof between or among the Company
and/or any of its Subsidiaries and the Investor or any of its affiliates, or any instruments the Investor or any of its affiliates
has received from the Company and/or any of its Subsidiaries prior to the date hereof, and all such agreements and instruments
shall continue in full force and effect. Except as specifically set forth herein or therein, neither the Company nor the Investor
makes any representation, warranty, covenant or undertaking with respect to such matters. For clarification purposes, the Recitals
are part of this Agreement. Provisions of this Agreement may be amended only with the written consent of the Company and the Investor,
and any amendment of any provision of this Agreement made in conformity with the provisions of this Section 8(e) shall be binding
upon the Investor and the Company. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party, and any waiver of any provision of this Agreement made in conformity with the provisions of this Section
8(e) shall be binding on the waiving party. The Company has not, directly or indirectly, made any agreements with the Investor
relating to the terms or conditions of the transactions contemplated by the Transaction Documents except as set forth in the Transaction
Documents. Without limiting the foregoing, the Company confirms that, except as set forth in this Agreement, the Investor has not
made any commitment or promise or has any other obligation to provide any financing to the Company, any Subsidiary or otherwise.
As a material inducement for the Investor to enter into this Agreement, the Company expressly acknowledges and agrees that (i)
no due diligence or other investigation or inquiry conducted by the Investor, any of its advisors or any of its representatives
shall affect the Investor’s right to rely on, or shall modify or qualify in any manner or be an exception to any of, the
Company’s representations and warranties contained in this Agreement or any other Transaction Document, (ii) nothing contained
in the Registration Statement, the Prospectus or the Prospectus Supplement shall affect the Investor’s right to rely on,
or shall modify or qualify in any manner or be an exception to any of, the Company’s representations and warranties contained
in this Agreement or any other Transaction Document and (iii) unless a provision of this Agreement or any other Transaction Document
is expressly preceded by the phrase “except as disclosed in the SEC Documents,” nothing contained in any of the SEC
Documents shall affect the Investor’s right to rely on, or shall modify or qualify in any manner or be an exception to any
of, the Company’s representations and warranties contained in this Agreement or any other Transaction Document.

 

    	 	37	 

     

    

 

(f)               
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms
of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, if delivered personally; (ii)
when sent, if sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on
file by the sending party); (iii) when sent, if sent by e-mail (provided that such sent e-mail is kept on file (whether electronically
or otherwise) by the sending party and the sending party does not receive an automatically generated message from the recipient’s
e-mail server that such e-mail could not be delivered to such recipient) and (iv) if sent by overnight courier service, one (1)
Business Day after deposit with an overnight courier service with next day delivery specified, in each case, properly addressed
to the party to receive the same. The addresses, facsimile numbers and/or e-mail addresses for such communications are as follows:

 

If to the Company:

 

Amyris, Inc.

5885 Hollis Street, Suite 100

Emeryville, CA 94608

Telephone Number: (510) 450-0761

Fax: (510) 225-2645

Email: GeneralCounsel@amyris.com

Attention: General Counsel

 

With a copy (for informational purposes only) to:

 

Fenwick & West LLP

Silicon Valley Center

801 California Street

Mountain View, CA 94041

Telephone Number: (650) 988-8500

Fax: (690) 938-5200

Email: dwinnike@fenwick.com

Attention: Daniel J. Winnike, Esq.

 

If to the Investor:

 

[

 

 

]

 

with a copy (for informational purposes only) to:

 

[

 

 

]

 

or to such other address, facsimile number or e-mail address and/or
to the attention of such other Person as the recipient party has specified by written notice given to each other party five (5)
days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent,
waiver or other communication, (B) mechanically or electronically generated by the sender’s facsimile machine containing
the time, date and recipient facsimile number or (C) provided by an overnight courier service shall be rebuttable evidence of personal
service, receipt by facsimile or receipt from an overnight courier service in accordance with clause (i), (ii) or (iv) above, respectively.
A copy of the e-mail transmission containing the time, date and recipient e-mail address shall be rebuttable evidence of receipt
by e-mail in accordance with clause (iii) above.

 

(g)              
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and assigns, including, as contemplated below, any assignee or transferee of any of the Securities. The Company shall
not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor (which may be
granted or withheld in the Investor’s sole discretion), including, without limitation, by way of a Fundamental Transaction
(as defined in the Notes) (unless the Company is in compliance with the applicable provisions governing Fundamental Transactions
set forth in the Notes). The Investor may assign some or all of its rights hereunder in connection with any assignment or transfer
of any of its Securities without the consent of the Company, in which event such assignee or transferee (as the case may be) shall
be deemed to be an Investor hereunder with respect to such assigned rights.

 

    	 	38	 

     

    

 

(h)              
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person,
other than the Indemnitees referred to in Section 8(k).

 

(i)                
Survival. The representations, warranties, agreements and covenants shall survive the Closing.

 

(j)                
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and
things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may
reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

(k)              
Indemnification.

 

(i)                
In consideration of the Investor’s execution and delivery of the Transaction Documents and acquiring the Securities
thereunder and in addition to all of the Company’s other obligations under the Transaction Documents, the Company shall defend,
protect, indemnify and hold harmless the Investor and each holder of any Securities and all of their stockholders, partners, members,
officers, directors, employees and direct or indirect investors and any of the foregoing Persons’ agents or other representatives
(including, without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively,
the “Indemnitees”) from and against any and all actions, causes of action, suits, claims, losses, costs, penalties,
fees, liabilities and damages, and expenses in connection therewith (irrespective of whether any such Indemnitee is a party to
the action for which indemnification hereunder is sought), and including reasonable attorneys’ fees and disbursements (the
“Indemnified Liabilities”), incurred by any Indemnitee as a result of, or arising out of, or relating to (a)
any misrepresentation or breach of any representation or warranty made by the Company in any of the Transaction Documents, or (b)
any breach of any covenant, agreement or obligation of the Company contained in any of the Transaction Documents. To the extent
that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law.

 

    	 	39	 

     

    

 

(ii)              
Promptly after receipt by an Indemnitee under this Section 8(k) of notice of the commencement of any action or proceeding
(including any governmental action or proceeding) involving an Indemnified Liability, such Indemnitee shall, if a claim in respect
thereof is to be made against the Company under this Section 8(k), deliver to the Company a written notice of the commencement
thereof, and the Company shall have the right to participate in, and, to the extent the Company so desires, to assume control of
the defense thereof with counsel mutually satisfactory to the Company and the Indemnitee; provided, however, that an Indemnitee
shall have the right to retain its own counsel with the fees and expenses of such counsel to be paid by the Company if: (i) the
Company has agreed in writing to pay such fees and expenses; (ii) the Company shall have failed promptly to assume the defense
of such Indemnified Liability and to employ counsel reasonably satisfactory to such Indemnitee in any such Indemnified Liability;
or (iii) the named parties to any such Indemnified Liability (including any impleaded parties) include both such Indemnitee and
the Company, and such Indemnitee shall have been advised by counsel that a conflict of interest is likely to exist if the same
counsel were to represent such Indemnitee and the Company (in which case, if such Indemnitee notifies the Company in writing that
it elects to employ separate counsel at the expense of the Company, then the Company shall not have the right to assume the defense
thereof and such counsel shall be at the expense of the Company), provided further, that in the case of clause (iii) above the
Company shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for such Indemnitee.
The Indemnitee shall reasonably cooperate with the Company in connection with any negotiation or defense of any such action or
Indemnified Liability by the Company and shall furnish to the Company all information reasonably available to the Indemnitee which
relates to such action or Indemnified Liability. The Company shall keep the Indemnitee reasonably apprised at all times as to the
status of the defense or any settlement negotiations with respect thereto. The Company shall not be liable for any settlement of
any action, claim or proceeding effected without its prior written consent, provided, however, that the Company shall not unreasonably
withhold, delay or condition its consent. The Company shall not, without the prior written consent of the Indemnitee, consent to
entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof
the giving by the claimant or plaintiff to such Indemnitee of a release from all liability in respect to such Indemnified Liability
or litigation, and such settlement shall not include any admission as to fault on the part of the Indemnitee. Following indemnification
as provided for hereunder, the Company shall be subrogated to all rights of the Indemnitee with respect to all third parties, firms
or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the Company
within a reasonable time of the commencement of any such action shall not relieve the Company of any liability to the Indemnitee
under this Section 8(k), except to the extent that the Company is materially and adversely prejudiced in its ability to defend
such action.

 

(iii)            
The indemnification required by this Section 8(k) shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as and when bills are received or Indemnified Liabilities are incurred.

 

(iv)            
The indemnity agreement contained herein shall be in addition to (A) any cause of action or similar right of the Indemnitee
against the Company or others, and (B) any liabilities the Company may be subject to pursuant to the law.

 

(l)                
Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party. No specific representation or warranty
shall limit the generality or applicability of a more general representation or warranty. Each and every reference to share prices,
shares of Common Stock and any other numbers in this Agreement that relate to the Common Stock shall be automatically adjusted
for stock splits, stock dividends, stock combinations and other similar transactions that occur with respect to the Common Stock
after the date of this Agreement. It is expressly understood and agreed that for all purposes of this Agreement, and without implication
that the contrary would otherwise be true, neither transactions nor purchases nor sales shall include the location and/or reservation
of borrowable shares of Common Stock. Unless expressly indicated otherwise, all section references are to sections of this Agreement.

 

    	 	40	 

     

    

 

(m)            
Remedies. The Investor and each holder of any Securities shall have all rights and remedies set forth in the Transaction
Documents and all rights and remedies which such holders have been granted at any time under any other agreement or contract and
all of the rights which such holders have under any law. Any Person having any rights under any provision of this Agreement shall
be entitled to enforce such rights specifically (without posting a bond or other security), to recover damages by reason of any
breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore, the Company recognizes
that in the event that it fails to perform, observe, or discharge any or all of its obligations under the Transaction Documents,
any remedy at law may prove to be inadequate relief to the Investor. The Company therefore agrees that the Investor shall be entitled
to seek specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of
competent jurisdiction in any such case without the necessity of proving actual damages and without posting a bond or other security.
The remedies provided in this Agreement and the other Transaction Documents shall be cumulative and in addition to all other remedies
available under this Agreement and the other Transaction Documents, at law or in equity (including, without limitation, a decree
of specific performance and/or other injunctive relief).

 

(n)              
Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) the Transaction Documents, whenever the Investor exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then the Investor may rescind
or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights.

 

(o)              
Payment Set Aside; Currency. To the extent that the Company makes a payment or payments to the Investor hereunder
or pursuant to any of the other Transaction Documents or the Investor enforces or exercises its rights hereunder or thereunder,
and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise
restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law,
foreign, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment
had not been made or such enforcement or setoff had not occurred. Unless otherwise expressly indicated, all dollar amounts referred
to in this Agreement and the other Transaction Documents are in United States Dollars (“U.S. Dollars”), and
all amounts owing under this Agreement and all other Transaction Documents shall be paid in U.S. Dollars. All amounts denominated
in other currencies (if any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on
the date of calculation. “Exchange Rate” means, in relation to any amount of currency to be converted into U.S.
Dollars pursuant to this Agreement, the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date
of calculation.

 

    	 	41	 

     

    

 

(p)              
Judgment Currency.

 

(i)           
If for the purpose of obtaining or enforcing judgment against the Company in any court in any jurisdiction it becomes
necessary to convert into any other currency (such other currency being hereinafter in this Section 8(p) referred to as the “Judgment
Currency”) an amount due in U.S. Dollars under this Agreement or any other Transaction Document, the conversion shall
be made at the Exchange Rate prevailing on the Trading Day immediately preceding: (1) the date actual payment of the amount due,
in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction that will give effect to such
conversion being made on such date or (2) the date on which the foreign court determines, in the case of any proceeding in the
courts of any other jurisdiction (the date as of which such conversion is made pursuant to this Section 8(p)(i) being hereinafter
referred to as the “Judgment Conversion Date”).

 

(ii)         
If in the case of any proceeding in the court of any jurisdiction referred to in Section 8(p)(i) above, there is
a change in the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due,
the applicable party shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency,
when converted at the Exchange Rate prevailing on the date of payment, will produce the amount of U.S. Dollars which could have
been purchased with the amount of Judgment Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing
on the Judgment Conversion Date.

 

(iii)       
Any amount due from the Company under this provision shall be due as a separate debt and shall not be affected by
judgment being obtained for any other amounts due under or in respect of this Agreement or any other Transaction Document.

 

 

 

[signature pages follow]

 

 

 

 

 

 

    	 	42	 

     

    

 

IN WITNESS WHEREOF, the Investor and
the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.

 

	 	COMPANY:	 
	 	 	 	 
	 	AMYRIS, INC.	 
	 	 	 
	 	 	 
	 	By:	 	 
	 	 	Name:	 
	 	 	Title:	 

 

 

 

 

 

 

 

 

 

     

     

    

 

IN WITNESS WHEREOF, the Investor and
the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.

 

 

	 	
        INVESTOR:

         

	 	
        [___________________]

         

         

	 	By: ______________________________

       Name:

       Title:

 

 

 

 

 

 

 

     

     

    

EXHIBIT A

 

ANY TRANSFEREE OF THIS NOTE SHOULD CAREFULLY REVIEW THE TERMS
OF THIS NOTE, INCLUDING SECTIONS 3(c)(iii) AND 16(a) HEREOF. THE PRINCIPAL AMOUNT REPRESENTED BY THIS NOTE AND, ACCORDINGLY, THE
SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION 3(c)(iii)
OF THIS NOTE.

 

Amyris,
Inc.

 

CONVERTIBLE
NOTE

 

	Issuance Date:  [_________], 2017	Original Principal Amount: $[_______]

 

FOR VALUE RECEIVED, Amyris, Inc., a Delaware
corporation (the “Company”), hereby promises to pay to [__________] or registered assigns (the “Holder”)
in cash and/or in shares of Common Stock (as defined below) the amount set out above as the Original Principal Amount (as reduced
pursuant to the terms hereof pursuant to redemption, conversion, amortization or otherwise, the “Principal”)
when due, whether upon the Maturity Date (as defined below), on any Installment Date (as defined below) with respect to the Installment
Amount (as defined below) due on such Installment Date, acceleration, redemption or otherwise (in each case in accordance with
the terms hereof). This Convertible Note (including all Convertible Notes issued in exchange, transfer or replacement hereof, this
“Note”) is one of a series of Convertible Notes issued pursuant to the Securities Purchase Agreement (as defined
below) either on the Initial Closing Date (as defined below) or on the Additional Closing Date (as defined below) (collectively,
the “Notes” and such other Convertible Notes, the “Other Notes”). Certain capitalized terms
used herein are defined in Section 29.

 

2.                 
PAYMENTS OF PRINCIPAL; PREPAYMENT. On each Installment Date, the Company shall pay to the Holder an amount equal
to the Installment Amount due on such Installment Date in accordance with Section 8. On the Maturity Date, the Company shall pay
to the Holder an amount in cash representing all outstanding Principal and accrued and unpaid Late Charges (as defined in Section
22(c)) on such Principal to the extent not otherwise converted into Common Stock pursuant hereto. Other than as specifically permitted
by this Note, the Company may not prepay any portion of the outstanding Principal or accrued and unpaid Late Charges on Principal,
if any. Notwithstanding anything herein to the contrary, if the daily Weighted Average Price of the Common Stock is less than the
Absolute Floor for 10 consecutive Trading Days (an “Acceleration Event”), then an amount equal to 118% of all
outstanding Principal and accrued and unpaid Late Charges on such Principal shall be accelerated and shall become due and payable
by the Company to the Holder in cash within thirty (30) days following such Acceleration Event.

 

    	 	A-1	 

     

    

3.                 
COMPANY OPTIONAL REDEMPTION. At any time or times after the date set out above as the Issuance Date (the “Issuance
Date”), the Company shall have the right to redeem, in whole or in part, the Conversion Amount (as defined below) then
remaining under this Note (each, a “Company Optional Redemption Amount”) on a Company Optional Redemption Date
(each as defined below) (each, a “Company Optional Redemption”). The portion of this Note subject to redemption
pursuant to this Section 2 shall be redeemed by the Company in cash at a price (the “Company Optional Redemption Price”)
equal to 118% of the Conversion Amount being redeemed as of the Company Optional Redemption Date. The Company may exercise its
right to require redemption under this Section 2 by delivering a written notice thereof by facsimile and overnight courier to all,
but not less than all, of the holders of Notes (each, a “Company Optional Redemption Notice” and the date all
of the holders of Notes received such notice is referred to as the “Company Optional Redemption Notice Date”).
The Company may deliver only one Company Optional Redemption Notice hereunder in any twenty (20) Trading Day period and such Company
Optional Redemption Notice shall be irrevocable. The Company Optional Redemption Notice shall (x) state the date on which the Company
Optional Redemption shall occur (the “Company Optional Redemption Date”), which date shall not be less than
five (5) Trading Days nor more than ninety (90) Trading Days following the Company Optional Redemption Notice Date, and (y) state
the aggregate Conversion Amount of the Notes which is being redeemed in such Company Optional Redemption from the Holder and all
of the other holders of the Notes pursuant to this Section 2 on the Company Optional Redemption Date. Notwithstanding anything
herein to the contrary, at any time prior to the date the Company Optional Redemption Price is paid, in full, the Company Optional
Redemption Amount may be converted, in whole or in part, by the Holder into shares of Common Stock pursuant to Section 3. All Conversion
Amounts converted by the Holder after the Company Optional Redemption Notice Date shall reduce the Company Optional Redemption
Amount of this Note required to be redeemed on the Company Optional Redemption Date. In the event of a partial redemption of this
Note pursuant hereto, the Principal amount redeemed shall be deducted in reverse order starting from the final Installment Amount
to be paid hereunder on the final Installment Date, unless the Holder otherwise indicates and allocates among any Installment Dates
hereunder in writing to the Company. Redemptions made pursuant to this Section 2 shall be made in accordance with Section 11. In
the event of the Company’s redemption of any portion of this Note under this Section 2, the Holder’s damages would
be uncertain and difficult to estimate because of the uncertainty of the availability of a suitable substitute investment opportunity
for the Holder. Accordingly, any redemption premium due under this Section 2 is intended by the parties to be, and shall be deemed,
a reasonable estimate of the Holder’s actual loss of its investment opportunity and not as a penalty. If the Company elects
to cause a Company Optional Redemption of this Note pursuant to Section 2, then it must simultaneously take the same action with
respect to all of the Other Notes.

 

4.                 
CONVERSION OF NOTES. At any time or times after the Issuance Date, this Note shall be convertible into validly issued,
fully paid and non-assessable shares of Common Stock on the terms and conditions set forth in this Section 3.

 

(a)               
Conversion Right. Subject to the provisions of Section 3(d), at any time or times on or after the Issuance Date,
the Holder shall be entitled to convert any portion of the outstanding and unpaid Conversion Amount into validly issued, fully
paid and non-assessable shares of Common Stock in accordance with Section 3(c), at the Conversion Rate (as defined below). The
Company shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance
of a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest whole
share. The Company shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation,
fees and expenses of the Transfer Agent (as defined below)) that may be payable with respect to the issuance and delivery of Common
Stock upon conversion of any Conversion Amount.

 

    	 	A-2	 

     

    

(b)              
Conversion Rate. The number of shares of Common Stock issuable upon conversion of any Conversion Amount pursuant
to Section 3(a) shall be determined by dividing (x) such Conversion Amount by (y) the Conversion Price (the “Conversion
Rate”).

 

(i)                
“Conversion Amount” means the sum of (A) the portion of the Principal to be converted, amortized, deferred,
accelerated, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid Late Charges,
if any, with respect to such Principal.

 

(ii)              
“Conversion Price” means, as of any Conversion Date or other date of determination, $1.90 per share,
subject to adjustment as provided herein.

 

(c)               
Mechanics of Conversion.

 

(i)                
Optional Conversion. To convert any Conversion Amount into shares of Common Stock on any date (a “Conversion
Date”), the Holder shall (A) transmit by facsimile or electronic mail (or otherwise deliver), for receipt on or prior
to 11:59 p.m., New York time, on such date, a copy of an executed notice of conversion in the form attached hereto as Exhibit
I (the “Conversion Notice”) to the Company and (B) if required by Section 3(c)(iii), surrender this Note
to a common carrier for delivery to the Company as soon as practicable on or following such date (or an indemnification undertaking
with respect to this Note in the case of its loss, theft or destruction). On or before the first (1st) Business Day following the
date of receipt of a Conversion Notice, the Company shall transmit by facsimile or electronic mail a confirmation of receipt of
such Conversion Notice to the Holder and the Transfer Agent. On or before the third (3rd) Trading Day following the date of receipt
of a Conversion Notice (the “Share Delivery Date”), the Company shall (x) provided that the Company's transfer
agent (the “Transfer Agent”) is participating in the Depository Trust Company (“DTC”) Fast
Automated Securities Transfer Program, credit such aggregate number of shares of Common Stock to which the Holder shall be entitled
to the Holder's or its designee's balance account with DTC through its Deposit Withdrawal At Custodian system or (y) if the Transfer
Agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver to the address as specified
in the Conversion Notice, a certificate, registered in the name of the Holder or its designee, for the number of shares of Common
Stock to which the Holder shall be entitled. If this Note is physically surrendered for conversion as required by Section 3(c)(iii)
and the outstanding Principal of this Note is greater than the Principal portion of the Conversion Amount being converted, then
the Company shall as soon as practicable and in no event later than three (3) Business Days after receipt of this Note and at its
own expense, issue and deliver to the Holder a new Note (in accordance with Section 16(d)) representing the outstanding Principal
not converted. The Person or Persons entitled to receive the shares of Common Stock issuable upon a conversion of this Note shall
be treated for all purposes as the record holder or holders of such shares of Common Stock on the Conversion Date, irrespective
of the date such Conversion Shares are credited to the Holder's account with DTC or the date of delivery of the certificates evidencing
such Conversion Shares, as the case may be. In the event that the Holder elects to convert a portion of the Principal amount of
this Note prior to any applicable Installment Date, the Conversion Amount so converted shall be deducted in reverse order starting
from the final Installment Amount to be paid hereunder on the final Installment Date, unless the Holder otherwise indicates and
allocates among any Installment Dates hereunder in the applicable Conversion Notice. Notwithstanding anything to the contrary contained
in this Note, the Company shall cause the Transfer Agent to deliver unlegended shares of Common Stock to the Holder (or its designee)
for delivery via DTC to the transferee in connection with any sale of Conversion Shares with respect to which the Holder has entered
into a contract for sale and for which the Holder has not yet settled.

 

    	 	A-3	 

     

    

(ii)              
Company's Failure to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the
Share Delivery Date, to issue and deliver a certificate to the Holder, if the Transfer Agent is not participating in the DTC Fast
Automated Securities Transfer Program, or credit the Holder's balance account with DTC, if the Transfer Agent is participating
in the DTC Fast Automated Securities Transfer Program, for the number of shares of Common Stock to which the Holder is entitled
upon the Holder's conversion of any Conversion Amount (a “Conversion Failure”), then, in addition to all other
remedies available to the Holder, (1) the Company shall pay in cash to the Holder on each day after such Share Delivery Date that
the issuance of such shares of Common Stock is not timely effected an amount equal to one percent (1%) of the product of (A) the
sum of the number of shares of Common Stock not issued to the Holder on a timely basis and to which the Holder is entitled multiplied
by (B) the Closing Sale Price (as defined below) of the Common Stock on the Trading Day immediately preceding the last possible
date which the Company could have issued such shares of Common Stock to the Holder without violating Section 3(c)(i) and (2) the
Holder, upon written notice to the Company, may void its Conversion Notice with respect to, and retain or have returned (as the
case may be) any portion of this Note that has not been converted pursuant to such Conversion Notice, provided that the voiding
of a Conversion Notice shall not affect the Company’s obligations to make any payments which have accrued prior to the date
of such notice pursuant to this Section 3(c)(ii)(1) or otherwise. In addition to the foregoing, if a Conversion Failure shall have
occurred, and if on or after the applicable Share Delivery Date the Holder purchases (in an open market transaction or otherwise)
shares of Common Stock to deliver in satisfaction of a sale by the Holder of Common Stock issuable upon such conversion that the
Holder anticipated receiving from the Company (a “Buy-In”), then, in addition to all other remedies available
to the Holder, the Company shall, within three (3) Trading Days after the Holder's request and in the Holder's discretion, either
(x) pay cash to the Holder in an amount equal to the Holder's total purchase price (including brokerage commissions and other out-of-pocket
expenses, if any) for the shares of Common Stock so purchased (the “Buy-In Price”), at which point the Company's
obligation to issue and deliver such certificate or credit the Holder's balance account with DTC for the shares of Common Stock
to which the Holder is entitled upon the Holder's conversion of the applicable Conversion Amount shall terminate, or (y) promptly
honor its obligation to deliver to the Holder a certificate or certificates representing such shares of Common Stock or credit
the Holder's balance account with DTC for such shares of Common Stock and pay cash to the Holder in an amount equal to the excess
(if any) of the Buy-In Price over the product of (I) such number of shares of Common Stock, times (II) the lowest Closing Sale
Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Conversion Notice and ending
on the Trading Day immediately preceding the date of such issuance and payment under this clause (y).

 

    	 	A-4	 

     

    

(iii)            
Book-Entry. Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Note
in accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Company unless (A)
the full Conversion Amount represented by this Note is being converted or (B) the Holder has provided the Company with prior written
notice (which notice may be included in a Conversion Notice) requesting reissuance of this Note upon physical surrender of this
Note. The Holder and the Company shall maintain records showing the Principal and Late Charges, if any, converted and the dates
of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as not to require
physical surrender of this Note upon conversion.

 

(iv)            
Disputes. In the event of a dispute as to the number of shares of Common Stock issuable to the Holder in connection
with a conversion of this Note, the Company shall issue to the Holder the number of shares of Common Stock not in dispute and resolve
such dispute in accordance with Section 21.

 

(d)              
Limitations on Conversions.

 

    	 	A-5	 

     

    

(i)                
Beneficial Ownership. The Company shall not effect the conversion of any portion of this Note, and the Holder shall
not have the right to convert any portion of this Note pursuant to the terms and conditions of this Note and any such conversion
shall be null and void and treated as if never made, to the extent that after giving effect to such conversion, the Holder together
with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the “Maximum Percentage”)
of the shares of Common Stock outstanding immediately after giving effect to such conversion. For purposes of the foregoing sentence,
the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution Parties (as defined below)
shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares
of Common Stock issuable upon conversion of this Note with respect to which the determination of such sentence is being made, but
shall exclude shares of Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted portion of this
Note beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised
or nonconverted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible
preferred stock or warrants) beneficially owned by the Holder or any other Attribution Party subject to a limitation on conversion
or exercise analogous to the limitation contained in this Section 3(d)(i). For purposes of this Section 3(d)(i), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act. For purposes of determining the number of outstanding
shares of Common Stock the Holder may acquire upon the conversion of this Note without exceeding the Maximum Percentage, the Holder
may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report
on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case may be,
(y) a more recent public announcement by the Company or (z) any other written notice by the Company or the Transfer Agent, if any,
setting forth the number of shares of Common Stock outstanding (the “Reported Outstanding Share Number”). If
the Company receives a Conversion Notice from the Holder at a time when the actual number of outstanding shares of Common Stock
is less than the Reported Outstanding Share Number, the Company shall notify the Holder in writing of the number of shares of Common
Stock then outstanding and, to the extent that such Conversion Notice would otherwise cause the Holder’s beneficial ownership,
as determined pursuant to this Section 3(d)(i), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced
number of shares of Common Stock to be purchased pursuant to such Conversion Notice. For any reason at any time, upon the written
or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail
to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock
shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Note, by the
Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event
that the issuance of shares of Common Stock to the Holder upon conversion of this Note results in the Holder and the other Attribution
Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares
of Common Stock (as determined under Section 13(d) of the Exchange Act), the number of shares so issued by which the Holder’s
and the other Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”)
shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer
the Excess Shares. Upon delivery of a written notice to the Company, the Holder may from time to time increase (with such increase
not effective until the sixty-first (61st) day after delivery of such notice) or decrease the Maximum Percentage to any other percentage
not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective
until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or decrease will apply
only to the Holder and the other Attribution Parties and not to any other holder of Notes that is not an Attribution Party of the
Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Note in excess of the Maximum
Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or
Rule 16a-1(a)(1) of the Exchange Act. No prior inability to convert this Note pursuant to this paragraph shall have any effect
on the applicability of the provisions of this paragraph with respect to any subsequent determination of convertibility. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section
3(d)(i) to the extent necessary to correct this paragraph (or any portion of this paragraph) which may be defective or inconsistent
with the intended beneficial ownership limitation contained in this Section 3(d)(i) or to make changes or supplements necessary
or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not be waived and shall
apply to a successor holder of this Note. For the purpose of this Section 3(d)(i), “Attribution Parties” means,
collectively, the following Persons and entities: (A) any investment vehicle, including, any funds, feeder funds or managed accounts,
currently, or from time to time after the Issuance Date, directly or indirectly managed or advised by the Holder’s investment
manager or any of its affiliates or principals, (B) any direct or indirect affiliates of the Holder or any of the foregoing, (C)
any Person acting or who could be deemed to be acting as a “group” (as that term is used in Section 13(d) of the 1934
Act and as defined in Rule 13d-5 thereunder) together with the Holder or any of the foregoing and (D) any other Persons whose beneficial
ownership of the Company’s Common Stock would or could be aggregated with the Holder’s and the other Attribution Parties
for purposes of Section 13(d) of the Exchange Act. For clarity, the purpose of the foregoing is to subject collectively the Holder
and all other Attribution Parties to the Maximum Percentage.

 

    	 	A-6	 

     

    

(ii)              
Principal Market Regulation. The Company shall not issue any shares of Common Stock upon conversion of this Note
or otherwise pursuant to the terms of this Note if the issuance of such shares of Common Stock (taken together with the issuance
of all other shares of Common Stock upon conversion of the Other Notes or otherwise pursuant to the terms of the Notes and taken
together with the issuance of all shares of Common Stock issued and issuable pursuant to any transaction or series of transactions
that may be aggregated with the transactions contemplated by the Securities Purchase Agreement under the rules or regulations of
the Principal Market) would exceed the aggregate number of shares of Common Stock which the Company may issue upon conversion of
the Notes and or otherwise pursuant to the terms of the Notes without breaching the Company’s obligations under the rules
or regulations of the Principal Market (the number of shares which may be issued without violating such rules and regulations,
the “Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the
approval of its stockholders as required by the applicable rules of the Principal Market for issuances of shares of Common Stock
in excess of such amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required,
which opinion shall be reasonably satisfactory to the Holder. Until such approval or such written opinion is obtained, no Holder
shall be issued in the aggregate, upon conversion of any Notes or otherwise pursuant to the terms of the Notes, shares of Common
Stock in an amount greater than the Exchange Cap. In the event that the Company is prohibited from issuing any shares of Common
Stock pursuant to this Section 3(d)(ii) (the “Exchange Cap Shares”), the Company shall pay cash in exchange
for cancellation of the Conversion Amount that is subject to such Conversion Notice in an amount equal to the sum of (i) the product
of (x) such number of Exchange Cap Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during
the period commencing on the date the Holder delivers the applicable Conversion Notice with respect to such Exchange Cap Shares
to the Company and ending on the Trading Day immediately preceding the date of such issuance and payment under this Section 3(d)(ii)
and (ii) to the extent the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction
of a sale by the Holder of Exchange Cap Shares, any brokerage commissions and other reasonable out-of-pocket expenses, if any,
of the Holder incurred in connection therewith.

 

    	 	A-7	 

     

    

5.                 
RIGHTS UPON EVENT OF DEFAULT.

 

(a)               
Event of Default. Each of the following events shall constitute an “Event of Default”:

 

(i)                
the suspension from trading or failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market
for a period of three (3) consecutive Trading Days or for more than an aggregate of ten (10) Trading Days in any 365-day period;

 

(ii)              
the Company's (A) failure to cure a Conversion Failure by delivery of the required number of shares of Common Stock (or
cash amount in accordance with Section 3(d)(ii), if applicable) within five (5) Business Days after the applicable Conversion Date
or (B) notice, written or oral, to the Holder or any holder of the Other Notes, including by way of public announcement or through
any of its agents, at any time, of its intention not to comply with a request for conversion of this Note or any Other Notes into
shares of Common Stock that is tendered in accordance with the provisions of this Note or the Other Notes, other than pursuant
to Section 3(d) (and analogous provisions under the Other Notes);

 

(iii)            
except to the extent the Company is in compliance with Section 10(b) below, at any time following the tenth (10th)
consecutive Business Day that the Company does not have reserved out of its authorized and unissued shares of Common Stock the
number of shares of Common Stock that the Holder would be entitled to receive upon a conversion of the full Conversion Amount of
this Note (without regard to any limitations on conversion set forth in Section 3(d) or otherwise);

 

(iv)            
the Company's failure to pay to the Holder any amount of Principal, Late Charges or other amounts when and as due under
this Note (including, without limitation, the Company's failure to pay any redemption, Late Charges or other amounts), or any other
Transaction Document (as defined in the Securities Purchase Agreement) or any other agreement, document, certificate or other instrument
delivered in connection with the transactions contemplated hereby and thereby to which the Holder is a party, if such failure continues
for a period of at least an aggregate of five (5) Business Days;

 

(v)              
any restrictive legend is placed on any certificate evidencing, or any stop transfer order is maintained against, any shares
of Common Stock issued to the Holder upon conversion of the Notes;

 

(vi)            
the Company or any of its Subsidiaries, pursuant to or within the meaning of Title 11, U.S. Code, or any similar Federal,
foreign or state law for the relief of debtors (collectively, “Bankruptcy Law”), (A) commences a voluntary case
or proceeding, (B) consents to the entry of an order for relief against it in an involuntary case or proceeding, (C) consents to
the appointment of a receiver, trustee, assignee, liquidator or similar official (a “Custodian”), (D) makes
a general assignment for the benefit of its creditors, (E) admits in writing that it is generally unable to pay its debts as they
become due, (F) taking of any action by any Person to commence a Uniform Commercial Code foreclosure sale or any other similar
action under federal, state or foreign law or (G) the taking of corporate action by the Company or any Subsidiary in furtherance
of any of the foregoing;

 

    	 	A-8	 

     

    

(vii)          
a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that (A) is for relief against the
Company or any of its Subsidiaries in an involuntary case, (B) appoints a Custodian of the Company or any of its Subsidiaries,
or (C) orders the liquidation of the Company or any of its Subsidiaries;

 

(viii)        
a final judgment or judgments for the payment of money aggregating in excess of $10,000,000 are rendered against the Company
or any of its Subsidiaries and which judgments are not; provided, however, that any judgment which is covered by
insurance or an indemnity from a credit worthy party shall not be included in calculating the $10,000,000 amount set forth above
so long as the Company provides the Holder a written statement from such insurer or indemnity provider (which written statement
shall be reasonably satisfactory to the Holder) to the effect that such judgment is covered by insurance or an indemnity;

 

(ix)            
the Company and/or any Subsidiary, individually or in the aggregate, fails to pay, when due, or within any applicable grace
period, any payment with respect to any Indebtedness in excess of $10,000,000 due to any third party (other than, with respect
to unsecured Indebtedness only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by
proper proceedings and with respect to which adequate reserves have been set aside for the payment thereof in accordance with GAAP)
or is otherwise in breach or violation of any agreement for monies owed or owing in an amount in excess of $10,000,000, which breach
or violation results in the acceleration of amounts due thereunder;

 

(x)              
other than as specifically set forth in another clause of this Section 4(a), the Company or any of its Subsidiaries breaches
any representation or warranty in any material respect (except with respect to any representation or warranty qualified by material
or material adverse effect, in any respect) or breaches any covenant or other term or condition of any Transaction Document, except,
in the case of a breach of a representation, warranty, covenant or other term or condition of any Transaction Document which is
curable, only if such breach continues for a period of at least an aggregate of ten (10) consecutive Business Days after notice
thereof;

 

(xi)            
any breach or failure in any respect to comply with any of Sections 1, 3, 4(b), 5(b), 8, 13(a), 13(b), 13(c) or 13(d) of
this Note;

 

(xii)          
a false or inaccurate certification (including a false or inaccurate deemed certification) by the Company that the Equity
Conditions are satisfied or that there has been no Equity Conditions Failure or as to whether any Event of Default or Change of
Control has occurred;

 

    	 	A-9	 

     

    

(xiii)        
any Event of Default (as defined in the Other Notes) occurs with respect to any Other Notes;

 

(xiv)        
any Material Adverse Effect (as defined in the Securities Purchase Agreement) has occurred and is continuing; or

 

(xv)          
any breach or failure by the Company in any respect to fully comply with all of its obligations, covenants and agreements
contained in Section 4(i) of the Securities Purchase Agreement.

 

(b)              
Event of Default Redemption Right. Upon the occurrence of an Event of Default with respect to this Note or any Other
Note, the Company shall within one (1) Business Day of obtaining knowledge thereof deliver written notice thereof via facsimile
or electronic mail and overnight courier (an “Event of Default Notice”) to the Holder. At any time after the
earlier of the Holder's receipt of an Event of Default Notice and the Holder becoming aware of an Event of Default, the Holder
may require the Company to redeem (an “Event of Default Redemption”) all or any portion of this Note by delivering
written notice thereof (the “Event of Default Redemption Notice”) to the Company, which Event of Default Redemption
Notice shall indicate the portion of this Note the Holder is electing to require the Company to redeem. Each portion of this Note
subject to redemption by the Company pursuant to this Section 4(b) shall be redeemed by the Company in cash by wire transfer of
immediately available funds at a price equal to the greater of (x) 118% of the Conversion Amount being redeemed and (y) the product
of (A) the Conversion Amount being redeemed and (B) the quotient determined by dividing (I) the greatest Closing Sale Price of
the shares of Common Stock during the period beginning on the date immediately preceding such Event of Default and ending on the
Trading Day immediately preceding the date Company makes the entire payment required to be made under this Section 4(b), by (II)
the lowest Installment Conversion Price in effect during such period (the “Event of Default Redemption Price”).
Redemptions required by this Section 4(b) shall be made in accordance with the provisions of Section 11. To the extent redemptions
required by this Section 4(b) are deemed or determined by a court of competent jurisdiction to be prepayments of the Note by the
Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this Section
4, but subject to Section 3(d), until the Event of Default Redemption Price (together with any Late Charges thereon) is paid in
full, the Conversion Amount submitted for redemption under this Section 4(b) (together with any Late Charges thereon) may be converted,
in whole or in part, by the Holder into Common Stock pursuant to Section 3. In the event of a partial redemption of this Note pursuant
hereto, the Principal amount redeemed shall be deducted in reverse order starting from the final Installment Amount to be paid
hereunder on the final Installment Date, unless the Holder otherwise indicates and allocates among any Installment Dates hereunder
in the applicable Event of Default Redemption Notice. The parties hereto agree that in the event of the Company's redemption of
any portion of the Note under this Section 4(b), the Holder's damages would be uncertain and difficult to estimate because of the
uncertainty of the availability of a suitable substitute investment opportunity for the Holder. Accordingly, any Event of Default
redemption premium due under this Section 4(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of
the Holder's actual loss of its investment opportunity and not as a penalty.

 

    	 	A-10	 

     

    

6.                 
RIGHTS UPON FUNDAMENTAL TRANSACTION AND CHANGE OF CONTROL.

 

(a)               
Assumption. The Company shall not enter into or be party to a Fundamental Transaction unless (i)  the Successor
Entity assumes in writing all of the obligations of the Company under this Note and the other Transaction Documents in accordance
with the provisions of this Section 5(a) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder prior to such Fundamental Transaction, including agreements, if so requested by the Holder, to deliver
to each holder of Notes in exchange for such Notes a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to the Notes, including, without limitation, having a principal amount equal to the principal amounts
of the Notes then outstanding held by such holder, having similar conversion rights and having similar ranking and security to
the Notes, and reasonably satisfactory to the Holder and (ii) except with respect to a Change of Control in which the Company (or
the Successor Entity, as applicable) complies with Section 5(b) in all respects, the Successor Entity (including its Parent Entity)
is a publicly traded corporation whose common capital stock is quoted on or listed for trading on an Eligible Market (a “Public
Company”). Any security issuable or potentially issuable to the Holder pursuant to the terms of this Note on the consummation
of a Fundamental Transaction shall be registered and freely tradable by the Holder without any restriction or limitation or the
requirement to be subject to any holding period pursuant to any applicable law. Upon the occurrence of any Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction,
the provisions of this Note and the other Transaction Documents referring to the “Company” shall refer instead to the
Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company
under this Note and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company
herein. If the Successor Entity (or its Parent Entity) is a Public Company and the Company (or the Successor Entity), as applicable,
complies with Section 5(b) below in all respects, upon consummation of a Fundamental Transaction, the Successor Entity shall deliver
to the Holder confirmation that there shall be issued upon conversion or redemption of this Note at any time after the consummation
of such Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except
such items still issuable under Section 6 which shall continue to be receivable thereafter) issuable upon the conversion or redemption
of the Notes prior to such Fundamental Transaction, such shares of the publicly traded common stock (or their equivalent) of the
Successor Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the happening of such
Fundamental Transaction had this Note been converted immediately prior to such Fundamental Transaction (without regard to any limitations
on the conversion of this Note), as adjusted in accordance with the provisions of this Note. Notwithstanding the foregoing, the
Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section 5(a) to permit the Fundamental
Transaction without the assumption of this Note. In addition to and not in substitution for any other rights hereunder, prior to
the occurrence or consummation of any Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled
to receive securities, cash, assets or other property with respect to or in exchange for shares of Common Stock (a “Corporate
Event”), the Company shall make appropriate provision to insure that, and any applicable Successor Entity or Successor
Entities shall ensure that the Holder will thereafter have the right to receive upon conversion of this Note at any time after
the occurrence or consummation of the Corporate Event, shares of Common Stock or Successor capital stock or, if so elected by the
Holder, in lieu of the shares of Common Stock (or other securities, cash, assets or other property) purchasable upon the conversion
of this Note prior to such Corporate Event (but not in lieu of such items still issuable under Sections 6(a) and 6(b), which shall
continue to be receivable on the Common Stock or on such shares of stock, securities, cash, assets or any other property otherwise
receivable with respect to or in exchange for shares of Common Stock), such shares of stock, securities, cash, assets or any other
property whatsoever (including warrants or other purchase or subscription rights and any shares of Common Stock) which the Holder
would have been entitled to receive upon the occurrence or consummation of such Corporate Event or the record, eligibility or other
determination date for the event resulting in such Corporate Event, had this Note been converted immediately prior to such Corporate
Event or the record, eligibility or other determination date for the event resulting in such Corporate Event (without regard to
any limitations on conversion of this Note) (the “Change of Control Consideration”). Provision made pursuant
to the preceding sentence shall be in a form and substance reasonably satisfactory to the Holder. The provisions of this Section
5(a) shall apply similarly and equally to successive Fundamental Transactions.

 

    	 	A-11	 

     

    

(b)              
Change of Control Redemption Right. Promptly after the public announcement of such Change of Control, the Company
shall deliver written notice thereof via facsimile or electronic mail and overnight courier to the Holder (a “Change of
Control Notice”). At any time during the period beginning on the earlier to occur of (x) any oral or written agreement
by the Company or any of its Subsidiaries, upon consummation of which the transaction contemplated thereby would reasonably be
expected to result in a Change of Control, (y) the Holder becoming aware of a Change of Control and (z) the Holder's receipt of
a Change of Control Notice and ending twenty-five (25) Trading Days after the date of the consummation of such Change of Control,
the Holder may require the Company to redeem (a “Change of Control Redemption”) all or any portion of this Note
by delivering written notice thereof (“Change of Control Redemption Notice”) to the Company, which Change of
Control Redemption Notice shall indicate the Conversion Amount the Holder is electing to require the Company to redeem. The portion
of this Note subject to redemption pursuant to this Section 5(b) shall be redeemed by the Company in cash by wire transfer of immediately
available funds at a price equal to the greatest of (x) 118% of the Conversion Amount being redeemed, (y) the product of (A) the
Conversion Amount being redeemed and (B) the quotient determined by dividing (I) the greatest Closing Sale Price of the shares
of Common Stock during the period beginning on the date immediately preceding the earlier to occur of (x) the consummation of the
Change of Control and (y) the public announcement of such Change of Control and ending on the date the Holder delivers the Change
of Control Redemption Notice, by (II) the lowest Installment Conversion Price in effect during such period and (z) the product
of (A) the Conversion Amount being redeemed multiplied by (B) the quotient of (I) the aggregate cash consideration and the aggregate
cash value of any non-cash consideration per share of Common Stock to be paid to the holders of the shares of Common Stock upon
consummation of such Change of Control (any such non-cash consideration constituting publicly-traded securities shall be valued
at the highest of the Closing Sale Price of such securities as of the Trading Day immediately prior to the consummation of such
Change of Control, the Closing Sale Price of such securities on the Trading Day immediately following the public announcement of
such proposed Change of Control and the Closing Sale Price of such securities on the Trading Day immediately prior to the public
announcement of such proposed Change of Control) divided by (II) the lowest Installment Conversion Price in effect during such
period (the “Change of Control Redemption Price”). Redemptions required by this Section 5 shall be made in accordance
with the provisions of Section 11. To the extent redemptions required by this Section 5(b) are deemed or determined by a court
of competent jurisdiction to be prepayments of the Note by the Company, such redemptions shall be deemed to be voluntary prepayments.
Notwithstanding anything to the contrary in this Section 5, but subject to Section 3(d), until the Change of Control Redemption
Price (together with any Late Charges thereon) is paid in full, the Conversion Amount submitted for redemption under this Section
5(b) (together with any Late Charges thereon) may be converted, in whole or in part, by the Holder into Common Stock (or, if after
the date of consummation of such Change of Control, into the applicable Change of Control Consideration) pursuant to Section 3.
In the event of a partial redemption of this Note pursuant hereto, the Principal amount redeemed shall be deducted in reverse order
starting from the final Installment Amount to be paid hereunder on the final Installment Date, unless the Holder otherwise indicates
and allocates among any Installment Dates hereunder in the applicable Change of Control Redemption Notice. The parties hereto agree
that in the event of the Company's redemption of any portion of the Note under this Section 5(b), the Holder's damages would be
uncertain and difficult to estimate because of the uncertainty of the availability of a suitable substitute investment opportunity
for the Holder. Accordingly, any Change of Control redemption premium due under this Section 5(b) is intended by the parties to
be, and shall be deemed, a reasonable estimate of the Holder's actual loss of its investment opportunity and not as a penalty.

 

    	 	A-12	 

     

    

7.                 
DISTRIBUTION OF ASSETS; RIGHTS UPON ISSUANCE OF PURCHASE RIGHTS AND OTHER CORPORATE EVENTS.

 

(a)               
Distribution of Assets. If the Company shall declare or make any dividend or other distributions of its assets (or
rights to acquire its assets) to all or substantially all of the holders of shares of Common Stock, by way of return of capital
or otherwise (including without limitation, any distribution of cash, stock or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the “Distributions”),
then the Holder will be entitled to such Distributions as if the Holder had held the number of shares of Common Stock acquirable
upon complete conversion of this Note (without taking into account any limitations or restrictions on the convertibility of this
Note) immediately prior to the date on which a record is taken for such Distribution or, if no such record is taken, the date as
of which the record holders of Common Stock are to be determined for such Distributions (provided, however, that
to the extent that the Holder's right to participate in any such Distribution would result in the Holder and its Affiliates exceeding
the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (and shall not
be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution (and beneficial ownership)
to such extent) and the portion of such Distribution shall be held in abeyance for the Holder until such time or times as its right
thereto would not result in the Holder and its Affiliates exceeding the Maximum Percentage, at which time or times the Holder shall
be granted such rights (and any rights under this Section 6(a) on such initial rights or on any subsequent such rights to be held
similarly in abeyance) to the same extent as if there had been no such limitation).

 

    	 	A-13	 

     

    

(b)              
Purchase Rights. If at any time the Company grants, issues or sells any Options, Convertible Securities or rights
to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common Stock (the “Purchase
Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate
Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon
complete conversion of this Note (without taking into account any limitations or restrictions on the convertibility of this Note)
immediately prior to the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or
sale of such Purchase Rights (provided, however, that to the extent that the Holder's right to participate in any
such Purchase Right would result in the Holder and its Affiliates exceeding the Maximum Percentage, then the Holder shall not be
entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership of such shares
of Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and such Purchase Right to such extent
shall be held in abeyance for the Holder until such time or times as its right thereto would not result in the Holder and its Affiliates
exceeding the Maximum Percentage, at which time or times the Holder shall be granted such right (and any Purchase Right granted,
issued or sold on such initial Purchase Right or on any subsequent Purchase Right to be held similarly in abeyance) to the same
extent as if there had been no such limitation).

 

8.                 
RIGHTS UPON ISSUANCE OF OTHER SECURITIES.

 

(a)               
Adjustment of Conversion Price upon Subdivision or Combination of Common Stock. If the Company at any time on or
after the Issuance Date subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its
outstanding shares of Common Stock into a greater number of shares, the Conversion Price in effect immediately prior to such subdivision
will be proportionately reduced. If the Company at any time on or after the Issuance Date combines (by combination, reverse stock
split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Conversion
Price in effect immediately prior to such combination will be proportionately increased. Any adjustment pursuant to this Section
7(a) shall become effective immediately after the effective date of such subdivision or combination.

 

(b)              
Voluntary Adjustment by Company. The Company may at any time during the term of this Note, with the prior written
consent of the Holder, reduce the then current Conversion Price to any amount and for any period of time deemed appropriate by
the Board of Directors of the Company. The Company may at any time during the term of this Note, without the prior written consent
of the Holder, either (i) reduce the Floor Price (as defined below) to any amount and for any period of time deemed appropriate
by the Board of Directors of the Company or (ii) waive the application of the Floor Price to the Installment Conversion (defined
below) and any Acceleration (defined below) by the Holder pursuant to Section 8 with respect to the entire applicable Installment
Period (defined below).

 

    	 	A-14	 

     

    

9.                 
INSTALLMENT CONVERSION OR REDEMPTION.

 

(a)               
General. On each applicable Installment Date (as defined below), provided there has been no Equity Conditions Failure
(as defined below), the Company shall pay to the Holder of this Note the Installment Amount due on such date by the conversion
of all or some of such Installment Amount into Common Stock, in accordance with this Section 8 (a “Installment Conversion”);
provided, however, that the Company may, at its option following notice to the Holder as set forth below, pay the
Installment Amount by redeeming such Installment Amount in cash (a “Installment Redemption”) or by any combination
of an Installment Conversion and an Installment Redemption so long as all of the outstanding applicable Installment Amount due
on any Installment Date shall be converted and/or redeemed by the Company on the applicable dates set forth in this Section 8,
subject to the provisions of this Section 8. On or prior to the date which is the fifth (5th) Trading Day prior to each Installment
Date (each, an “Installment Notice Due Date”), the Company shall deliver written notice (each, a “Company
Installment Notice” and the date all of the Holders receive such notice is referred to as the “Company Installment
Notice Date”), to each holder of Notes which Company Installment Notice shall (i) either (A) confirm that the applicable
Installment Amount of the Holder's Note shall be converted to Common Stock in whole or in part pursuant to an Installment Conversion
(such amount to be converted, the “Installment Conversion Amount”) or (B) (1) state that the Company elects
to redeem for cash, or is required to redeem for cash in accordance with the provisions of the Notes, in whole or in part, the
applicable Installment Amount pursuant to an Installment Redemption and (2) specify the portion (including Late Charges, if any,
on such amount) which the Company elects or is required to redeem pursuant to an Installment Redemption (such amount to be redeemed,
the “Installment Redemption Amount”) and the portion (including Late Charges, if any, on such amount) that is
the Installment Conversion Amount, which amounts, when added together, must equal the applicable Installment Amount and (ii) if
the Installment Amount is to be paid, in whole or in part, in Common Stock pursuant to an Installment Conversion, certify that
there has been no Equity Conditions Failure as of the Company Installment Notice Date. Each Company Installment Notice shall be
irrevocable. If the Company does not timely deliver a Company Installment Notice in accordance with this Section 8, then the Company
shall be deemed to have delivered an irrevocable Company Installment Notice confirming an Installment Conversion and shall be deemed
to have certified that there has been no Equity Conditions Failure in connection with any such conversion on the Company Installment
Notice Date and Installment Date. Except as expressly provided in this Section 8(a), the Company shall convert and/or redeem the
applicable Installment Amount of this Note pursuant to this Section 8 and the corresponding Installment Amounts of the Other Notes
pursuant to the corresponding provisions of the Other Notes in the same ratio of the Installment Amount being converted and/or
redeemed hereunder. The Installment Conversion Amount (whether set forth in the Company Installment Notice or by operation of this
Section 8) shall be converted in accordance with Section 8(b) and the Installment Redemption Amount shall be redeemed in accordance
with Section 8(c) and Section 11. Notwithstanding anything herein to the contrary, except in the case of an Acceleration, in the
event of any partial conversion or redemption of this Note, the Principal amount converted or redeemed shall be deducted in reverse
order starting from the final Installment Amount to be paid hereunder on the final Installment Date, unless the Holder otherwise
indicates and allocates among any Installment Dates hereunder in the applicable Conversion Notice or Redemption Notice, as applicable.

 

    	 	A-15	 

     

    

(b)  
Mechanics of Installment Conversion. If the Company delivers a Company Installment Notice and confirms, or is deemed
to have confirmed, in whole or in part, an Installment Conversion in accordance with Section 8(a), then on the applicable Installment
Date, the Company (i) shall confirm in writing to the Investor the applicable Floor Price for the applicable Installment Period
and (ii) shall, or shall direct the Transfer Agent to, credit the Holder's account with DTC (or if the Transfer Agent is not participating
in the DTC Fast Automated Securities Transfer Program, issue and deliver to the Holder a certificate) for a number of shares of
Common Stock equal to 125% of the quotient of (x) the applicable Installment Conversion Amount as of the applicable Installment
Date divided by (y) the Installment Conversion Price calculated as of the applicable Installment Date (collectively, the “Initial
Installment Shares”); provided, that there has been no Equity Conditions Failure (or such Equity Conditions Failure
is not waived in writing by the Holder) on each day during the period commencing on such Company Installment Notice Date through
and including the applicable Installment Date. During the period commencing on the applicable Installment Date and ending on the
Trading Day immediately prior to the next Installment Date (each, an “Installment Period”), the Holder may elect,
at its option and in its sole discretion, at one or more times during such Installment Period, to convert the applicable Installment
Conversion Amount into a number of shares of Common Stock equal to the quotient of (x) the applicable Installment Conversion Amount
as of the applicable Installment Date divided by (y) the Installment Conversion Price then in effect on such date of conversion
(collectively, the “Installment Shares”), in accordance with the conversion procedures set forth in Section
3 hereunder (except as provided in this Section 8 with respect to delivery of Conversion Shares), mutatis mutandis (with
“Installment Conversion Price” replacing “Conversion Price” for all purposes hereunder with respect to
an Installment Conversion); provided, that there has been no Equity Conditions Failure (or such Equity Conditions Failure
is not waived in writing by the Holder) on each day during the Installment Period. The Installment Shares to be issued to the Holder
pursuant to this Section 8(b) with respect to any Installment Period shall be credited against the Initial Installment Shares issued
to the Holder on the applicable Installment Date. If, as of 4:00 p.m., New York time, on the last Trading Day of the applicable
Installment Period, the number of Installment Shares to be issued to the Holder pursuant to this Section 8(b) with respect to such
Installment Period exceeds the number of Initial Installment Shares previously issued to the Holder on the applicable Installment
Date, then, not later than 4:00 p.m., New York time, on the second (2nd) Trading Day immediately following the last
Trading Day of the applicable Installment Period, the Company shall, or shall direct the Transfer Agent to, credit the Holder's
account with DTC (or if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and
deliver to the Holder a certificate) for a number of shares of Common Stock equal to the amount by which the number of Installment
Shares to be issued to the Holder pursuant to this Section 8(b) with respect to such Installment Period exceeds the number of Initial
Installment Shares previously issued to the Holder on the applicable Installment Date. If, as of 4:00 p.m., New York time, on the
last Trading Day of the applicable Installment Period, the number of Installment Shares to be issued to the Holder pursuant to
this Section 8(b) with respect to such Installment Period is less than the number of Initial Installment Shares previously issued
to the Holder on the applicable Installment Date, then, such excess Initial Installment Shares shall be credited to the number
of Initial Installment Shares the Company shall be required to issue to the Holder on the next applicable Installment Date with
respect to which the Company delivers a Company Installment Notice and confirms, or is 

    	 	A-16	 

     

    

deemed to have confirmed, in whole or in
part, an Installment Conversion in accordance with Section 8(a). Notwithstanding anything herein to the contrary, any portion of
an Installment Conversion Amount that is not converted by the Holder pursuant to this Section 8(b) shall not be deducted from the
Principal amount outstanding under this Note, but rather all of such non-converted Installment Conversion Amount shall be added
to the next Installment Amount to be paid hereunder; provided, however, that the par value of any Initial Installment Shares delivered
with respect to such Installment Conversion Amount that is not so converted shall be deducted from the Principal amount outstanding
under this Note and shall be netted against any future Installment Conversions with respect to such Initial Installment Shares;
provided, further, that any Installment Conversion Amount outstanding on the Maturity Date will be automatically converted into
shares of Common Stock at the Installment Conversion Price in effect on the Maturity Date, provided that such Installment Conversion
Price is above the Absolute Floor. All Installment Shares shall be fully paid and nonassessable shares of Common Stock (rounded
to the nearest whole share). If an Event of Default occurs during the period commencing on the applicable Company Installment Notice
Date through the expiration of the applicable Installment Period, the Holder may elect an Event of Default Redemption in accordance
with Section 4(b). If there is an Equity Conditions Failure as of the Company Installment Notice Date, then unless the Company
has elected to redeem such Installment Amount, the Company Installment Notice shall indicate that unless the Holder waives the
Equity Conditions Failure, the Installment Amount shall be redeemed for cash. If the Company confirmed (or is deemed to have confirmed
by operation of Section 8(a)) the conversion of the applicable Installment Conversion Amount, in whole or in part, and there was
no Equity Conditions Failure as of the applicable Company Installment Notice Date (or is deemed to have certified that there has
been no Equity Conditions Failure in connection with any such conversion have been satisfied by operation of Section 8(a)) but
an Equity Conditions Failure occurred at any time during the period commencing on the applicable Company Installment Notice Date
and ending on the expiration of the applicable Installment Period, the Company shall provide the Holder a subsequent notice to
that effect. If there is an Equity Conditions Failure (or such Equity Conditions Failure is not waived in writing by the Holder)
during the period commencing on the applicable Company Installment Notice Date ending on the expiration of the applicable Installment
Period, then at the option of the Holder designated in writing to the Company, the Holder may require the Company to do either
one or both of the following: (i) the Company shall redeem all or any part designated by the Holder of the Installment Conversion
Amount (such designated amount is referred to as the “Equity Conditions Failure Redemption Amount”) on or prior
to the third (3rd) Trading Day after written notice thereof (the “Equity Conditions Failure Redemption Notice”)
is provided to the Company (the “Equity Conditions Failure Redemption Date”) and the Company shall pay to the
Holder on such Equity Conditions Failure Redemption Date, by wire transfer of immediately available funds, an amount in cash equal
to 118% of such Equity Conditions Failure Redemption Amount (the “Equity Conditions Failure Redemption Price”)
and/or (ii) the Installment Conversion shall be null and void with respect to all or any part designated by the Holder of the unconverted
Installment Conversion Amount and the Holder shall be entitled to all the rights of a holder of this Note with respect to such
amount of the Installment Conversion Amount; provided, however, that the Installment Conversion Price for such unconverted
Installment Conversion Amount shall thereafter be adjusted to equal the lesser of (A) the Installment Conversion Price as in effect
on the date on which the Holder voided the Installment Conversion and (B) the Installment Conversion Price as in effect on the
date on which the Holder delivers a Conversion Notice relating thereto. If the Company fails to redeem any Equity Conditions Failure
Redemption Amount on or before the applicable Equity Conditions Failure Redemption Date by payment of such amount on the applicable
Equity Conditions Failure Redemption Date, then the Holder shall have the rights set forth in Section 11 as if the Company failed
to pay the applicable Company Installment Redemption Price (as defined below) and all other rights under this Note (including,
without limitation, such failure constituting an Event of Default described in Section 4(a)(xi)).

 

    	 	A-17	 

     

    

(c)   
Mechanics of Installment Redemption. If the Company elects an Installment Redemption in accordance with Section 8,
then the Installment Redemption Amount which is to be paid to the Holder on the applicable Installment Date shall be redeemed by
the Company and the Company shall pay to the Holder on such Installment Date, by wire transfer of immediately available funds,
an amount in cash (the “Company Installment Redemption Price”) equal to 118% of the Installment Redemption Amount.
If the Company fails to redeem the Installment Redemption Amount on the applicable Installment Date by payment of the Company Installment
Redemption Price on such date, then at the option of the Holder designated in writing to the Company (any such designation shall
be deemed a “Conversion Notice” pursuant to Section 3(c) for purposes of this Note), (i) the Holder shall have the
rights set forth in Section 11 as if the Company failed to pay the applicable Company Installment Redemption Price and all other
rights as a Holder of Notes (including, without limitation, such failure constituting an Event of Default described in Section
4(a)(xi)) and (ii) the Holder may, at its option and in its sole discretion, at one or more times during the Installment Period,
require the Company to convert all or any part of the Installment Redemption Amount into Installment Shares at the Installment
Conversion Price then in effect at the time of such conversion. Conversions required by this Section 8(c) shall be made in accordance
with the provisions of Section 8(b) and, with respect to issuances of Installment Shares, Section 3(c), but subject to Section
3(d). Notwithstanding anything to the contrary in this Section 8(c), but subject to Section 3(d), until the Company Installment
Redemption Price (together with any Late Charges thereon) is paid in full, the Installment Redemption Amount (together with any
Late Charges thereon) may be converted, in whole or in part, by the Holder into Common Stock pursuant to Section 3. In the event
the Holder elects to convert all or any portion of the Installment Redemption Amount prior to the applicable Installment Date as
set forth in the immediately preceding sentence, the Installment Redemption Amount so converted shall be deducted in reverse order
starting from the final Installment Amount to be paid hereunder on the final Installment Date, unless the Holder otherwise indicates
and allocates among any Installment Dates hereunder in the applicable Conversion Notice.

 

(d)  
Deferred Installment Amount. Notwithstanding any provision of this Section 8 to the contrary, the Holder may, at
its option and in its sole discretion, deliver a written notice to the Company no later than the Trading Day immediately prior
to the applicable Installment Date electing to have the payment of all or any portion of an Installment Amount payable on such
Installment Date deferred (such amount(s) deferred, the “Holder Deferral Amount”) until any subsequent Installment
Date selected by the Holder, in its sole discretion, in which case, the Holder Deferral Amount shall be added to, and become part
of, the Installment Amount to be paid on such subsequent Installment Date. Any notice delivered by the Holder pursuant to this
Section 8(d) shall be irrevocable and shall set forth (i) the Holder Deferral Amount and (ii) the date that such Holder Deferral
Amount shall now be payable.

 

    	 	A-18	 

     

    

(e)   
Accelerated Installment Amount. Notwithstanding any provision of this Section 8 to the contrary, if the Company delivers
a Company Installment Notice and confirms, or is deemed to have delivered and confirmed, in whole or in part, an Installment Conversion
in accordance with Section 8(a) with respect to an Installment Date, during the applicable Installment Period, the Holder may elect,
at its option and in its sole discretion, at one or more times during such Installment Period (each, an “Acceleration”,
and each such election date, an “Acceleration Date”), to convert all or any portion of any applicable Acceleration
Amount, in addition to any applicable Installment Conversion Amount with respect to which the Holder may elect to convert into
Installment Shares pursuant to Section 8(b), into a number of shares of Common Stock equal to the quotient of (x) the applicable
Acceleration Amount as of the applicable Acceleration Date divided by (y) the Installment Conversion Price then in effect on such
applicable Acceleration Date (the “Acceleration Shares”), in accordance with the conversion procedures set forth
in Section 3 hereunder, mutatis mutandis (with “Installment Conversion Price” replacing “Conversion Price”
for all purposes hereunder with respect to such Acceleration). The Acceleration Shares to be issued to the Holder pursuant to this
Section 8(e) with respect to any Installment Period shall not be credited against the Initial Installment Shares issued to the
Holder on the applicable Installment Date, but rather shall be issued to the Holder in accordance with Section 3(c), but subject
to Section 3(d). All Acceleration Shares shall be fully paid and nonassessable shares of Common Stock (rounded to the nearest whole
share). Notwithstanding anything herein to the contrary, in the event of any partial conversion of this Note by the Holder pursuant
to an Acceleration, the Principal amount converted or redeemed shall not be deducted in reverse order starting from the final Installment
Amount to be paid hereunder on the final Installment Date, but rather a pro rata amount of the Principal amount converted pursuant
to such Acceleration shall be deducted from each of the remaining Installment Amounts to be paid hereunder.

 

10.             
NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate
of Incorporation, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution,
issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Note, and will at all times in good faith carry out all of the provisions of this Note and take all action as may
be required to protect the rights of the Holder of this Note.

 

11.             
RESERVATION OF AUTHORIZED SHARES.

 

(a)               
Reservation. The Company shall initially reserve out of its authorized and unissued shares of Common Stock a number
of shares of Common Stock for each of this Note and the Other Notes equal to 150% of the Conversion Rate with respect to the Conversion
Amount of each such Note as of the Issuance Date. So long as any of this Note and the Other Notes are outstanding, the Company
shall take all action necessary to reserve and keep available out of its authorized and unissued Common Stock, solely for the purpose
of effecting the conversion of this Note and the Other Notes, the number of shares of Common Stock specified above in this Section
10(a) as shall from time to time be necessary to effect the conversion of all of the Notes then outstanding; provided, that
at no time shall the number of shares of Common Stock so reserved be less than the number of shares required to be reserved pursuant
hereto (in each case, without regard to any limitations on conversions) (the “Required Reserve Amount”).

 

    	 	A-19	 

     

    

(b)              
Insufficient Authorized Shares. If at any time while any of the Notes remain outstanding the Company does not have
a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance upon
conversion of the Notes at least a number of shares of Common Stock equal to the Required Reserve Amount (an “Authorized
Share Failure”), then the Company shall immediately take all action necessary to increase the Company's authorized shares
of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount for the Notes then outstanding.
Without limiting the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized
Share Failure, but in no event later than ninety (90) days after the occurrence of such Authorized Share Failure, the Company shall
either (x) obtain the written consent of its stockholders for the approval of an increase in the number of authorized shares of
Common Stock and provide each stockholder with an information statement with respect thereto or (y) hold a meeting of its stockholders
for the approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company
shall provide each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders' approval of such
increase in authorized shares of Common Stock and to cause its Board of Directors to recommend to the stockholders that they approve
such proposal. In the event that the Company is prohibited from issuing shares of Common Stock upon any conversion due to the failure
by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common Stock (such
unavailable number of shares of Common Stock, the “Authorized Failure Shares”), in lieu of delivering such Authorized
Failure Shares to the Holder, the Company shall pay cash in exchange for the redemption of such portion of the Conversion Amount
convertible into such Authorized Failure Shares at a price equal to the sum of (i) the product of (x) such number of Authorized
Failure Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the
date the Holder delivers the applicable Conversion Notice with respect to such Authorized Failure Shares to the Company and ending
on the Trading Day immediately preceding the date of such issuance and payment under this Section 10(b) and (ii) to the extent
the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by
the Holder of Authorized Failure Shares, any brokerage commissions and other out-of-pocket expenses, if any, of the Holder incurred
in connection therewith. Nothing contained in Section 10(a) or this Section 10(b) shall limit any obligations of the Company under
any provision of the Securities Purchase Agreement.

 

    	 	A-20	 

     

    

12.             
REDEMPTIONS. The Company shall deliver the applicable Company Optional Redemption Price to the Holder in cash on
the applicable Company Optional Redemption Date. The Company shall deliver the applicable Event of Default Redemption Price to
the Holder within three (3) Business Days after the Company's receipt of the Holder's Event of Default Redemption Notice. If the
Holder has submitted a Change of Control Redemption Notice in accordance with Section 5(b), the Company shall deliver the applicable
Change of Control Redemption Price to the Holder (i) concurrently with the consummation of such Change of Control if such notice
is received on or prior to third (3rd) Business Day prior to the consummation of such Change of Control and (ii) within
three (3) Business Days after the Company's receipt of such notice otherwise. The Company shall deliver the applicable Equity Conditions
Failure Redemption Price to the Holder on the applicable Equity Conditions Failure Redemption Date. The Company shall deliver the
applicable Company Installment Redemption Price to the Holder on the applicable Installment Date. The Company shall pay the applicable
Redemption Price to the Holder in cash by wire transfer of immediately available funds pursuant to wire instruction provided by
the holder in writing to the Company on the applicable due date. In the event of a redemption of less than all of the Conversion
Amount of this Note, if requested by the Holder and upon delivery by the Holder to the Company of this Note, the Company shall
promptly cause to be issued and delivered to the Holder a new Note (in accordance with Section 16(d)) representing the outstanding
Principal which has not been redeemed which shall be calculated as if no Redemption Notice has been delivered. Notwithstanding
anything herein to the contrary, in connection with any redemption hereunder at a time the Holder is entitled to receive a cash
payment under any of the other Transaction Documents and the Company does not timely pay such amounts as required by such Transaction
Documents, at the option of the Holder delivered in writing to the Company, the applicable Redemption Price hereunder shall be
increased by the amount of such cash payment owed to the Holder under such other Transaction Document and, upon payment in full
or conversion in accordance herewith, shall satisfy the Company’s payment obligation under such other Transaction Document.
In the event that the Company does not pay the applicable Redemption Price to the Holder within the time period required, at any
time thereafter and until the Company pays such unpaid Redemption Price in full, the Holder shall have the option, in lieu of redemption,
to require the Company to promptly return to the Holder all or any portion of this Note representing the Conversion Amount that
was submitted for redemption and for which the applicable Redemption Price (together with any Late Charges thereon) has not been
paid. Upon the Company's receipt of such notice, (x) the applicable Redemption Notice shall be null and void with respect to such
Conversion Amount, and (y) the Company shall immediately return this Note, or issue a new Note (in accordance with Section 16(d))
to the Holder representing such Conversion Amount to be redeemed. The Holder's delivery of a notice voiding a Redemption Notice
and exercise of its rights following such notice shall not affect the Company's obligations to make any payments of Late Charges
which have accrued prior to the date of such notice with respect to the Conversion Amount subject to such notice.

 

13.             
VOTING RIGHTS. The Holder shall have no voting rights as the holder of this Note, except as required by law and as
expressly provided in this Note.

 

14.             
COVENANTS.

 

(a)               
Rank.All payments due under this Note shall rank pari passu with all Other Notes and all other unsecured
indebtedness of the Company.

 

(b)              
Change in Nature of Business. The Company shall not, and the Company shall cause each of its Subsidiaries to not,
directly or indirectly, engage in any material line of business substantially different from those lines of business conducted
by the Company and each of its Subsidiaries on the Issuance Date or any business substantially related or incidental thereto.

 

    	 	A-21	 

     

    

(c)               
Preservation of Existence, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain
and preserve, its existence, rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain,
duly qualified and in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which
the transaction of its business makes such qualification necessary, except to the extent that the failure to be so qualified or
in good standing would not reasonably be expected to have a Material Adverse Effect (as defined in the Securities Purchase Agreement);
provided, however, that any wholly-owned Subsidiary may merge with or into another wholly-owned Subsidiary or the Company.

 

(d)              
Maintenance of Properties, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain
and preserve, all of its material properties which are necessary in the proper conduct of its business in good working order and
condition, ordinary wear and tear excepted, and comply, and cause each of its Subsidiaries to comply, at all times in all material
respects with the provisions of all material leases to which it is a party as lessee or under which it occupies property, so as
to prevent any loss or forfeiture thereof or thereunder.

 

(e)               
Maintenance of Insurance. The Company shall maintain, and cause each of its Subsidiaries to maintain, insurance with
responsible and reputable insurance companies or associations (including, without limitation, comprehensive general liability,
hazard, rent and business interruption insurance) with respect to its properties (including all real properties leased or owned
by it) and business, in such amounts and covering such risks as is required by any governmental authority having jurisdiction with
respect thereto or as management determines is appropriate in light of the risks faced by the business.

 

(f)               
Independent Investigation. At the request of the Holder, at no more than one time in any twelve month period, either
(x) at any time when an Event of Default has occurred and is continuing, (y) upon the occurrence of an event that with the passage
of time or giving of notice would constitute an Event of Default or (z) at any time the Holder reasonably believes an Event of
Default may have occurred or be continuing, the Company shall hire an independent, reputable investment bank selected by the Company
and approved by the Holder to investigate as to whether any breach of this Note has occurred (the “Independent Investigator”).
If the Independent Investigator determines that such breach of this Note has occurred, the Independent Investigator shall notify
the Company of such breach and the Company shall deliver written notice to each holder of a Note of such breach. In connection
with such investigation, the Independent Investigator may, during normal business hours and upon signing a confidentiality agreement
in a form reasonably acceptable to the Company, inspect all contracts, books, records, personnel, offices and other facilities
and properties of the Company and its Subsidiaries and, to the extent available to the Company after the Company uses reasonable
efforts to obtain them, the records of its legal advisors and accountants (including the accountants’ work papers) and any
books of account, records, reports and other papers not contractually required of the Company to be confidential or secret, or
subject to attorney-client or other evidentiary privilege, and the Independent Investigator may make such copies and inspections
thereof as the Independent Investigator may reasonably request. The Company shall furnish the Independent Investigator with such
financial and operating data and other information with respect to the business and properties of the Company as the Independent
Investigator may reasonably request. The Company shall permit the Independent Investigator to discuss the affairs, finances and
accounts of the Company with, and to make proposals and furnish advice with respect thereto to, the Company’s officers, directors,
key employees and independent public accountants or any of them (and by this provision the Company authorizes said accountants
to discuss with such Independent Investigator the finances and affairs of the Company and any Subsidiaries), all at such reasonable
times, upon reasonable notice, and as often as may be reasonably requested.

 

    	 	A-22	 

     

    

15.             
AMENDING THE TERMS OF THIS NOTE. The prior written consent of the Holder and the Company shall be required for any
change or amendment to this Note.

 

16.             
TRANSFER. This Note and any shares of Common Stock issued upon conversion of this Note may be offered, sold, assigned
or transferred by the Holder without the consent of the Company; provided, however, that any purchaser, assignee or transferee
of this Note shall agree in writing to be bound by the terms of the Securities Purchase Agreement and this Note.

 

17.             
REISSUANCE OF THIS NOTE.

 

(a)               
Transfer. If this Note is to be transferred, the Holder shall surrender this Note to the Company, whereupon the Company
will forthwith issue and deliver upon the order of the Holder a new Note (in accordance with Section 16(d)), registered as the
Holder may request, representing the outstanding Principal being transferred by the Holder and, if less than the entire outstanding
Principal is being transferred, a new Note (in accordance with Section 16(d)) to the Holder representing the outstanding Principal
not being transferred. The Holder and any assignee, by acceptance of this Note, acknowledge and agree that, by reason of the provisions
of Section 3(c)(iii) following conversion or redemption of any portion of this Note, the outstanding Principal represented by this
Note may be less than the Principal stated on the face of this Note.

 

(b)              
Lost, Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification
undertaking by the Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation
of this Note, the Company shall execute and deliver to the Holder a new Note (in accordance with Section 16(d)) representing the
outstanding Principal.

 

(c)               
Note Exchangeable for Different Denominations. This Note is exchangeable, upon the surrender hereof by the Holder
at the principal office of the Company, for a new Note or Notes (in accordance with Section 16(d) and in Principal amounts of at
least $1,000) representing in the aggregate the outstanding Principal of this Note, and each such new Note will represent such
portion of such outstanding Principal as is designated by the Holder at the time of such surrender.

 

(d)              
Issuance of New Notes. Whenever the Company is required to issue a new Note pursuant to the terms of this Note, such
new Note (i) shall be of like tenor with this Note, (ii) shall represent, as indicated on the face of such new Note, the Principal
remaining outstanding (or in the case of a new Note being issued pursuant to Section 16(a) or Section 16(c), the Principal designated
by the Holder which, when added to the principal represented by the other new Notes issued in connection with such issuance, does
not exceed the Principal remaining outstanding under this Note immediately prior to such issuance of new Notes), (iii) shall have
an issuance date, as indicated on the face of such new Note, which is the same as the Issuance Date of this Note, (iv) shall have
the same rights and conditions as this Note, and (v) shall represent accrued and unpaid Late Charges, if any, on the Principal
of this Note, from the Issuance Date.

 

    	 	A-23	 

     

    

18.             
REMEDIES, CHARACTERIZATIONS, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Note
shall be cumulative and in addition to all other remedies available under this Note and any of the other Transaction Documents
at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit
the Holder's right to pursue actual damages for any failure by the Company to comply with the terms of this Note. The Company covenants
to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts
set forth or provided for herein with respect to payments, conversion and the like (and the computation thereof) shall be the amounts
to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company
(or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable
harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the
event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies, to seek
an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being
required. The Company shall provide all information and documentation to the Holder that is reasonably requested by the Holder
to enable the Holder to confirm the Company’s compliance with the terms and conditions of this Note.

 

19.             
PAYMENT OF COLLECTION, ENFORCEMENT AND OTHER COSTS. If (a) this Note is placed in the hands of an attorney for collection
or enforcement or is collected or enforced through any legal proceeding or the Holder otherwise takes action to collect amounts
due under this Note or to enforce the provisions of this Note or (b) there occurs any bankruptcy, reorganization, receivership
of the Company or other proceedings affecting Company creditors' rights and involving a claim under this Note, then the Company
shall pay the reasonable out-of-pocket costs incurred by the Holder for such collection, enforcement or action or in connection
with such bankruptcy, reorganization, receivership or other proceeding, including, without limitation, reasonable attorneys’
fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under this Note shall be affected, or
limited, by the fact that the purchase price paid for this Note was less than the original Principal amount hereof.

 

20.  CONSTRUCTION;
HEADINGS. This Note shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against
any Person as the drafter hereof. The headings of this Note are for convenience of reference and shall not form part of, or affect
the interpretation of, this Note. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include
the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,” “includes,”
“include” and words of like import shall be construed broadly as if followed by the words “without limitation.”
The terms “herein,” “hereunder,” “hereof” and words of like import refer to this entire Agreement
instead of just the provision in which they are found. Unless expressly indicated otherwise, all section references are to sections
of this Note. Terms used in this Note and not otherwise defined herein but defined in the other Transaction Documents shall have
the meanings ascribed to such terms on the Closing Date in such other Transaction Documents unless otherwise consented to in writing
by the Holder. In the event that one or more events have occurred that would permit either the Company or the Holder to redeem
or accelerate, or cause the redemption or acceleration of, or would otherwise result in the acceleration of, all or a portion of
this Note, and there is a conflict between the redemption or acceleration prices or amounts relating to such event(s) under this
Note, the greater of such redemption or acceleration prices or amounts shall govern and control.

 

    	 	A-24	 

     

    

21.             
FAILURE OR INDULGENCE NOT WAIVER. No failure or delay on the part of the Holder or the Company in the exercise of
any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such
power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege. No waiver shall
be effective unless it is in writing and signed by an authorized representative of the waiving party. Notwithstanding the foregoing,
nothing contained in this Section 20 shall permit any waiver of any provision of Section 3(d).

 

22.             
DISPUTE RESOLUTION.

 

(a)               
Submission to Dispute Resolution.

 

(i)                
In the case of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Installment Conversion
Price, a Weighted Average Price or a fair market value or the arithmetic calculation of a Conversion Rate or the applicable Redemption
Price (as the case may be) (including, without limitation, a dispute relating to the determination of any of the foregoing), the
Company or the Holder (as the case may be) shall submit the dispute to the other party via facsimile (A) if by the Company, at
any time after the occurrence of the circumstances giving rise to such dispute or (B) if by the Holder at any time after the Holder
learned of the circumstances giving rise to such dispute. If the Holder and the Company are unable to promptly resolve such dispute
relating to such Closing Bid Price, such Closing Sale Price, such Conversion Price, such Installment Conversion Price, such Weighted
Average Price or such fair market value, or the arithmetic calculation of such Conversion Rate or such applicable Redemption Price
(as the case may be), at any time after the second (2nd) Business Day following such initial notice by the Company or
the Holder (as the case may be) of such dispute to the Company or the Holder (as the case may be), then the Holder may, at its
sole option, select an independent, reputable investment bank with the consent of the Company, not to be unreasonably withheld,
to resolve such dispute.

 

(ii)              
The Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered
in accordance with the first sentence of this Section 21 and (B) written documentation supporting its position with respect to
such dispute, in each case, no later than 5:00 p.m. (New York time) by the fifth (5th) Business Day immediately following
the date on which the Holder selected such investment bank (the “Dispute Submission Deadline”) (the documents
referred to in the immediately preceding clauses (A) and (B) are collectively referred to herein as the “Required Dispute
Documentation”) (it being understood and agreed that if either the Holder or the Company fails to so deliver all of the
Required Dispute Documentation by the Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute
Documentation shall no longer be entitled to (and hereby waives its right to) deliver or submit any written documentation or other
support to such investment bank with respect to such dispute and such investment bank shall resolve such dispute based solely on
the Required Dispute Documentation that was delivered to such investment bank prior to the Dispute Submission Deadline). Unless
otherwise agreed to in writing by both the Company and the Holder or otherwise requested by such investment bank, neither the Company
nor the Holder shall be entitled to deliver or submit any written documentation or other support to such investment bank in connection
with such dispute (other than the Required Dispute Documentation).

 

    	 	A-25	 

     

    

(iii)            
The Company and the Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company
and the Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The
fees and expenses of such investment bank shall be borne by the Company and such investment bank’s resolution of such dispute
shall be final and binding upon all parties absent manifest error.

 

(b)              
Miscellaneous. The Company expressly acknowledges and agrees that (i) this Section 21 constitutes an agreement to
arbitrate between the Company and the Holder (and constitutes an arbitration agreement) under § 7501, et seq. of the New York
Civil Practice Law and Rules (“CPLR”) and that the Holder is authorized to apply for an order to compel arbitration
pursuant to CPLR § 7503(a) in order to compel compliance with this Section 21, (ii) the terms of this Note and each other
applicable Transaction Document shall serve as the basis for the selected investment bank’s resolution of the applicable
dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the
like that such investment bank determines are required to be made by such investment bank in connection with its resolution of
such dispute and in resolving such dispute such investment bank shall apply such findings, determinations and the like to the terms
of this Note and any other applicable Transaction Documents, (iii) the Holder (and only the Holder), in its sole discretion, shall
have the right to submit any dispute described in this Section 21 to any state or federal court sitting in The City of New York,
Borough of Manhattan in lieu of utilizing the procedures set forth in this Section 21 and (iv) nothing in this Section 21 shall
limit the Holder from obtaining any injunctive relief or other equitable remedies (including, without limitation, with respect
to any matters described in this Section 21).

 

23.             
NOTICES; CURRENCY; PAYMENTS.

 

(a)               
Notices. Whenever notice is required to be given under this Note, unless otherwise provided herein, such notice shall
be given in accordance with Section 8(f) of the Securities Purchase Agreement. The Company shall provide the Holder with prompt
written notice of all actions taken pursuant to this Note, including in reasonable detail a description of such action and the
reason therefore. Without limiting the generality of the foregoing, the Company shall give written notice to the Holder (i) promptly
upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment
and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect
to any dividend or distribution upon the Common Stock, (B) with respect to any pro rata subscription offer to holders of Common
Stock or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in
each case that such information shall be made known to the public prior to or in conjunction with such notice being provided to
the Holder.

 

    	 	A-26	 

     

    

(b)              
Currency. All dollar amounts referred to in this Note are in United States Dollars (“U.S. Dollars”),
and all amounts owing under this Note shall be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall
be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange
Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Note, the U.S.
Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed
that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date
of such period of time).

 

(c)               
Payments. Whenever any payment of cash is to be made by the Company to any Person pursuant to this Note, such payment
shall be made in lawful money of the United States of America by a check drawn on the account of the Company and sent via overnight
courier service to such Person at such address as previously provided to the Company in writing (which address, in the case of
each of the Purchasers, shall initially be as set forth on the Schedule of Buyers attached to the Securities Purchase Agreement);
provided, that the Holder may elect to receive a payment of cash via wire transfer of immediately available funds by providing
the Company with prior written notice setting out such request and the Holder's wire transfer instructions. Whenever any amount
expressed to be due by the terms of this Note is due on any day which is not a Business Day, the same shall instead be due on the
next succeeding day which is a Business Day. Any amount of Principal or other amounts due under the Transaction Documents which
is not paid when due shall result in a late charge being incurred and payable by the Company in an amount equal to interest on
such amount at the rate of eighteen percent (18.0%) per annum from the date such amount was due until the same is paid in full
(“Late Charge”).

 

24.  CANCELLATION.
After all Principal, Late Charges and other amounts at any time owed on this Note have been paid in full, this Note shall automatically
be deemed canceled, shall be surrendered to the Company for cancellation and shall not be reissued.

 

25.             
WAIVER OF NOTICE. To the extent permitted by law and except as expressly set forth herein, the Company hereby irrevocably
waives demand, notice, presentment, protest and all other demands and notices in connection with the delivery, acceptance, performance,
default or enforcement of this Note and the Securities Purchase Agreement.

 

    	 	A-27	 

     

    

26.  GOVERNING
LAW; JURISDICTION; JURY TRIAL. This Note shall be construed and enforced in accordance with, and all questions concerning the
construction, validity, interpretation and performance of this Note shall be governed by, the internal laws of the State of New
York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any
other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. The Company
hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough
of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue
of such suit, action or proceeding is improper. The Company hereby irrevocably waives personal service of process and consents
to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address it set forth
on the signature page hereto and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing
contained herein (i) shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained
herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company in
any other jurisdiction to collect on the Company's obligations to the Holder, to realize on any collateral or any other security
for such obligations, or to enforce a judgment or other court ruling in favor of the Holder or (ii) shall limit, or shall be deemed
or construed to limit, any provision of Section 21. EACH OF THE COMPANY AND, BY ITS ACCEPTANCE OF THIS NOTE, THE HOLDER HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR IN CONNECTION WITH OR ARISING OUT OF THIS NOTE OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

27.  Severability.
If any provision of this Note is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the
broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect
the validity of the remaining provisions of this Note so long as this Note as so modified continues to express, without material
change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties
or the practical realization of the benefits that would otherwise be conferred upon the parties.
The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid
provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

 

28.  DISCLOSURE.
Upon receipt or delivery by the Company of any notice in accordance with the terms of this Note, unless the Company has in good
faith determined that the matters relating to such notice do not constitute material, nonpublic information relating to the Company
or its Subsidiaries, the Company shall within two (2) Business Days after any such receipt or delivery publicly disclose such material,
nonpublic information on a Current Report on Form 8-K or otherwise. In the event that the Company believes that a notice contains
material, nonpublic information relating to the Company or its Subsidiaries, the Company so shall indicate to such Holder contemporaneously
with delivery of such notice, and in the absence of any such indication, the Holder shall be allowed to presume that all matters
relating to such notice do not constitute material, nonpublic information relating to the Company or its Subsidiaries. Nothing
contained in this Section 27 shall limit any obligations of the Company, or any rights of the Holder, under Section 4(i) of the
Securities Purchase Agreement.

 

    	 	A-28	 

     

    

29.             
MAXIMUM PAYMENTS. Nothing contained herein shall be deemed to establish or require the payment of a rate of interest
or other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest required to be paid
or other charges hereunder exceed the maximum permitted by such law, any payments in excess of such maximum shall be credited against
amounts owed by the Company to the Holder and thus refunded to the Company.

 

30.             
CERTAIN DEFINITIONS. For purposes of this Note, the following terms shall have the following meanings:

 

(a)               
“Acceleration Amount” means, with respect to any Installment Period, an amount equal to 50% of the cumulative
sum of all Excess Trading Volume Amounts for all Trading Days during such Installment Period.

 

(b)              
“Additional Closing Date” shall have the meaning set forth in the Securities Purchase Agreement, which
date is the date the Company initially issued Additional Notes (as defined in the Securities Purchase Agreement) pursuant to the
terms of the Securities Purchase Agreement.

 

(c)               
“Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls,
is controlled by, or is under common control with, such Person, it being understood for purposes of this definition that “control”
of a Person means the power directly or indirectly to direct or cause the direction of the management and policies of such Person
whether by contract or otherwise.

 

(d)              
“Bloomberg” means Bloomberg Financial Markets.

 

(e)               
“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The
City of New York are authorized or required by law to remain closed.

 

(f)               
“Change of Control” means any Fundamental Transaction other than (i) any merger of the Company or any
of its, direct or indirect, wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization
or reclassification of the Common Stock in which holders of the Company's voting power immediately prior to such reorganization,
recapitalization or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly
traded securities and, directly or indirectly, are, in all material respect, the holders of the voting power of the surviving entity
(or entities with the authority or voting power to elect the members of the board of directors (or their equivalent if other than
a corporation) of such entity or entities) after such reorganization, recapitalization or reclassification or (iii) pursuant to
a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company.

 

    	 	A-29	 

     

    

(g)              
“Closing Bid Price” and “Closing Sale Price” means, for any security as of any date,
the last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by
Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price
or the closing trade price, as the case may be, then the last bid price or last trade price, respectively, of such security prior
to 4:00:00 p.m., New York Time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange
or trading market for such security, the last closing bid price or last trade price, respectively, of such security on the principal
securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do
not apply, the last closing bid price or last trade price, respectively, of such security in the over-the-counter market on the
electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price or last trade price, respectively,
is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers
for such security as reported in the OTC Link or “pink sheets” by OTC Markets Group Inc. (formerly Pink OTC Markets
Inc.). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the
foregoing bases, the Closing Bid Price or the Closing Sale Price, as the case may be, of such security on such date shall be the
fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon
the fair market value of such security, then such dispute shall be resolved pursuant to Section 21. All such determinations to
be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction during
the applicable calculation period.

 

(h)              
“Common Stock” means (i) the Company's shares of common stock, par value $0.0001 per share, and
(ii) any capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification
of such common stock.

 

(i)                
“Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise,
of that Person with respect to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or
intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability
that such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders
of such liability will be protected (in whole or in part) against loss with respect thereto.

 

(j)                
“Conversion Shares” means shares of Common Stock issuable by the Company pursuant to the terms of any
of the Notes, including any related Late Charges so converted, amortized or redeemed.

 

(k)              
“Convertible Securities” means any stock or securities (other than Options) directly or indirectly convertible
into or exercisable or exchangeable for shares of Common Stock.

 

    	 	A-30	 

     

    

(l)    
“Eligible Market” means the Principal Market, The New York Stock Exchange, The Nasdaq
Global Market, The NASDAQ Capital Market or the NYSE MKT.

 

(m)            
“Equity Conditions” means each of the following conditions: (i) on each day during the Equity Conditions
Measuring Period, all Conversion Shares issuable upon conversion of the Notes shall be eligible for sale without restriction under
the Securities Act and any applicable state securities laws; (ii) on each day during the Equity Conditions Measuring Period, the
Common Stock is listed for trading on the Principal Market or any other Eligible Market and shall not have been suspended from
trading on such exchange or market (other than suspensions of not more than two (2) days and occurring prior to the applicable
date of determination due to business announcements by the Company) nor shall the Company have received any final and non-appealable
notice that the listing or quotation of the Common Stock on the Principal Market shall be terminated on a date certain (unless,
prior to such date certain, the Common Stock is listed or quoted on any other Eligible Market); (iii) during the one (1) year period
ending on and including the date immediately preceding the applicable date of determination, the Company shall have delivered the
Conversion Shares upon conversion of the Notes to the Holders on a timely basis as set forth in Section 3(c)(ii) hereof; (iv) the
shares of Common Stock issuable upon conversion of the Installment Conversion Amount and Acceleration Amount (if any) that is subject
to the applicable Installment Conversion requiring the satisfaction of the Equity Conditions may be issued in full without violating
Section 3(d) hereof and the rules or regulations of the Principal Market or any other applicable Eligible Market; (v) during the
Equity Conditions Measuring Period, the Company shall not have failed to timely make any payments within five (5) Business Days
of when such payment is due pursuant to any Transaction Document; (vi) during the Equity Conditions Measuring Period, there shall
not have occurred either (A) the public announcement of a pending, proposed or intended Fundamental Transaction which has not been
abandoned, terminated or consummated or (B) an Event of Default; (vii) the Company shall have no knowledge of any fact that would
cause any Conversion Shares issuable upon conversion of the Notes not to be eligible for sale without restriction pursuant to the
Securities Act and any applicable state securities laws; (viii) during the Equity Conditions Measuring Period, the Company otherwise
shall have been in compliance with and shall not have breached any provision, covenant, representation or warranty of any Transaction
Document; (ix) the Holder shall not be in possession of any material, nonpublic information received from the Company, any Subsidiary
or its respective agent or Affiliates; (x) the shares of Common Stock issuable upon conversion of the Installment Conversion Amount
and Acceleration Amount (if any) that is subject to the applicable Installment Conversion requiring the satisfaction of the Equity
Conditions are duly authorized and listed and eligible for trading without restriction on an Eligible Market; and (xi) the daily
dollar value trading volume of the Common Stock as reported by Bloomberg for each Trading Day during the ten (10) Trading Day period
ending on the Trading Day immediately prior to the applicable date of determination shall be at least $125,000.

 

(n)              
“Equity Conditions Failure” means that on any day during the period commencing ten (10) Trading Days
prior to the applicable date of determination through the applicable date of determination, the Equity Conditions have not each
been satisfied (or waived in writing by the Holder).

 

    	 	A-31	 

     

    

(o)              
“Equity Conditions Measuring Period” means each day during the period beginning twenty (20) Trading Days
prior to the applicable date of determination and ending on and including the applicable date of determination.

 

(p)              
“Equity Interests” means (a) all shares of capital stock (whether denominated as common capital stock
or preferred capital stock), equity interests, beneficial, partnership or membership interests, joint venture interests, participations
or other ownership or profit interests in or equivalents (regardless of how designated) of or in a Person (other than an individual),
whether voting or non-voting and (b) all securities convertible into or exchangeable for any of the foregoing and all warrants,
options or other rights to purchase, subscribe for or otherwise acquire any of the foregoing, whether or not presently convertible,
exchangeable or exercisable.

 

(q)              
“Excess Trading Volume Amount” means, with respect to any Trading Day during an Installment Period, the
amount, if any, by which the daily dollar value trading volume of the Common Stock as reported by Bloomberg for such Trading Day
exceeds $200,000.

 

(r)                
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

 

(s)               
“Fundamental Transaction” means that (i) the Company or any of its Subsidiaries shall, directly or indirectly,
in one or more related transactions, (1) consolidate or merge with or into any other Person unless the Company or any of its Subsidiaries
is the surviving corporation, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially
all of its respective properties or assets to any other Person, or (3) allow any other Person to make a purchase, tender or exchange
offer that is accepted by the holders of more than 50% of the outstanding shares of Voting Stock of the Company (not including
any shares of Voting Stock of the Company held by the Person or Persons making or party to, or associated or affiliated with the
Persons making or party to, such purchase, tender or exchange offer), or (4) consummate a stock or share purchase agreement or
other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement)
with any other Person whereby such other Person acquires more than 50% of the outstanding shares of Voting Stock of the Company
(not including any shares of Voting Stock of the Company held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination),
or (5) the Company or any of its Subsidiaries shall, directly or indirectly, in one or more related transactions, reorganize, recapitalize
or reclassify the Common Stock (which shall not include a reverse stock split), or (ii) any “person” or “group”
(as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) is or shall become the “beneficial
owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the aggregate ordinary voting
power represented by issued and outstanding Voting Stock of the Company.

 

(t)                
“GAAP” means United States generally accepted accounting principles, consistently applied.

 

    	 	A-32	 

     

    

(u)              
“Holiday” means a day other than a Business Day or on which trading does not take place on the Principal
Market.

 

(v)              
“Indebtedness” of any Person means, without duplication (i) all indebtedness for borrowed money, (ii)
all obligations issued, undertaken or assumed as the deferred purchase price of property or services, including (without limitation)
“capital leases” in accordance with GAAP (other than trade payables entered into in the ordinary course of business),
(iii) all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (iv)
all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection
with the acquisition of property, assets or businesses, (v) all indebtedness created or arising under any conditional sale or other
title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds
of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are
limited to repossession or sale of such property), (vi) all monetary obligations under any leasing or similar arrangement which,
in connection with GAAP, consistently applied for the periods covered thereby, is classified as a capital lease, (vii) all indebtedness
referred to in clauses (i) through (vi) above secured by (or for which the holder of such Indebtedness has an existing right, contingent
or otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property
or assets (including accounts and contract rights) owned by any Person, even though the Person which owns such assets or property
has not assumed or become liable for the payment of such indebtedness, and (viii) all Contingent Obligations in respect of indebtedness
or obligations of others of the kinds referred to in clauses (i) through (vii) above.

 

(w)            
“Initial Closing Date” shall have the meaning set forth in the Securities Purchase Agreement, which date
is the date the Company initially issued Initial Notes (as defined in the Securities Purchase Agreement) pursuant to the terms
of the Securities Purchase Agreement.

 

(x)              
“Installment Amount” means an amount equal to the sum of (i) the lesser of (A) $[__________] (as such
amount may be increased pursuant to Section 8(b) hereof) and (B) the Principal outstanding on such Installment Date, (ii) any Holder
Deferral Amount deferred pursuant to Section 8(d) and included in such Installment Amount, (iii) any Acceleration Amount that increases
(and is included in) such Installment Amount pursuant to Section 8(e) and (iv) accrued and unpaid Late Charges, if any, with respect
to such Principal, as any such Installment Amount for each Holder may be reduced pursuant to the terms hereof, whether upon conversion,
redemption or otherwise. In the event the Holder shall sell or otherwise transfer or assign any portion of this Note, the transferee
shall be allocated a pro rata portion of each unpaid Installment Amount hereunder.

 

(y)              
“Installment Conversion Price” means as of any date of determination, that price which shall be the lower
of (i) the Conversion Price then in effect and (ii) the Market Price as of such date of determination.

 

    	 	A-33	 

     

    

(z)               
“Installment Date” means each of [________], 2017, [________], 201[_] and every calendar month anniversary
thereafter through and including the Maturity Date, or, if any such date falls on a Holiday, the next day that is not a Holiday.

 

(aa)           
“Market Price” means, as of any applicable date of determination, the higher of (i) 90% of the lesser
of (a) the arithmetic average of the lowest four (4) daily Weighted Average Prices of the Common Stock during the seven (7) consecutive
Trading Day period ending on the Trading Day immediately preceding the applicable date of determination and (b) the daily Weighted
Average Price of the Common Stock on the Trading Day immediately preceding the applicable date of determination and (ii) $1.00
(in each case, as adjusted for any stock split, stock dividend, stock combination, reclassification or other similar transaction)
(the “Floor Price”); provided, however, that in the event that the arithmetic average of the five
(5) daily Weighted Average Prices of the Common Stock during the five (5) consecutive Trading Day period ending on the Trading
Day immediately preceding such Installment Date is less than $1.00 (as adjusted for any stock split, stock dividend, stock combination,
reclassification or other similar transaction), then the Floor Price for the applicable Installment Period shall be the lesser
of (A) 80% of the arithmetic average of the five (5) daily Weighted Average Prices of the Common Stock during the five (5) consecutive
Trading Day period ending on the Trading Day immediately preceding such Installment Date and (B) such price deemed appropriate
by the Board of Directors of the Company and set forth in writing to the Investor on such Trading Day (in each case as adjusted
for any stock split, stock dividend, stock combination, reclassification or other similar transaction); provided, further,
however, that under no circumstances shall the Floor Price for any Installment Period be less than $0.10 (which upon any stock
split, stock dividend, stock combination, reclassification or other similar transaction shall be adjusted to the lower of (i) the
adjusted price and (ii) $0.10) (the “Absolute Floor”).

 

(bb)          
“Maturity Date” shall mean [________], 201[_] (as such date may be accelerated pursuant to Section 1;
provided, however, the Maturity Date may be extended at the option of the Holder (i) in the event that, and for so long as, an
Event of Default shall have occurred and be continuing or any event shall have occurred and be continuing that with the passage
of time and the failure to cure would result in an Event of Default or (ii) through the date that is twenty (20) Business Days
after the consummation of a Fundamental Transaction in the event that a Fundamental Transaction is publicly announced or a Change
of Control Notice is delivered prior to the Maturity Date, and (iii) if a Holder elects to convert some or all of this Note pursuant
to Section 3 hereof, and the Conversion Amount would be limited pursuant to Section 3(d) hereunder, until such time as such provision
shall not limit the conversion of this Note.

 

(cc)           
“Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or
Convertible Securities.

 

(dd)         
“Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person,
including such entity whose common capital stock or equivalent equity security is quoted or listed on an Eligible Market (or, if
so elected by the Holder, any other market, exchange or quotation system), or, if there is more than one such Person or such entity,
the Person or entity designated by the Holder or in the absence of such designation, such Person or entity with the largest public
market capitalization as of the date of consummation of the Fundamental Transaction.

 

    	 	A-34	 

     

    

(ee)           
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation,
a trust, an unincorporated organization, any other entity and a government or any department or agency thereof.

 

(ff)            
“Principal Market” means The NASDAQ Global Select Market.

 

(gg)          
“Redemption Notices” means, collectively, the Company Optional Redemption Notices, the Event of Default
Redemption Notices, the Change of Control Redemption Notices, the Company Installment Notices and the Equity Conditions Failure
Redemption Notices, each of the foregoing, individually, a “Redemption Notice”.

 

(hh)          
“Redemption Prices” means, collectively, the Company Optional Redemption Price, the Event of Default
Redemption Price, the Change of Control Redemption Price, the Company Installment Redemption Price and the Equity Conditions Failure
Redemption Price, each of the foregoing, individually, a “Redemption Price”.

 

(ii)              
“SEC” means the United States Securities and Exchange Commission.

 

(jj)              
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations thereunder.

 

(kk)          
“Securities Purchase Agreement” means that certain securities purchase agreement, dated as of the Initial
Closing Date, by and between the Company and [_______], pursuant to which the Company issued this Note, as may be amended from
time to time.

 

(ll)              
“Successor Entity” means one or more Person or Persons (or, if so elected by the Holder, the Company
or Parent Entity) formed by, resulting from or surviving any Fundamental Transaction or one or more Person or Persons (or, if so
elected by the Holder, the Company or the Parent Entity) with which such Fundamental Transaction shall have been entered into.

 

(mm)      
“Trading Day” means any day on which the Common Stock is traded on the Principal Market, or, if the Principal
Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market
on which the Common Stock is then traded; provided that “Trading Day” shall not include any day on which the Common
Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from
trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance
the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York Time) unless such
day is otherwise designated as a Trading Day in writing by the Holder.

 

    	 	A-35	 

     

    

(nn)          
“Voting Stock” of a Person means capital stock of such Person of the class or classes pursuant to which
the holders thereof have the general voting power to elect, or the general power to appoint, at least a majority of the board of
directors, managers, trustees or other similar governing body of such Person (irrespective of whether or not at the time capital
stock of any other class or classes shall have or might have voting power by reason of the happening of any contingency).

 

(oo)          
“Weighted Average Price” means, for any security as of any date, the dollar volume-weighted average price
for such security on the Principal Market during the period beginning at 9:30:01 a.m., New York Time (or such other time as the
Principal Market publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York Time (or such other
time as the Principal Market publicly announces is the official close of trading) as reported by Bloomberg through its “Volume
at Price” functions, or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the
over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York
Time (or such other time as such market publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York
Time (or such other time as such market publicly announces is the official close of trading) as reported by Bloomberg, or, if no
dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing
bid price and the lowest closing ask price of any of the market makers for such security as reported in the OTC Link or “pink
sheets” by OTC Markets Group Inc. (formerly Pink OTC Markets Inc.). If the Weighted Average Price cannot be calculated for
a security on a particular date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be
the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon
the fair market value of such security, then such dispute shall be resolved pursuant to Section 21. All such determinations to
be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction during
the applicable calculation period.

 

[Signature Page Follows]

 

 

 

    	 	A-36	 

     

    

IN WITNESS WHEREOF, the Company has caused this
Note to be duly executed as of the Issuance Date set out above.

 

 

	 	Amyris, Inc.

                                                                  

                                                                  

                                                                  

	 	By:   _________________________________
	 	Name:
	 	Title:

 

 

 

 

 

 

 

 

 

 

     

     

    

EXHIBIT I

AMYRIS, inc.

 

 

CONVERSION NOTICE

 

Reference is made to the Senior Convertible Note (the “Note”)
issued to the undersigned by Amyris, Inc., a Delaware corporation (the “Company”). In accordance with and pursuant
to the Note, the undersigned hereby elects to convert the Conversion Amount (as defined in the Note) of the Note indicated below
into shares of Common Stock, par value $0.0001 per share (the “Common Stock”), of the Company, as of the date
specified below. Capitalized terms not defined herein shall have the meaning as set forth in the Note.

 

	Date of Conversion:	 
	Aggregate Conversion Amount to be converted:	 
	Please confirm the following information:
	Conversion Price:	 
	Number of shares of Common Stock to be issued:	 
	
        [_]    If
        this Conversion Notice is being delivered with respect to an Installment Conversion or an Acceleration, check here if Holder is
        electing to use the following Installment Conversion Price:____________ on the following date:_______________.

        Please issue the Common Stock into which the Note is being converted
        to Holder, or for its benefit, as follows:

	[_]    Check here if requesting delivery as a certificate to the
    following name and to the following address:
	Issue to:	 
	 	 
	 	 
	 	 
	[_]    Check here if requesting delivery by
    Deposit/Withdrawal at Custodian as follows:
	DTC Participant:	 
	DTC Number:	 
	 	 	 	 	 	 	 	 	 

     

     

    

	Account Number:	 
	Installment Amounts to be reduced (or accelerated) and amount of reduction (or acceleration): ___________________________	 
	 	 	 	 	 	 	 	 	 

 

 

	
        Date: _____________ __,           

         

        _________________________

Name of Registered Holder

         

         

         

	
        By:  _____________________

        Name:

        Title:

        

         

        Tax ID:_____________________

         

        Facsimile:___________________

         

	 

 

 

 

 

 

     

     

    

[INSERT AMYRIS, INC. LETTERHEAD]

 

 

ACKNOWLEDGMENT AND INSTRUCTION LETTER

 

 

 

The Company hereby acknowledges this Conversion
Notice and hereby directs Wells Fargo Shareowner Services to issue the above indicated number of shares of Common Stock in accordance
with the Transfer Agent Instructions dated [__________], 2017 from the Company and acknowledged and agreed to by Wells Fargo Shareowner
Services.

 

 

	 	Amyris, Inc.

                                                                   

                                                                   

	 	By:   _________________________________
	 	Name:
	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]